|
{ |
|
"id": "H00026", |
|
"disease": { |
|
"id": "H00026", |
|
"names": [ |
|
"Endometrial cancer" |
|
], |
|
"dbLinks": { |
|
"icd10": [ |
|
"C54" |
|
], |
|
"mesh": [ |
|
"D016889" |
|
] |
|
}, |
|
"category": "Cancer" |
|
}, |
|
"riskFactors": [ |
|
{ |
|
"text": "dyslipidemia", |
|
"score": 14.31306266784668, |
|
"articlesIDs": [ |
|
"30788634", |
|
"32190316", |
|
"37149578" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes and hypertension, and increased endometrial thickness", |
|
"score": 14.243288040161133, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "women with 2 or more episodes of postmenopausal bleeding", |
|
"score": 14.20191764831543, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "decreased serum adiponectin or increased visfatin levels", |
|
"score": 14.19981575012207, |
|
"articlesIDs": [ |
|
"30702161" |
|
] |
|
}, |
|
{ |
|
"text": "hyperlipidemia", |
|
"score": 14.1859712600708, |
|
"articlesIDs": [ |
|
"34703315", |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "prolonged menstrual cycle, decreased shbg, and dyslipidemia", |
|
"score": 14.162583351135254, |
|
"articlesIDs": [ |
|
"37149578" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickness ≥ 1.15 cm, and color doppler flow imaging blood flow", |
|
"score": 14.156980514526367, |
|
"articlesIDs": [ |
|
"36827011" |
|
] |
|
}, |
|
{ |
|
"text": "family history of gynecological malignancies", |
|
"score": 14.138118743896484, |
|
"articlesIDs": [ |
|
"36827011" |
|
] |
|
}, |
|
{ |
|
"text": "vaginal bleeding, family history of gynecological malignancies", |
|
"score": 14.126276969909668, |
|
"articlesIDs": [ |
|
"36827011" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, prolonged menstrual cycle, decreased shbg, and dyslipidemia", |
|
"score": 14.117377281188965, |
|
"articlesIDs": [ |
|
"37149578" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, hyperlipidemia", |
|
"score": 14.098164558410645, |
|
"articlesIDs": [ |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "multifetal pregnancy", |
|
"score": 14.074357986450195, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "family history of gynecological malignancies, endometrial thickness ≥ 1.15 cm", |
|
"score": 14.07432746887207, |
|
"articlesIDs": [ |
|
"36827011" |
|
] |
|
}, |
|
{ |
|
"text": "preeclampsia", |
|
"score": 14.06412124633789, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, vaginal bleeding, family history of gynecological malignancies", |
|
"score": 14.063129425048828, |
|
"articlesIDs": [ |
|
"36827011" |
|
] |
|
}, |
|
{ |
|
"text": "delivery of a large-for-gestational-age infant, and preeclampsia", |
|
"score": 14.054117202758789, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "multiparity, multifetal pregnancy", |
|
"score": 14.050146102905273, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes mellitus", |
|
"score": 14.03704833984375, |
|
"articlesIDs": [ |
|
"31203571", |
|
"32527101", |
|
"36042597", |
|
"29454147" |
|
] |
|
}, |
|
{ |
|
"text": "thyroid cancer", |
|
"score": 14.036023139953613, |
|
"articlesIDs": [ |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "thyroid cancer and liver cancer", |
|
"score": 14.009960174560547, |
|
"articlesIDs": [ |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "hyperlipidemia, thyroid cancer", |
|
"score": 13.982604026794434, |
|
"articlesIDs": [ |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "advanced maternal age, multiparity, multifetal pregnancy", |
|
"score": 13.958355903625488, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "hyperlipidemia, thyroid cancer and liver cancer", |
|
"score": 13.956541061401367, |
|
"articlesIDs": [ |
|
"35927682" |
|
] |
|
}, |
|
{ |
|
"text": "elevated levels of ca125", |
|
"score": 13.946386337280273, |
|
"articlesIDs": [ |
|
"36453189" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding", |
|
"score": 13.918211936950684, |
|
"articlesIDs": [ |
|
"35753596", |
|
"31874475", |
|
"32233174", |
|
"32360632", |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "multifetal pregnancy, cesarean section", |
|
"score": 13.917360305786133, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "people with type 2 diabetes", |
|
"score": 13.909994125366211, |
|
"articlesIDs": [ |
|
"36690836" |
|
] |
|
}, |
|
{ |
|
"text": "multiparity, multifetal pregnancy, cesarean section", |
|
"score": 13.893148422241211, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding, increased endometrial thickness", |
|
"score": 13.866397857666016, |
|
"articlesIDs": [ |
|
"32233174" |
|
] |
|
}, |
|
{ |
|
"text": "clomiphene citrate", |
|
"score": 13.865784645080566, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "chemotherapy for bc", |
|
"score": 13.861242294311523, |
|
"articlesIDs": [ |
|
"32233174" |
|
] |
|
}, |
|
{ |
|
"text": "cesarean section, delivery of a large-for-gestational-age infant", |
|
"score": 13.856734275817871, |
|
"articlesIDs": [ |
|
"30921436" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic ln involvement", |
|
"score": 13.817849159240723, |
|
"articlesIDs": [ |
|
"28523533" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovarian syndrome (pcos)", |
|
"score": 13.807207107543945, |
|
"articlesIDs": [ |
|
"33337742", |
|
"31485206", |
|
"37172411" |
|
] |
|
}, |
|
{ |
|
"text": "longer time after last menstrual period", |
|
"score": 13.796751022338867, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "increased endometrial thickness, and chemotherapy for bc", |
|
"score": 13.759639739990234, |
|
"articlesIDs": [ |
|
"32233174" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome (pcos)", |
|
"score": 13.751945495605469, |
|
"articlesIDs": [ |
|
"32103691", |
|
"30278576", |
|
"34822059", |
|
"34288042", |
|
"33645403", |
|
"34872233", |
|
"32747035", |
|
"29741763", |
|
"28901968", |
|
"35686317", |
|
"34617616", |
|
"31657237", |
|
"31420039", |
|
"36243118", |
|
"34268601", |
|
"37395825" |
|
] |
|
}, |
|
{ |
|
"text": "large mass size, longer time after last menstrual period", |
|
"score": 13.738365173339844, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion (mmi)", |
|
"score": 13.733566284179688, |
|
"articlesIDs": [ |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "elevated baseline serum ca 125 levels, deep myometrial invasion (mmi)", |
|
"score": 13.723037719726562, |
|
"articlesIDs": [ |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "lymph node metastasis, and elevated levels of ca125", |
|
"score": 13.720964431762695, |
|
"articlesIDs": [ |
|
"36453189" |
|
] |
|
}, |
|
{ |
|
"text": "women with a first hospital-diagnosed postmenopausal bleeding", |
|
"score": 13.714292526245117, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "those who had either diabetes or hypertension", |
|
"score": 13.695651054382324, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "thickening endometrium", |
|
"score": 13.684795379638672, |
|
"articlesIDs": [ |
|
"31874475" |
|
] |
|
}, |
|
{ |
|
"text": "malat1 rs664589 c\u003eg polymorphism", |
|
"score": 13.672648429870605, |
|
"articlesIDs": [ |
|
"31880028" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion, lymph node metastasis, and elevated levels of ca125", |
|
"score": 13.661186218261719, |
|
"articlesIDs": [ |
|
"36453189" |
|
] |
|
}, |
|
{ |
|
"text": "hyperglycemia", |
|
"score": 13.641153335571289, |
|
"articlesIDs": [ |
|
"32547697", |
|
"34703315", |
|
"35785211", |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "endometriosis", |
|
"score": 13.630992889404297, |
|
"articlesIDs": [ |
|
"34199930", |
|
"36357191", |
|
"29742675", |
|
"34502183", |
|
"33415752", |
|
"34268601" |
|
] |
|
}, |
|
{ |
|
"text": "dyslipidaemia", |
|
"score": 13.60931396484375, |
|
"articlesIDs": [ |
|
"30286675" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion (mmi), adnexal involvement", |
|
"score": 13.594432830810547, |
|
"articlesIDs": [ |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparity", |
|
"score": 13.567828178405762, |
|
"articlesIDs": [ |
|
"33608145", |
|
"33118172", |
|
"33438376", |
|
"32630728" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension, hyperglycemia", |
|
"score": 13.563261032104492, |
|
"articlesIDs": [ |
|
"34703315" |
|
] |
|
}, |
|
{ |
|
"text": "age at menopause", |
|
"score": 13.554750442504883, |
|
"articlesIDs": [ |
|
"31275987" |
|
] |
|
}, |
|
{ |
|
"text": "longer time after last menstrual period, and older age", |
|
"score": 13.54197883605957, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "higher body mass index, higher plasminogen activator inhibitor-1 (pai-1)", |
|
"score": 13.533384323120117, |
|
"articlesIDs": [ |
|
"35615721" |
|
] |
|
}, |
|
{ |
|
"text": "uterine fibroids", |
|
"score": 13.530366897583008, |
|
"articlesIDs": [ |
|
"34268601", |
|
"35615721" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension and dyslipidaemia", |
|
"score": 13.524749755859375, |
|
"articlesIDs": [ |
|
"30286675" |
|
] |
|
}, |
|
{ |
|
"text": "mi ≥ 50%", |
|
"score": 13.521312713623047, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": "patients with mild-to-moderate ckd", |
|
"score": 13.52090072631836, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "squamous epithelial differentiation", |
|
"score": 13.520212173461914, |
|
"articlesIDs": [ |
|
"28448305" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes and high bmi", |
|
"score": 13.51517105102539, |
|
"articlesIDs": [ |
|
"29195904", |
|
"29803268" |
|
] |
|
}, |
|
{ |
|
"text": "blood type o", |
|
"score": 13.51170539855957, |
|
"articlesIDs": [ |
|
"36606697" |
|
] |
|
}, |
|
{ |
|
"text": "history of endometrial hyperplasia", |
|
"score": 13.506879806518555, |
|
"articlesIDs": [ |
|
"33912318" |
|
] |
|
}, |
|
{ |
|
"text": "african american race, greater bmi/weight gain", |
|
"score": 13.503355979919434, |
|
"articlesIDs": [ |
|
"31897901" |
|
] |
|
}, |
|
{ |
|
"text": "infertility, nulliparity", |
|
"score": 13.498173713684082, |
|
"articlesIDs": [ |
|
"32630728" |
|
] |
|
}, |
|
{ |
|
"text": "positive peritoneal cytology", |
|
"score": 13.492805480957031, |
|
"articlesIDs": [ |
|
"31435773", |
|
"35225474", |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "type 2 diabetes, uterine fibroids", |
|
"score": 13.490351676940918, |
|
"articlesIDs": [ |
|
"35615721" |
|
] |
|
}, |
|
{ |
|
"text": "increased blood cadmium concentration", |
|
"score": 13.483682632446289, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "large mass size, longer time after last menstrual period, and older age", |
|
"score": 13.483592987060547, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "higher levels of cancer antigen 125 (ca 125)", |
|
"score": 13.483373641967773, |
|
"articlesIDs": [ |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "current use of estrogen-only and estrogen plus progestin fmh", |
|
"score": 13.483068466186523, |
|
"articlesIDs": [ |
|
"29475971" |
|
] |
|
}, |
|
{ |
|
"text": "older age and obesity", |
|
"score": 13.469247817993164, |
|
"articlesIDs": [ |
|
"29741696" |
|
] |
|
}, |
|
{ |
|
"text": "uterine fibroids, higher body mass index", |
|
"score": 13.459525108337402, |
|
"articlesIDs": [ |
|
"35615721" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal status", |
|
"score": 13.458089828491211, |
|
"articlesIDs": [ |
|
"33118172", |
|
"31844128", |
|
"35054175", |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "clomiphene citrate exposure in nulliparous women", |
|
"score": 13.440364837646484, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion, positive peritoneal cytology, and lvsi", |
|
"score": 13.432126998901367, |
|
"articlesIDs": [ |
|
"31435773" |
|
] |
|
}, |
|
{ |
|
"text": "spec patients having greater than a 10-year interval from prior malignancy", |
|
"score": 13.430994033813477, |
|
"articlesIDs": [ |
|
"32620620" |
|
] |
|
}, |
|
{ |
|
"text": "younger age at menarche, late age at menopause, infertility, nulliparity", |
|
"score": 13.429712295532227, |
|
"articlesIDs": [ |
|
"32630728" |
|
] |
|
}, |
|
{ |
|
"text": "mu/ow", |
|
"score": 13.426950454711914, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "type 2 diabetes, uterine fibroids, higher body mass index", |
|
"score": 13.419509887695312, |
|
"articlesIDs": [ |
|
"35615721" |
|
] |
|
}, |
|
{ |
|
"text": "african american race, greater bmi/weight gain, and tamoxifen treatment", |
|
"score": 13.414989471435547, |
|
"articlesIDs": [ |
|
"31897901" |
|
] |
|
}, |
|
{ |
|
"text": "adnexal involvement and positive peritoneal cytology", |
|
"score": 13.412519454956055, |
|
"articlesIDs": [ |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, type 2 diabetes, hypertension and dyslipidaemia", |
|
"score": 13.409557342529297, |
|
"articlesIDs": [ |
|
"30286675" |
|
] |
|
}, |
|
{ |
|
"text": "women with the polycystic ovarian syndrome (pcos)", |
|
"score": 13.407943725585938, |
|
"articlesIDs": [ |
|
"33337742" |
|
] |
|
}, |
|
{ |
|
"text": "gonadotropin-releasing hormone agonist use", |
|
"score": 13.399744987487793, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology", |
|
"score": 13.390518188476562, |
|
"articlesIDs": [ |
|
"37386310", |
|
"32905281", |
|
"31435773", |
|
"36316771", |
|
"34078319" |
|
] |
|
}, |
|
{ |
|
"text": "chronic anovulation, and polycystic ovarian syndrome", |
|
"score": 13.380430221557617, |
|
"articlesIDs": [ |
|
"36357974" |
|
] |
|
}, |
|
{ |
|
"text": "patients with diabetes", |
|
"score": 13.3765230178833, |
|
"articlesIDs": [ |
|
"32392663" |
|
] |
|
}, |
|
{ |
|
"text": "young adulthood obesity", |
|
"score": 13.362258911132812, |
|
"articlesIDs": [ |
|
"37029916" |
|
] |
|
}, |
|
{ |
|
"text": "women with pcos", |
|
"score": 13.356502532958984, |
|
"articlesIDs": [ |
|
"32103691", |
|
"30278576", |
|
"34288042", |
|
"33645403", |
|
"28901968", |
|
"32747035", |
|
"29741763", |
|
"31485206", |
|
"31657237", |
|
"31420039" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial infiltration, lymph node metastasis", |
|
"score": 13.354009628295898, |
|
"articlesIDs": [ |
|
"36453189" |
|
] |
|
}, |
|
{ |
|
"text": "longer exposure to overweight and obesity across a lifetime", |
|
"score": 13.344710350036621, |
|
"articlesIDs": [ |
|
"34962692" |
|
] |
|
}, |
|
{ |
|
"text": "tamoxifen use", |
|
"score": 13.344388961791992, |
|
"articlesIDs": [ |
|
"36916539" |
|
] |
|
}, |
|
{ |
|
"text": "higher preoperative levels of serum he4 and ca125", |
|
"score": 13.341737747192383, |
|
"articlesIDs": [ |
|
"31435773" |
|
] |
|
}, |
|
{ |
|
"text": "comorbid conditions like pcos-obesity", |
|
"score": 13.334446907043457, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "use of nsaids", |
|
"score": 13.324265480041504, |
|
"articlesIDs": [ |
|
"28376204" |
|
] |
|
}, |
|
{ |
|
"text": "age at bca diagnosis \u003e 50 years", |
|
"score": 13.318652153015137, |
|
"articlesIDs": [ |
|
"31897901" |
|
] |
|
}, |
|
{ |
|
"text": "mi ≥ 50%, nonendometrioid histology", |
|
"score": 13.314366340637207, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": "type 2 diabetes mellitus (t2dm)", |
|
"score": 13.312522888183594, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology, deep myometrial invasion", |
|
"score": 13.312517166137695, |
|
"articlesIDs": [ |
|
"31435773" |
|
] |
|
}, |
|
{ |
|
"text": "hyperglycemia and subsequently t2dm", |
|
"score": 13.31141471862793, |
|
"articlesIDs": [ |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "decline in gfr", |
|
"score": 13.306644439697266, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "increasing age, postmenopausal status", |
|
"score": 13.298210144042969, |
|
"articlesIDs": [ |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "patients with a history of polycystic ovary syndrome (pcos) and smoking", |
|
"score": 13.296228408813477, |
|
"articlesIDs": [ |
|
"31226466" |
|
] |
|
}, |
|
{ |
|
"text": "older people with type 2 diabetes", |
|
"score": 13.293341636657715, |
|
"articlesIDs": [ |
|
"36690836" |
|
] |
|
}, |
|
{ |
|
"text": "reduced gfr. patients with mild-to-moderate ckd", |
|
"score": 13.290766716003418, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "large tumor size, and deep myometrial invasion", |
|
"score": 13.280381202697754, |
|
"articlesIDs": [ |
|
"28448305" |
|
] |
|
}, |
|
{ |
|
"text": "irregular menstruation in the past", |
|
"score": 13.274553298950195, |
|
"articlesIDs": [ |
|
"35013057" |
|
] |
|
}, |
|
{ |
|
"text": "higher preoperative levels of serum he4 and ca125, non-endometrioid histology", |
|
"score": 13.27418327331543, |
|
"articlesIDs": [ |
|
"31435773" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic ln metastasis", |
|
"score": 13.27398681640625, |
|
"articlesIDs": [ |
|
"28523533" |
|
] |
|
}, |
|
{ |
|
"text": "presence of diffuse lvsi", |
|
"score": 13.265045166015625, |
|
"articlesIDs": [ |
|
"33217679" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space invasion (lvsi)", |
|
"score": 13.260248184204102, |
|
"articlesIDs": [ |
|
"31324453", |
|
"30056447", |
|
"35225474", |
|
"28523533", |
|
"31373248" |
|
] |
|
}, |
|
{ |
|
"text": "women undergoing cholecystectomy", |
|
"score": 13.257597923278809, |
|
"articlesIDs": [ |
|
"35326635" |
|
] |
|
}, |
|
{ |
|
"text": "genetically predicted higher levels of vitc", |
|
"score": 13.253727912902832, |
|
"articlesIDs": [ |
|
"35402429" |
|
] |
|
}, |
|
{ |
|
"text": "women with blood type o", |
|
"score": 13.248533248901367, |
|
"articlesIDs": [ |
|
"36606697" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi), polycystic ovary syndrome (pcos)", |
|
"score": 13.246688842773438, |
|
"articlesIDs": [ |
|
"37395825" |
|
] |
|
}, |
|
{ |
|
"text": "age at bca diagnosis \u003e 50 years, african american race", |
|
"score": 13.24498462677002, |
|
"articlesIDs": [ |
|
"31897901" |
|
] |
|
}, |
|
{ |
|
"text": "patients with endometrial cancer", |
|
"score": 13.243349075317383, |
|
"articlesIDs": [ |
|
"30262383", |
|
"30718311", |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "hyperlipidemia are the main risk factors. hypertension, hyperglycemia", |
|
"score": 13.238515853881836, |
|
"articlesIDs": [ |
|
"34703315" |
|
] |
|
}, |
|
{ |
|
"text": "frequency of bleeding, diabetes and hypertension", |
|
"score": 13.236592292785645, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes mellitus (dm)", |
|
"score": 13.23542594909668, |
|
"articlesIDs": [ |
|
"36042597" |
|
] |
|
}, |
|
{ |
|
"text": "hormonal disorder pcos", |
|
"score": 13.230627059936523, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "highest dbp levels", |
|
"score": 13.223098754882812, |
|
"articlesIDs": [ |
|
"35622390" |
|
] |
|
}, |
|
{ |
|
"text": "women who reported infertility", |
|
"score": 13.214427947998047, |
|
"articlesIDs": [ |
|
"36849034" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal women with high/increasing et on tvs", |
|
"score": 13.21373176574707, |
|
"articlesIDs": [ |
|
"31614036" |
|
] |
|
}, |
|
{ |
|
"text": "family history of bc", |
|
"score": 13.206415176391602, |
|
"articlesIDs": [ |
|
"28562469" |
|
] |
|
}, |
|
{ |
|
"text": "increased body mass index (bmi)", |
|
"score": 13.204324722290039, |
|
"articlesIDs": [ |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal women with neh", |
|
"score": 13.19662094116211, |
|
"articlesIDs": [ |
|
"31389091" |
|
] |
|
}, |
|
{ |
|
"text": "bmi above 40", |
|
"score": 13.184633255004883, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal status, higher levels of ca 125", |
|
"score": 13.175622940063477, |
|
"articlesIDs": [ |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal vaginal bleeding", |
|
"score": 13.169025421142578, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "presence of lvsi and pelvic ln involvement", |
|
"score": 13.166007995605469, |
|
"articlesIDs": [ |
|
"28523533" |
|
] |
|
}, |
|
{ |
|
"text": "history of prior cesarean deliveries or sterilization", |
|
"score": 13.153396606445312, |
|
"articlesIDs": [ |
|
"28796675" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension and history of endometrial hyperplasia", |
|
"score": 13.153227806091309, |
|
"articlesIDs": [ |
|
"33912318" |
|
] |
|
}, |
|
{ |
|
"text": "myometrial invasion of 50% or greater and lvsi", |
|
"score": 13.151094436645508, |
|
"articlesIDs": [ |
|
"35225474" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, and polycystic ovary syndrome (pcos)", |
|
"score": 13.135997772216797, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "insulin levels", |
|
"score": 13.126066207885742, |
|
"articlesIDs": [ |
|
"29533014" |
|
] |
|
}, |
|
{ |
|
"text": "blood cadmium concentration above the median", |
|
"score": 13.1039457321167, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "codon 389 polymorphism of pict-1", |
|
"score": 13.102209091186523, |
|
"articlesIDs": [ |
|
"29617699" |
|
] |
|
}, |
|
{ |
|
"text": "uterine volume and weight \u003e 75th percentile and chemotherapy", |
|
"score": 13.098445892333984, |
|
"articlesIDs": [ |
|
"34183164" |
|
] |
|
}, |
|
{ |
|
"text": "visceral adiposity tissue", |
|
"score": 13.09382438659668, |
|
"articlesIDs": [ |
|
"33197987" |
|
] |
|
}, |
|
{ |
|
"text": "women with a family history of bc", |
|
"score": 13.08896255493164, |
|
"articlesIDs": [ |
|
"28562469" |
|
] |
|
}, |
|
{ |
|
"text": "bmi \u003e 40", |
|
"score": 13.083516120910645, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "free testosterone", |
|
"score": 13.083402633666992, |
|
"articlesIDs": [ |
|
"34363033" |
|
] |
|
}, |
|
{ |
|
"text": "young age, and history of prior cesarean deliveries or sterilization", |
|
"score": 13.083307266235352, |
|
"articlesIDs": [ |
|
"28796675" |
|
] |
|
}, |
|
{ |
|
"text": "higher circulating vitc at physiological levels", |
|
"score": 13.08029556274414, |
|
"articlesIDs": [ |
|
"35402429" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (bmi ≥ 27)", |
|
"score": 13.079721450805664, |
|
"articlesIDs": [ |
|
"35462044" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension and endometrial thickness", |
|
"score": 13.07694149017334, |
|
"articlesIDs": [ |
|
"36006486" |
|
] |
|
}, |
|
{ |
|
"text": "women at an age ≥ 51 years with complex naeh", |
|
"score": 13.075277328491211, |
|
"articlesIDs": [ |
|
"32945047" |
|
] |
|
}, |
|
{ |
|
"text": "those with masses over 1.5 cm in size", |
|
"score": 13.067367553710938, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "hyperinsulinemia and insulin resistance", |
|
"score": 13.05659294128418, |
|
"articlesIDs": [ |
|
"29434922" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome (pcos), anemia, infertility", |
|
"score": 13.051655769348145, |
|
"articlesIDs": [ |
|
"37395825" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, chronic anovulation, and polycystic ovarian syndrome", |
|
"score": 13.05127239227295, |
|
"articlesIDs": [ |
|
"36357974" |
|
] |
|
}, |
|
{ |
|
"text": "cbht use", |
|
"score": 13.048182487487793, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "elevated fasting glucose", |
|
"score": 13.047361373901367, |
|
"articlesIDs": [ |
|
"32360632" |
|
] |
|
}, |
|
{ |
|
"text": "symptomatology", |
|
"score": 13.04411792755127, |
|
"articlesIDs": [ |
|
"32527101" |
|
] |
|
}, |
|
{ |
|
"text": "genetic predispositions (eg, lynch syndrome)", |
|
"score": 13.042550086975098, |
|
"articlesIDs": [ |
|
"36357974" |
|
] |
|
}, |
|
{ |
|
"text": "long-term use of unopposed estrogens during hormone replacement therapy", |
|
"score": 13.042150497436523, |
|
"articlesIDs": [ |
|
"32630728" |
|
] |
|
}, |
|
{ |
|
"text": "rt, hpv", |
|
"score": 13.029647827148438, |
|
"articlesIDs": [ |
|
"35507749" |
|
] |
|
}, |
|
{ |
|
"text": "elevated level of ca125", |
|
"score": 13.026594161987305, |
|
"articlesIDs": [ |
|
"35054175" |
|
] |
|
}, |
|
{ |
|
"text": "mpo polymorphism", |
|
"score": 13.025611877441406, |
|
"articlesIDs": [ |
|
"29631687" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome", |
|
"score": 13.01850700378418, |
|
"articlesIDs": [ |
|
"31686413", |
|
"35785211", |
|
"29115033", |
|
"32439832", |
|
"27993480", |
|
"35276057", |
|
"32600790", |
|
"36981906", |
|
"29699953", |
|
"33258710", |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion, lymphovascular space invasion (lvsi)", |
|
"score": 13.01759147644043, |
|
"articlesIDs": [ |
|
"28523533" |
|
] |
|
}, |
|
{ |
|
"text": "squamous epithelial differentiation, large tumor size", |
|
"score": 13.016326904296875, |
|
"articlesIDs": [ |
|
"28448305" |
|
] |
|
}, |
|
{ |
|
"text": "increasing age, postmenopausal status, higher levels of ca 125", |
|
"score": 13.015741348266602, |
|
"articlesIDs": [ |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension (or 2.725, 95% ci 1.108-3.431) and severe hyperplasia", |
|
"score": 13.01451587677002, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "lymphadenectomy (or = 4.00; 95% ci, 1.89-8.46; p \u003c 0.001), bmi \u003e 40", |
|
"score": 13.012788772583008, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "weight gain (≥ 10 pounds)", |
|
"score": 13.009445190429688, |
|
"articlesIDs": [ |
|
"28165909" |
|
] |
|
}, |
|
{ |
|
"text": "genetic predispositions (eg, lynch syndrome), obesity", |
|
"score": 12.99899673461914, |
|
"articlesIDs": [ |
|
"36357974" |
|
] |
|
}, |
|
{ |
|
"text": "having a higher body mass index (bmi) at baseline or age 21 years", |
|
"score": 12.991157531738281, |
|
"articlesIDs": [ |
|
"33723396" |
|
] |
|
}, |
|
{ |
|
"text": "lymphadenectomy, bmi above 40", |
|
"score": 12.988958358764648, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "bmi and polycystic ovarian syndrome (pcos)", |
|
"score": 12.987000465393066, |
|
"articlesIDs": [ |
|
"37172411" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome, oral contraceptives, and tamoxifen", |
|
"score": 12.985786437988281, |
|
"articlesIDs": [ |
|
"32630728" |
|
] |
|
}, |
|
{ |
|
"text": "women with a bmi ≥30 kg/m", |
|
"score": 12.98243236541748, |
|
"articlesIDs": [ |
|
"34223280" |
|
] |
|
}, |
|
{ |
|
"text": "severe obesity (bmi \u003e 35 kg/m2)", |
|
"score": 12.98214340209961, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "hyperuricemia, and hyperlipidemia", |
|
"score": 12.977733612060547, |
|
"articlesIDs": [ |
|
"34703315" |
|
] |
|
}, |
|
{ |
|
"text": "squamous differentiation", |
|
"score": 12.977265357971191, |
|
"articlesIDs": [ |
|
"31600211" |
|
] |
|
}, |
|
{ |
|
"text": "high histologic grade (g2-g3)", |
|
"score": 12.97159194946289, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "report of ec in ≥1 first- or second-degree relative", |
|
"score": 12.965766906738281, |
|
"articlesIDs": [ |
|
"28822557" |
|
] |
|
}, |
|
{ |
|
"text": "a history of infertility", |
|
"score": 12.961831092834473, |
|
"articlesIDs": [ |
|
"36849034" |
|
] |
|
}, |
|
{ |
|
"text": "age \u003e60 years", |
|
"score": 12.94916820526123, |
|
"articlesIDs": [ |
|
"29454147", |
|
"32640199" |
|
] |
|
}, |
|
{ |
|
"text": "higher dietary inflammatory and insulinemic potential", |
|
"score": 12.942802429199219, |
|
"articlesIDs": [ |
|
"36515492" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome (pcos), anemia, infertility, menostaxis, aub type", |
|
"score": 12.939159393310547, |
|
"articlesIDs": [ |
|
"37395825" |
|
] |
|
}, |
|
{ |
|
"text": "women with bc", |
|
"score": 12.937118530273438, |
|
"articlesIDs": [ |
|
"28562469" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic disorders like t2dm and obesity, hormonal disorder pcos", |
|
"score": 12.935922622680664, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "obesity in adulthood", |
|
"score": 12.932382583618164, |
|
"articlesIDs": [ |
|
"37029916" |
|
] |
|
}, |
|
{ |
|
"text": "higher bmi categories (25-27.4 and ≥ 27.5 kg/m)", |
|
"score": 12.931987762451172, |
|
"articlesIDs": [ |
|
"34880165" |
|
] |
|
}, |
|
{ |
|
"text": "elevated body mass index (bmi)", |
|
"score": 12.928548812866211, |
|
"articlesIDs": [ |
|
"35436960", |
|
"37290247", |
|
"29706522" |
|
] |
|
}, |
|
{ |
|
"text": "older age and higher body weight measures", |
|
"score": 12.925326347351074, |
|
"articlesIDs": [ |
|
"31897901" |
|
] |
|
}, |
|
{ |
|
"text": "polypoid mass-like lesions", |
|
"score": 12.924905776977539, |
|
"articlesIDs": [ |
|
"35013057" |
|
] |
|
}, |
|
{ |
|
"text": "relatively high scb intake", |
|
"score": 12.918693542480469, |
|
"articlesIDs": [ |
|
"33220638" |
|
] |
|
}, |
|
{ |
|
"text": "pten loss in eh", |
|
"score": 12.918082237243652, |
|
"articlesIDs": [ |
|
"30915635" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi), polycystic ovary syndrome (pcos), anemia, infertility", |
|
"score": 12.912999153137207, |
|
"articlesIDs": [ |
|
"37395825" |
|
] |
|
}, |
|
{ |
|
"text": "women with endometriosis", |
|
"score": 12.904958724975586, |
|
"articlesIDs": [ |
|
"36357191" |
|
] |
|
}, |
|
{ |
|
"text": "elevated agr2", |
|
"score": 12.90212345123291, |
|
"articlesIDs": [ |
|
"28402678" |
|
] |
|
}, |
|
{ |
|
"text": "myomas with a transverse diameter of ≥5 cm", |
|
"score": 12.898785591125488, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "rt, hpv, and smoking", |
|
"score": 12.898143768310547, |
|
"articlesIDs": [ |
|
"35507749" |
|
] |
|
}, |
|
{ |
|
"text": "a bmi ≥ 25 kg/m", |
|
"score": 12.89397144317627, |
|
"articlesIDs": [ |
|
"34880165" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index and waist-to-hip ratio", |
|
"score": 12.890966415405273, |
|
"articlesIDs": [ |
|
"30387875" |
|
] |
|
}, |
|
{ |
|
"text": "early age at menarche (\u003c11 vs. 12-13 years", |
|
"score": 12.889760971069336, |
|
"articlesIDs": [ |
|
"28361447" |
|
] |
|
}, |
|
{ |
|
"text": "higher levels of ca 125, larger endometrioma, and long-standing disease", |
|
"score": 12.882499694824219, |
|
"articlesIDs": [ |
|
"33415752" |
|
] |
|
}, |
|
{ |
|
"text": "arg399gln and arg194trp", |
|
"score": 12.880925178527832, |
|
"articlesIDs": [ |
|
"34918657", |
|
"28391259" |
|
] |
|
}, |
|
{ |
|
"text": "current smokers", |
|
"score": 12.876962661743164, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome, in particular central adiposity", |
|
"score": 12.875480651855469, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "thicker et", |
|
"score": 12.86816120147705, |
|
"articlesIDs": [ |
|
"35013057" |
|
] |
|
}, |
|
{ |
|
"text": "compounded bioidentical ht (cbht) use", |
|
"score": 12.867244720458984, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "ag genotype", |
|
"score": 12.866336822509766, |
|
"articlesIDs": [ |
|
"29631687" |
|
] |
|
}, |
|
{ |
|
"text": "malignant peritoneal cytology", |
|
"score": 12.862884521484375, |
|
"articlesIDs": [ |
|
"32690393" |
|
] |
|
}, |
|
{ |
|
"text": "lower uterine segment involvement, lymphovascular space invasion (lvsi)", |
|
"score": 12.86136245727539, |
|
"articlesIDs": [ |
|
"35225474" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (4.1% vs. 2.7%, p = 0.044, or = 1.55), and elevated fasting glucose", |
|
"score": 12.858894348144531, |
|
"articlesIDs": [ |
|
"32360632" |
|
] |
|
}, |
|
{ |
|
"text": "espen2 malnutrition", |
|
"score": 12.853425979614258, |
|
"articlesIDs": [ |
|
"35241292" |
|
] |
|
}, |
|
{ |
|
"text": "hyperuricemia, and hyperlipidemia are the main risk factors. hypertension", |
|
"score": 12.851534843444824, |
|
"articlesIDs": [ |
|
"34703315" |
|
] |
|
}, |
|
{ |
|
"text": "increased bmi", |
|
"score": 12.848514556884766, |
|
"articlesIDs": [ |
|
"32981178" |
|
] |
|
}, |
|
{ |
|
"text": "suspicious peritoneal cytology", |
|
"score": 12.848396301269531, |
|
"articlesIDs": [ |
|
"34118157" |
|
] |
|
}, |
|
{ |
|
"text": "deeper myometrial invasion", |
|
"score": 12.845499038696289, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "higher average concentrations of dbps (95th percentile: tthm , haa5 )", |
|
"score": 12.844594955444336, |
|
"articlesIDs": [ |
|
"35622390" |
|
] |
|
}, |
|
{ |
|
"text": "hogg1 ser326cys polymorphism", |
|
"score": 12.840806007385254, |
|
"articlesIDs": [ |
|
"33210702" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, diabetes and smoking", |
|
"score": 12.837390899658203, |
|
"articlesIDs": [ |
|
"33422300" |
|
] |
|
}, |
|
{ |
|
"text": "hyperglycemia and elevated ca199", |
|
"score": 12.834918975830078, |
|
"articlesIDs": [ |
|
"34703315" |
|
] |
|
}, |
|
{ |
|
"text": "higher agr2 expression", |
|
"score": 12.832837104797363, |
|
"articlesIDs": [ |
|
"28402678" |
|
] |
|
}, |
|
{ |
|
"text": "irregular menstruation in the past, have postmenopausal bleeding", |
|
"score": 12.830434799194336, |
|
"articlesIDs": [ |
|
"35013057" |
|
] |
|
}, |
|
{ |
|
"text": "women 55 or older", |
|
"score": 12.828179359436035, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "women with ovulatory dysfunction", |
|
"score": 12.825997352600098, |
|
"articlesIDs": [ |
|
"34223280" |
|
] |
|
}, |
|
{ |
|
"text": "mdm2 rs2279744 polymorphism", |
|
"score": 12.81661605834961, |
|
"articlesIDs": [ |
|
"29096752" |
|
] |
|
}, |
|
{ |
|
"text": "closer relatedness and younger ec diagnosis age in ≥1 relative", |
|
"score": 12.816230773925781, |
|
"articlesIDs": [ |
|
"28822557" |
|
] |
|
}, |
|
{ |
|
"text": "at least two prior cesarean deliveries", |
|
"score": 12.814274787902832, |
|
"articlesIDs": [ |
|
"28796675" |
|
] |
|
}, |
|
{ |
|
"text": "positive lvsi, and high histologic grade (g2-g3)", |
|
"score": 12.807321548461914, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "patients at an age ≥ 51 years with complex naeh", |
|
"score": 12.806771278381348, |
|
"articlesIDs": [ |
|
"32945047" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal bleeding, endometrial thickness≥5 mm", |
|
"score": 12.801042556762695, |
|
"articlesIDs": [ |
|
"36973218" |
|
] |
|
}, |
|
{ |
|
"text": "cervical involvement, adnexal involvement, lower uterine segment involvement", |
|
"score": 12.798484802246094, |
|
"articlesIDs": [ |
|
"35225474" |
|
] |
|
}, |
|
{ |
|
"text": "selective estrogen receptor modulator (serm) after gynecological surgery", |
|
"score": 12.791082382202148, |
|
"articlesIDs": [ |
|
"31874475" |
|
] |
|
}, |
|
{ |
|
"text": "thick endometrium (≥7 mm)", |
|
"score": 12.78989028930664, |
|
"articlesIDs": [ |
|
"29741763" |
|
] |
|
}, |
|
{ |
|
"text": "history of sterilization", |
|
"score": 12.788238525390625, |
|
"articlesIDs": [ |
|
"28796675" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding, age \u003e 60 years", |
|
"score": 12.786577224731445, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparous status", |
|
"score": 12.783775329589844, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "exposure to any ovary-stimulating drug", |
|
"score": 12.7822265625, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "grade 2 disease", |
|
"score": 12.781208992004395, |
|
"articlesIDs": [ |
|
"36438921" |
|
] |
|
}, |
|
{ |
|
"text": "women whose menopausal age over 46.5 years old", |
|
"score": 12.779980659484863, |
|
"articlesIDs": [ |
|
"31275987" |
|
] |
|
}, |
|
{ |
|
"text": "had irregular menstruation in the past, have postmenopausal bleeding", |
|
"score": 12.777830123901367, |
|
"articlesIDs": [ |
|
"35013057" |
|
] |
|
}, |
|
{ |
|
"text": "ptd ≥ 20 mm", |
|
"score": 12.77724838256836, |
|
"articlesIDs": [ |
|
"30056447" |
|
] |
|
}, |
|
{ |
|
"text": "prolonged operative time, hysterectomy type, pelvic lymphadenectomy", |
|
"score": 12.776556968688965, |
|
"articlesIDs": [ |
|
"28643026" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding and thickening endometrium", |
|
"score": 12.77640438079834, |
|
"articlesIDs": [ |
|
"31874475" |
|
] |
|
}, |
|
{ |
|
"text": "measured peridiagnosis bmi", |
|
"score": 12.776232719421387, |
|
"articlesIDs": [ |
|
"34597394" |
|
] |
|
}, |
|
{ |
|
"text": "obesity in adulthood (or = 2.85, 95% ci = 2.47-3.29) and young adulthood", |
|
"score": 12.775179862976074, |
|
"articlesIDs": [ |
|
"37029916" |
|
] |
|
}, |
|
{ |
|
"text": "higher prediagnosis amh levels", |
|
"score": 12.770586967468262, |
|
"articlesIDs": [ |
|
"32252965" |
|
] |
|
}, |
|
{ |
|
"text": "lvi, stage, uterine volume and weight \u003e 75th percentile and chemotherapy", |
|
"score": 12.767391204833984, |
|
"articlesIDs": [ |
|
"34183164" |
|
] |
|
}, |
|
{ |
|
"text": "hydrometra", |
|
"score": 12.767191886901855, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic lymphadenectomy, non-β-lactam antibiotics", |
|
"score": 12.764480590820312, |
|
"articlesIDs": [ |
|
"28643026" |
|
] |
|
}, |
|
{ |
|
"text": "parous women exposed to clomiphene citrate", |
|
"score": 12.760311126708984, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "myometrial invasion of 50% or greater, vaginal involvement", |
|
"score": 12.754396438598633, |
|
"articlesIDs": [ |
|
"35225474" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding, age \u003e 60 years, and nulliparous status", |
|
"score": 12.752220153808594, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space invasion (lvsi), and positive peritoneal cytology", |
|
"score": 12.751504898071289, |
|
"articlesIDs": [ |
|
"35225474" |
|
] |
|
}, |
|
{ |
|
"text": "sii", |
|
"score": 12.75009822845459, |
|
"articlesIDs": [ |
|
"34992410" |
|
] |
|
}, |
|
{ |
|
"text": "current smoking", |
|
"score": 12.747416496276855, |
|
"articlesIDs": [ |
|
"33608145" |
|
] |
|
}, |
|
{ |
|
"text": "women with ovarian endometriosis", |
|
"score": 12.74659538269043, |
|
"articlesIDs": [ |
|
"29742675" |
|
] |
|
}, |
|
{ |
|
"text": "myometrial invasion, lvi, stage, uterine volume and weight \u003e 75th percentile", |
|
"score": 12.74615478515625, |
|
"articlesIDs": [ |
|
"34183164" |
|
] |
|
}, |
|
{ |
|
"text": "bmi above 40 and previous vte", |
|
"score": 12.74603271484375, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "scb intake in the highest tertile", |
|
"score": 12.74551773071289, |
|
"articlesIDs": [ |
|
"33220638" |
|
] |
|
}, |
|
{ |
|
"text": "mpo g+ genotype and ag genotype", |
|
"score": 12.745047569274902, |
|
"articlesIDs": [ |
|
"29631687" |
|
] |
|
}, |
|
{ |
|
"text": "polygenic susceptibility to cardiometabolic traits", |
|
"score": 12.74410343170166, |
|
"articlesIDs": [ |
|
"36846987" |
|
] |
|
}, |
|
{ |
|
"text": "advanced age, obesity, nulliparity", |
|
"score": 12.736001968383789, |
|
"articlesIDs": [ |
|
"33438376" |
|
] |
|
}, |
|
{ |
|
"text": "daily recreational screen time, particularly tv viewing", |
|
"score": 12.730949401855469, |
|
"articlesIDs": [ |
|
"32746843" |
|
] |
|
}, |
|
{ |
|
"text": "former smokers (ahr, 1.32, 95% ci, 1.14-1.54), current smokers", |
|
"score": 12.728185653686523, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "genetic predispositions (eg, lynch syndrome), obesity, chronic anovulation", |
|
"score": 12.726558685302734, |
|
"articlesIDs": [ |
|
"36357974" |
|
] |
|
}, |
|
{ |
|
"text": "proliferative endometrium histology", |
|
"score": 12.726415634155273, |
|
"articlesIDs": [ |
|
"32640199" |
|
] |
|
}, |
|
{ |
|
"text": "age younger than 35 years", |
|
"score": 12.723560333251953, |
|
"articlesIDs": [ |
|
"28796675" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding (aub)", |
|
"score": 12.72319221496582, |
|
"articlesIDs": [ |
|
"35793641", |
|
"32349386", |
|
"35753596", |
|
"29696944" |
|
] |
|
}, |
|
{ |
|
"text": "hysterectomy type, pelvic lymphadenectomy, non-β-lactam antibiotics", |
|
"score": 12.722099304199219, |
|
"articlesIDs": [ |
|
"28643026" |
|
] |
|
}, |
|
{ |
|
"text": "later age at first birth (≥30 vs. \u003c20 years", |
|
"score": 12.720648765563965, |
|
"articlesIDs": [ |
|
"28361447" |
|
] |
|
}, |
|
{ |
|
"text": "lower and higher birth weights", |
|
"score": 12.720202445983887, |
|
"articlesIDs": [ |
|
"29331371" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparity and the use of exogenous hormones", |
|
"score": 12.71136474609375, |
|
"articlesIDs": [ |
|
"33438376" |
|
] |
|
}, |
|
{ |
|
"text": "patients who additionally had radiation therapy and/or chemotherapy", |
|
"score": 12.710973739624023, |
|
"articlesIDs": [ |
|
"29741696" |
|
] |
|
}, |
|
{ |
|
"text": "clinical symptom of abnormal uterine bleeding and thickening endometrium", |
|
"score": 12.710561752319336, |
|
"articlesIDs": [ |
|
"31874475" |
|
] |
|
}, |
|
{ |
|
"text": "women with circulating leptin concentrations in the highest tertile", |
|
"score": 12.703392028808594, |
|
"articlesIDs": [ |
|
"32507648" |
|
] |
|
}, |
|
{ |
|
"text": "those classified as mu/nw", |
|
"score": 12.698286056518555, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "overweight and weight gain", |
|
"score": 12.696477890014648, |
|
"articlesIDs": [ |
|
"32963209" |
|
] |
|
}, |
|
{ |
|
"text": "patients who underwent rt after ec", |
|
"score": 12.688365936279297, |
|
"articlesIDs": [ |
|
"35058550" |
|
] |
|
}, |
|
{ |
|
"text": "at least 50% deep myometrial invasion", |
|
"score": 12.686765670776367, |
|
"articlesIDs": [ |
|
"33118165" |
|
] |
|
}, |
|
{ |
|
"text": "positive lymphonode metastasis", |
|
"score": 12.678910255432129, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "excess body fatness", |
|
"score": 12.678873062133789, |
|
"articlesIDs": [ |
|
"30935715" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal pap smear results", |
|
"score": 12.677077293395996, |
|
"articlesIDs": [ |
|
"31554386" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome (pcos) and uterine fibroids", |
|
"score": 12.676939964294434, |
|
"articlesIDs": [ |
|
"34268601" |
|
] |
|
}, |
|
{ |
|
"text": "sex steroid hormones", |
|
"score": 12.673454284667969, |
|
"articlesIDs": [ |
|
"35105367" |
|
] |
|
}, |
|
{ |
|
"text": "rural patients with more advanced stages of cancer", |
|
"score": 12.668083190917969, |
|
"articlesIDs": [ |
|
"31291920" |
|
] |
|
}, |
|
{ |
|
"text": "hyperandrogenaemia", |
|
"score": 12.664917945861816, |
|
"articlesIDs": [ |
|
"31485206" |
|
] |
|
}, |
|
{ |
|
"text": "bmi 1 year before diagnosis", |
|
"score": 12.66431713104248, |
|
"articlesIDs": [ |
|
"34597394" |
|
] |
|
}, |
|
{ |
|
"text": "women with than without endometriosis", |
|
"score": 12.661481857299805, |
|
"articlesIDs": [ |
|
"36357191" |
|
] |
|
}, |
|
{ |
|
"text": "progesterone receptor", |
|
"score": 12.659774780273438, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "estrogen receptor ( \u003c 0.001), progesterone receptor", |
|
"score": 12.654460906982422, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "albumin\u003c3.5", |
|
"score": 12.653141975402832, |
|
"articlesIDs": [ |
|
"35241292" |
|
] |
|
}, |
|
{ |
|
"text": "mets persistence", |
|
"score": 12.6514310836792, |
|
"articlesIDs": [ |
|
"37139668" |
|
] |
|
}, |
|
{ |
|
"text": "higher intakes of lcn3pufa", |
|
"score": 12.647594451904297, |
|
"articlesIDs": [ |
|
"36934308" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparity and diabetes", |
|
"score": 12.644123077392578, |
|
"articlesIDs": [ |
|
"33608145" |
|
] |
|
}, |
|
{ |
|
"text": "(bmi \u003e 30 and \u003c35 kg/m2)", |
|
"score": 12.63669204711914, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "smoking (15+g tobacco/day)", |
|
"score": 12.636493682861328, |
|
"articlesIDs": [ |
|
"32169796" |
|
] |
|
}, |
|
{ |
|
"text": "open surgery, lymphadenectomy", |
|
"score": 12.633455276489258, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "lifetime excess body weight", |
|
"score": 12.628410339355469, |
|
"articlesIDs": [ |
|
"35908000" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, advanced stage, prolonged operative time, hysterectomy type", |
|
"score": 12.624855041503906, |
|
"articlesIDs": [ |
|
"28643026" |
|
] |
|
}, |
|
{ |
|
"text": "nonendometrioid compared to endometrioid histology", |
|
"score": 12.621695518493652, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": "current long-term mht use", |
|
"score": 12.620534896850586, |
|
"articlesIDs": [ |
|
"30935715" |
|
] |
|
}, |
|
{ |
|
"text": "open surgery, lymphadenectomy, bmi above 40", |
|
"score": 12.619722366333008, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "lower selenium concentration", |
|
"score": 12.616205215454102, |
|
"articlesIDs": [ |
|
"35267933" |
|
] |
|
}, |
|
{ |
|
"text": "closer relatedness and younger age at ec diagnosis in relatives", |
|
"score": 12.614771842956543, |
|
"articlesIDs": [ |
|
"28822557" |
|
] |
|
}, |
|
{ |
|
"text": "patients with myomas and adenomyosis", |
|
"score": 12.61111068725586, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥25 kg/m2", |
|
"score": 12.603737831115723, |
|
"articlesIDs": [ |
|
"34183566" |
|
] |
|
}, |
|
{ |
|
"text": "(bmi \u003e 30 and \u003c35 kg/m2) and severe obesity (bmi \u003e 35 kg/m2)", |
|
"score": 12.591632843017578, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "presence of squamous differentiation", |
|
"score": 12.591103553771973, |
|
"articlesIDs": [ |
|
"31600211" |
|
] |
|
}, |
|
{ |
|
"text": "advanced age, obesity, nulliparity and the use of exogenous hormones", |
|
"score": 12.588804244995117, |
|
"articlesIDs": [ |
|
"33438376" |
|
] |
|
}, |
|
{ |
|
"text": "weight cycling", |
|
"score": 12.584500312805176, |
|
"articlesIDs": [ |
|
"30426278", |
|
"28069684" |
|
] |
|
}, |
|
{ |
|
"text": "number of lymph nodes with metastasis", |
|
"score": 12.568981170654297, |
|
"articlesIDs": [ |
|
"33101471" |
|
] |
|
}, |
|
{ |
|
"text": "elevated sii", |
|
"score": 12.56789493560791, |
|
"articlesIDs": [ |
|
"34992410" |
|
] |
|
}, |
|
{ |
|
"text": "elevated waist circumference (≥88 cm", |
|
"score": 12.557583808898926, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "mh/ow individuals", |
|
"score": 12.554525375366211, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "tg/hdl-c ratio", |
|
"score": 12.551474571228027, |
|
"articlesIDs": [ |
|
"30887645" |
|
] |
|
}, |
|
{ |
|
"text": "lymphadenectomy, bmi above 40 and previous vte", |
|
"score": 12.550357818603516, |
|
"articlesIDs": [ |
|
"31378374" |
|
] |
|
}, |
|
{ |
|
"text": "cdo1 δct≤8.4, and celf4 δct≤8.8", |
|
"score": 12.539562225341797, |
|
"articlesIDs": [ |
|
"36973218" |
|
] |
|
}, |
|
{ |
|
"text": "presence of lvsi and ptd ≥ 20 mm", |
|
"score": 12.532959938049316, |
|
"articlesIDs": [ |
|
"30056447" |
|
] |
|
}, |
|
{ |
|
"text": "greater consumption of dietary total folate, natural folate, b2, b6 and b12", |
|
"score": 12.532346725463867, |
|
"articlesIDs": [ |
|
"30544261" |
|
] |
|
}, |
|
{ |
|
"text": "deeper myometrial invasion, positive lymphonode metastasis", |
|
"score": 12.529540061950684, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "sii, ca125, ca153 and lvsi", |
|
"score": 12.527475357055664, |
|
"articlesIDs": [ |
|
"34992410" |
|
] |
|
}, |
|
{ |
|
"text": "ccl2-2518a/g (rs1024611) polymorphism", |
|
"score": 12.52342414855957, |
|
"articlesIDs": [ |
|
"29458367" |
|
] |
|
}, |
|
{ |
|
"text": "obstructive sleep apnoea, nonalcoholic fatty liver disease", |
|
"score": 12.519891738891602, |
|
"articlesIDs": [ |
|
"34617616" |
|
] |
|
}, |
|
{ |
|
"text": "elevated serum he4", |
|
"score": 12.519688606262207, |
|
"articlesIDs": [ |
|
"29463191" |
|
] |
|
}, |
|
{ |
|
"text": "systolic and diastolic blood pressure", |
|
"score": 12.518716812133789, |
|
"articlesIDs": [ |
|
"31189941" |
|
] |
|
}, |
|
{ |
|
"text": "menopausal status and patient bmi", |
|
"score": 12.515366554260254, |
|
"articlesIDs": [ |
|
"37630795" |
|
] |
|
}, |
|
{ |
|
"text": "presence of high-volume metastases in the pelvic lymph nodes", |
|
"score": 12.511564254760742, |
|
"articlesIDs": [ |
|
"31324453" |
|
] |
|
}, |
|
{ |
|
"text": "being diagnosed with metabolic syndrome", |
|
"score": 12.505407333374023, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "genetically predicted vitamin c levels", |
|
"score": 12.502228736877441, |
|
"articlesIDs": [ |
|
"36771310" |
|
] |
|
}, |
|
{ |
|
"text": "increasing lnym", |
|
"score": 12.485332489013672, |
|
"articlesIDs": [ |
|
"29782643" |
|
] |
|
}, |
|
{ |
|
"text": "presence of endocervical invasion", |
|
"score": 12.477607727050781, |
|
"articlesIDs": [ |
|
"31600211" |
|
] |
|
}, |
|
{ |
|
"text": "elevated concentrations of leptin, vaspin, and omentin-1", |
|
"score": 12.474291801452637, |
|
"articlesIDs": [ |
|
"29559794" |
|
] |
|
}, |
|
{ |
|
"text": "obesity and diabetes", |
|
"score": 12.473926544189453, |
|
"articlesIDs": [ |
|
"32489965", |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "television watching", |
|
"score": 12.469024658203125, |
|
"articlesIDs": [ |
|
"37148539" |
|
] |
|
}, |
|
{ |
|
"text": "number of removed lymph nodes", |
|
"score": 12.468597412109375, |
|
"articlesIDs": [ |
|
"33101471" |
|
] |
|
}, |
|
{ |
|
"text": "age, frequency of bleeding, diabetes and hypertension", |
|
"score": 12.468345642089844, |
|
"articlesIDs": [ |
|
"34566302" |
|
] |
|
}, |
|
{ |
|
"text": "intake of acrylamide", |
|
"score": 12.466583251953125, |
|
"articlesIDs": [ |
|
"31284691" |
|
] |
|
}, |
|
{ |
|
"text": "age greater than or equal to 60 years, stage iii/iv advanced disease", |
|
"score": 12.463656425476074, |
|
"articlesIDs": [ |
|
"32147891" |
|
] |
|
}, |
|
{ |
|
"text": "pcos patients", |
|
"score": 12.462911605834961, |
|
"articlesIDs": [ |
|
"34872233", |
|
"36243118", |
|
"35686317" |
|
] |
|
}, |
|
{ |
|
"text": "presence of lvsi, a primary tumor diameter of at least 3 cm", |
|
"score": 12.460540771484375, |
|
"articlesIDs": [ |
|
"33118165" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology, stages 3 and 4 disease", |
|
"score": 12.456165313720703, |
|
"articlesIDs": [ |
|
"32905281" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index \u003e35 kg/m", |
|
"score": 12.452306747436523, |
|
"articlesIDs": [ |
|
"32640199" |
|
] |
|
}, |
|
{ |
|
"text": "-2548 g/a snp of lep", |
|
"score": 12.449322700500488, |
|
"articlesIDs": [ |
|
"28964972" |
|
] |
|
}, |
|
{ |
|
"text": "women with diabetes", |
|
"score": 12.441404342651367, |
|
"articlesIDs": [ |
|
"29706522" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome (mets)", |
|
"score": 12.436915397644043, |
|
"articlesIDs": [ |
|
"37139668", |
|
"32439832", |
|
"30932741", |
|
"32489965", |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi, kg/m )", |
|
"score": 12.435773849487305, |
|
"articlesIDs": [ |
|
"32011733" |
|
] |
|
}, |
|
{ |
|
"text": "having an elevated waist circumference (≥88 cm", |
|
"score": 12.428380966186523, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "ca125 ≥ 35 u/ml", |
|
"score": 12.422906875610352, |
|
"articlesIDs": [ |
|
"35054175", |
|
"29296235" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes and the presence of other co-morbidities", |
|
"score": 12.419556617736816, |
|
"articlesIDs": [ |
|
"29706522" |
|
] |
|
}, |
|
{ |
|
"text": "reported ec in first- or second-degree relatives", |
|
"score": 12.415895462036133, |
|
"articlesIDs": [ |
|
"28822557" |
|
] |
|
}, |
|
{ |
|
"text": "a higher bmi and current long-term mht use", |
|
"score": 12.405794143676758, |
|
"articlesIDs": [ |
|
"30935715" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, smoking", |
|
"score": 12.402972221374512, |
|
"articlesIDs": [ |
|
"33422300" |
|
] |
|
}, |
|
{ |
|
"text": "number of years ovulating", |
|
"score": 12.40257740020752, |
|
"articlesIDs": [ |
|
"36320039" |
|
] |
|
}, |
|
{ |
|
"text": "the intake of acrylamide", |
|
"score": 12.397216796875, |
|
"articlesIDs": [ |
|
"31284691" |
|
] |
|
}, |
|
{ |
|
"text": "high grade; specific histological type", |
|
"score": 12.393976211547852, |
|
"articlesIDs": [ |
|
"35910482" |
|
] |
|
}, |
|
{ |
|
"text": "patients with abnormal uterine bleeding", |
|
"score": 12.393966674804688, |
|
"articlesIDs": [ |
|
"32360632" |
|
] |
|
}, |
|
{ |
|
"text": "gout drugs", |
|
"score": 12.393636703491211, |
|
"articlesIDs": [ |
|
"29427783" |
|
] |
|
}, |
|
{ |
|
"text": "lvsi of at least 50%", |
|
"score": 12.381587982177734, |
|
"articlesIDs": [ |
|
"33118165" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, smoking and diabetes", |
|
"score": 12.378011703491211, |
|
"articlesIDs": [ |
|
"33422300" |
|
] |
|
}, |
|
{ |
|
"text": "patients undergoing hormonal therapy", |
|
"score": 12.370386123657227, |
|
"articlesIDs": [ |
|
"28562469" |
|
] |
|
}, |
|
{ |
|
"text": "time since last menstrual period of over 15 days", |
|
"score": 12.362966537475586, |
|
"articlesIDs": [ |
|
"28816389" |
|
] |
|
}, |
|
{ |
|
"text": "deep mmi and elevated baseline serum ca 125 levels", |
|
"score": 12.36136531829834, |
|
"articlesIDs": [ |
|
"30419557" |
|
] |
|
}, |
|
{ |
|
"text": "higher creatinine-adjusted cadmium exposure", |
|
"score": 12.359847068786621, |
|
"articlesIDs": [ |
|
"28742092" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial cancer survivors", |
|
"score": 12.357320785522461, |
|
"articlesIDs": [ |
|
"29741696", |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "17-hydroxypregnenolone", |
|
"score": 12.351324081420898, |
|
"articlesIDs": [ |
|
"34465588" |
|
] |
|
}, |
|
{ |
|
"text": "recovered, developed, and persistent mets in postmenopausal women", |
|
"score": 12.351269721984863, |
|
"articlesIDs": [ |
|
"37139668" |
|
] |
|
}, |
|
{ |
|
"text": "increased visfatin (1.010, 1.003-1.017; p=0.042) levels", |
|
"score": 12.340095520019531, |
|
"articlesIDs": [ |
|
"30702161" |
|
] |
|
}, |
|
{ |
|
"text": "those \u003e80 years old", |
|
"score": 12.339591979980469, |
|
"articlesIDs": [ |
|
"34763940" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (body mass index (bmi) \u003e 25)", |
|
"score": 12.339014053344727, |
|
"articlesIDs": [ |
|
"34501584" |
|
] |
|
}, |
|
{ |
|
"text": "women at high risk (lynch syndrome)", |
|
"score": 12.335077285766602, |
|
"articlesIDs": [ |
|
"32205051" |
|
] |
|
}, |
|
{ |
|
"text": "women with a proliferative endometrium", |
|
"score": 12.333015441894531, |
|
"articlesIDs": [ |
|
"32640199" |
|
] |
|
}, |
|
{ |
|
"text": "diagnosis age, body mass index, and smoking (pack-years)", |
|
"score": 12.332603454589844, |
|
"articlesIDs": [ |
|
"35040017" |
|
] |
|
}, |
|
{ |
|
"text": "trunk fat:trunk fat free mass ratio", |
|
"score": 12.329357147216797, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "high dietary gi", |
|
"score": 12.32791519165039, |
|
"articlesIDs": [ |
|
"27986350" |
|
] |
|
}, |
|
{ |
|
"text": "patients with prior/concurrent oc", |
|
"score": 12.326468467712402, |
|
"articlesIDs": [ |
|
"32108150" |
|
] |
|
}, |
|
{ |
|
"text": "thai women with pcos and a thick endometrium (≥7 mm)", |
|
"score": 12.325380325317383, |
|
"articlesIDs": [ |
|
"29741763" |
|
] |
|
}, |
|
{ |
|
"text": "grade 3 tumor, deep myometrial invasion, lymphovascular space invasion (lvsi)", |
|
"score": 12.319523811340332, |
|
"articlesIDs": [ |
|
"28523533" |
|
] |
|
}, |
|
{ |
|
"text": "neutrophil (ne), monocyte (mo) counts, sii", |
|
"score": 12.315749168395996, |
|
"articlesIDs": [ |
|
"34992410" |
|
] |
|
}, |
|
{ |
|
"text": "weight increment ≥+5 kg since age 20", |
|
"score": 12.31316089630127, |
|
"articlesIDs": [ |
|
"32963209" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 30, current smoking", |
|
"score": 12.293277740478516, |
|
"articlesIDs": [ |
|
"33608145" |
|
] |
|
}, |
|
{ |
|
"text": "age \u003e65 years", |
|
"score": 12.288497924804688, |
|
"articlesIDs": [ |
|
"33232359" |
|
] |
|
}, |
|
{ |
|
"text": "elevated dii", |
|
"score": 12.286478996276855, |
|
"articlesIDs": [ |
|
"30887752" |
|
] |
|
}, |
|
{ |
|
"text": "each 5 kg/m increase in bmi", |
|
"score": 12.282674789428711, |
|
"articlesIDs": [ |
|
"37139871" |
|
] |
|
}, |
|
{ |
|
"text": "women with metabolic dysfunction", |
|
"score": 12.27859878540039, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal bleeding (pmb)", |
|
"score": 12.265986442565918, |
|
"articlesIDs": [ |
|
"36332539", |
|
"30083701", |
|
"35401014", |
|
"30234731", |
|
"31104512" |
|
] |
|
}, |
|
{ |
|
"text": "ercc2-751gln", |
|
"score": 12.260824203491211, |
|
"articlesIDs": [ |
|
"30194171" |
|
] |
|
}, |
|
{ |
|
"text": "normal weight women reporting cysts", |
|
"score": 12.259766578674316, |
|
"articlesIDs": [ |
|
"35272258" |
|
] |
|
}, |
|
{ |
|
"text": "radiotherapy", |
|
"score": 12.254953384399414, |
|
"articlesIDs": [ |
|
"33101471" |
|
] |
|
}, |
|
{ |
|
"text": "tumor differentiation grade 2 or 3", |
|
"score": 12.247446060180664, |
|
"articlesIDs": [ |
|
"31600211" |
|
] |
|
}, |
|
{ |
|
"text": "removed lymph nodes, obesity and radiotherapy", |
|
"score": 12.246387481689453, |
|
"articlesIDs": [ |
|
"33101471" |
|
] |
|
}, |
|
{ |
|
"text": "women with familial er-positive breast cancer", |
|
"score": 12.246185302734375, |
|
"articlesIDs": [ |
|
"37243749" |
|
] |
|
}, |
|
{ |
|
"text": "higher hydrometra volume, higher bmi, and abnormal vaginal bleeding", |
|
"score": 12.24322509765625, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes (or: 3.6, -value \u003c.001), hormonal therapy use", |
|
"score": 12.242094993591309, |
|
"articlesIDs": [ |
|
"35442132" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickness (et) and abnormal uterine bleeding (aub)", |
|
"score": 12.240647315979004, |
|
"articlesIDs": [ |
|
"32349386" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome and type 2 diabetes", |
|
"score": 12.237420082092285, |
|
"articlesIDs": [ |
|
"36981906" |
|
] |
|
}, |
|
{ |
|
"text": "high grade; specific histological type; high tumor and node stages", |
|
"score": 12.236604690551758, |
|
"articlesIDs": [ |
|
"35910482" |
|
] |
|
}, |
|
{ |
|
"text": "atypical endometrial hyperplasia (ah)", |
|
"score": 12.234575271606445, |
|
"articlesIDs": [ |
|
"35793641" |
|
] |
|
}, |
|
{ |
|
"text": "number of removed lymph nodes (for cervical cancer patients) and obesity", |
|
"score": 12.229280471801758, |
|
"articlesIDs": [ |
|
"33101471" |
|
] |
|
}, |
|
{ |
|
"text": "hogg1-326cys", |
|
"score": 12.22877025604248, |
|
"articlesIDs": [ |
|
"30194171" |
|
] |
|
}, |
|
{ |
|
"text": "trunk fat:leg fat mass ratio", |
|
"score": 12.227538108825684, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology, non-diploid tumors, lymphovascular space invasion", |
|
"score": 12.227380752563477, |
|
"articlesIDs": [ |
|
"34078319" |
|
] |
|
}, |
|
{ |
|
"text": "inflammatory bowel disease (ibd) with or without immune suppressive treatment", |
|
"score": 12.227025985717773, |
|
"articlesIDs": [ |
|
"29462389" |
|
] |
|
}, |
|
{ |
|
"text": "current users of estrogen-only", |
|
"score": 12.226906776428223, |
|
"articlesIDs": [ |
|
"29475971" |
|
] |
|
}, |
|
{ |
|
"text": "women with obesity (body mass index (bmi) \u003e 25)", |
|
"score": 12.226271629333496, |
|
"articlesIDs": [ |
|
"34501584" |
|
] |
|
}, |
|
{ |
|
"text": "number of live births", |
|
"score": 12.225743293762207, |
|
"articlesIDs": [ |
|
"36320039" |
|
] |
|
}, |
|
{ |
|
"text": "sex steroid hormones and risk of breast and endometrial cancer; and lipids", |
|
"score": 12.216870307922363, |
|
"articlesIDs": [ |
|
"35105367" |
|
] |
|
}, |
|
{ |
|
"text": "women who receive radiation for cervical cancer", |
|
"score": 12.215387344360352, |
|
"articlesIDs": [ |
|
"31069490" |
|
] |
|
}, |
|
{ |
|
"text": "stage iii/iv advanced disease, clear cell carcinoma", |
|
"score": 12.196661949157715, |
|
"articlesIDs": [ |
|
"32147891" |
|
] |
|
}, |
|
{ |
|
"text": "patients with reduced gfr", |
|
"score": 12.195907592773438, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "free carnitine", |
|
"score": 12.189759254455566, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "cbht use, and the prevalence of obesity", |
|
"score": 12.185470581054688, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "weight cycling and weight gain", |
|
"score": 12.175707817077637, |
|
"articlesIDs": [ |
|
"28069684" |
|
] |
|
}, |
|
{ |
|
"text": "hogg1-326cys (or=1.60, 95% ci=1.36-1.88; p\u003c0.0001) and ercc2-751gln", |
|
"score": 12.173117637634277, |
|
"articlesIDs": [ |
|
"30194171" |
|
] |
|
}, |
|
{ |
|
"text": "patients with diffuse lvsi", |
|
"score": 12.171609878540039, |
|
"articlesIDs": [ |
|
"33217679" |
|
] |
|
}, |
|
{ |
|
"text": "ca125≥35 u/ml, postmenopausal bleeding", |
|
"score": 12.167895317077637, |
|
"articlesIDs": [ |
|
"36973218" |
|
] |
|
}, |
|
{ |
|
"text": "highest intakes of b2", |
|
"score": 12.1674222946167, |
|
"articlesIDs": [ |
|
"30544261" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space invasion and increasing age", |
|
"score": 12.165534973144531, |
|
"articlesIDs": [ |
|
"34078319" |
|
] |
|
}, |
|
{ |
|
"text": "rural endometrial cancer patients diagnosed at advanced stage", |
|
"score": 12.164889335632324, |
|
"articlesIDs": [ |
|
"31291920" |
|
] |
|
}, |
|
{ |
|
"text": "lymphatic vascular space invasion (lvsi)", |
|
"score": 12.164304733276367, |
|
"articlesIDs": [ |
|
"29061125" |
|
] |
|
}, |
|
{ |
|
"text": "cd and excess body weight", |
|
"score": 12.159286499023438, |
|
"articlesIDs": [ |
|
"32190316" |
|
] |
|
}, |
|
{ |
|
"text": "chronic diseases (cd)", |
|
"score": 12.15578842163086, |
|
"articlesIDs": [ |
|
"32190316" |
|
] |
|
}, |
|
{ |
|
"text": "never use of oral contraceptives (ocs)", |
|
"score": 12.155777931213379, |
|
"articlesIDs": [ |
|
"30935715" |
|
] |
|
}, |
|
{ |
|
"text": "ec survivors", |
|
"score": 12.152948379516602, |
|
"articlesIDs": [ |
|
"36008183", |
|
"36924355" |
|
] |
|
}, |
|
{ |
|
"text": "lsb in form of television watching", |
|
"score": 12.147859573364258, |
|
"articlesIDs": [ |
|
"37148539" |
|
] |
|
}, |
|
{ |
|
"text": "higher circulating concentrations of total", |
|
"score": 12.143592834472656, |
|
"articlesIDs": [ |
|
"34363033" |
|
] |
|
}, |
|
{ |
|
"text": "trunk fat mass index", |
|
"score": 12.141441345214844, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "male infertility", |
|
"score": 12.141286849975586, |
|
"articlesIDs": [ |
|
"30611645" |
|
] |
|
}, |
|
{ |
|
"text": "older patients", |
|
"score": 12.139311790466309, |
|
"articlesIDs": [ |
|
"33879792" |
|
] |
|
}, |
|
{ |
|
"text": "allele xrcc2-188his", |
|
"score": 12.137045860290527, |
|
"articlesIDs": [ |
|
"30194171" |
|
] |
|
}, |
|
{ |
|
"text": "age greater than or equal to 60 years, clear cell carcinoma", |
|
"score": 12.135218620300293, |
|
"articlesIDs": [ |
|
"32147891" |
|
] |
|
}, |
|
{ |
|
"text": "subjects with evening chronotype", |
|
"score": 12.134394645690918, |
|
"articlesIDs": [ |
|
"36349806" |
|
] |
|
}, |
|
{ |
|
"text": "insulin resistance, metabolic syndrome and type 2 diabetes", |
|
"score": 12.132163047790527, |
|
"articlesIDs": [ |
|
"36981906" |
|
] |
|
}, |
|
{ |
|
"text": "patients 75-79 years old", |
|
"score": 12.124381065368652, |
|
"articlesIDs": [ |
|
"34763940" |
|
] |
|
}, |
|
{ |
|
"text": "anthropometric indices", |
|
"score": 12.123210906982422, |
|
"articlesIDs": [ |
|
"35105367" |
|
] |
|
}, |
|
{ |
|
"text": "existence of aub", |
|
"score": 12.117969512939453, |
|
"articlesIDs": [ |
|
"28763739" |
|
] |
|
}, |
|
{ |
|
"text": "brachytherapy", |
|
"score": 12.11591625213623, |
|
"articlesIDs": [ |
|
"35058550" |
|
] |
|
}, |
|
{ |
|
"text": "trunk fat:trunk fat free mass ratio, trunk fat:leg fat mass ratio", |
|
"score": 12.107145309448242, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "high tumor and node stages; larger tumor size", |
|
"score": 12.102788925170898, |
|
"articlesIDs": [ |
|
"35910482" |
|
] |
|
}, |
|
{ |
|
"text": "distinct body shape phenotypes", |
|
"score": 12.100000381469727, |
|
"articlesIDs": [ |
|
"36460776" |
|
] |
|
}, |
|
{ |
|
"text": "high compared to low sedentary behavior", |
|
"score": 12.099569320678711, |
|
"articlesIDs": [ |
|
"30887424" |
|
] |
|
}, |
|
{ |
|
"text": "use of postmenopausal hormone therapy (ht) and oral contraceptives (oc)", |
|
"score": 12.098861694335938, |
|
"articlesIDs": [ |
|
"32011733" |
|
] |
|
}, |
|
{ |
|
"text": "tumor long diameter greater than or equal to 40 mm for cervical cancer", |
|
"score": 12.090235710144043, |
|
"articlesIDs": [ |
|
"32147891" |
|
] |
|
}, |
|
{ |
|
"text": "every 1 kg/m increase in bmi", |
|
"score": 12.089686393737793, |
|
"articlesIDs": [ |
|
"37139871" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickness≥5 mm, cdo1 δct≤8.4, and celf4 δct≤8.8", |
|
"score": 12.087244033813477, |
|
"articlesIDs": [ |
|
"36973218" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome (ms)", |
|
"score": 12.079630851745605, |
|
"articlesIDs": [ |
|
"33258710", |
|
"29699953", |
|
"29115033" |
|
] |
|
}, |
|
{ |
|
"text": "outdoor light at night (lan)", |
|
"score": 12.073324203491211, |
|
"articlesIDs": [ |
|
"36222982" |
|
] |
|
}, |
|
{ |
|
"text": "women with pmb", |
|
"score": 12.06894588470459, |
|
"articlesIDs": [ |
|
"30234731", |
|
"30083701" |
|
] |
|
}, |
|
{ |
|
"text": "high cardiometabolic polygenic scores", |
|
"score": 12.062521934509277, |
|
"articlesIDs": [ |
|
"36846987" |
|
] |
|
}, |
|
{ |
|
"text": "current smoking, and parity ≥ 3", |
|
"score": 12.061395645141602, |
|
"articlesIDs": [ |
|
"33608145" |
|
] |
|
}, |
|
{ |
|
"text": "level of selenium in the blood serum", |
|
"score": 12.060432434082031, |
|
"articlesIDs": [ |
|
"35267933" |
|
] |
|
}, |
|
{ |
|
"text": "relatively high ssb and fruit juice intake", |
|
"score": 12.059860229492188, |
|
"articlesIDs": [ |
|
"33220638" |
|
] |
|
}, |
|
{ |
|
"text": "higher body mass index (\u003e23.92 kg/m)", |
|
"score": 12.058588027954102, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "self-reported endometriosis", |
|
"score": 12.057686805725098, |
|
"articlesIDs": [ |
|
"28299512" |
|
] |
|
}, |
|
{ |
|
"text": "receiving ebrt (hr = 1.97, 95% ci [1.64-2.36]) or brachytherapy", |
|
"score": 12.054887771606445, |
|
"articlesIDs": [ |
|
"35058550" |
|
] |
|
}, |
|
{ |
|
"text": "the codon 389 polymorphism of pict-1", |
|
"score": 12.053133010864258, |
|
"articlesIDs": [ |
|
"29617699" |
|
] |
|
}, |
|
{ |
|
"text": "parametrial invasion", |
|
"score": 12.050359725952148, |
|
"articlesIDs": [ |
|
"36316771" |
|
] |
|
}, |
|
{ |
|
"text": "tamoxifen use and ec", |
|
"score": 12.04401969909668, |
|
"articlesIDs": [ |
|
"36916539" |
|
] |
|
}, |
|
{ |
|
"text": "post-diagnostic low-dose aspirin use", |
|
"score": 12.041950225830078, |
|
"articlesIDs": [ |
|
"31845990" |
|
] |
|
}, |
|
{ |
|
"text": "lower bmi", |
|
"score": 12.033323287963867, |
|
"articlesIDs": [ |
|
"32817584", |
|
"28339318" |
|
] |
|
}, |
|
{ |
|
"text": "higher plasma vitc levels (per 1 sd increase, approximately 20 μmol/l)", |
|
"score": 12.032899856567383, |
|
"articlesIDs": [ |
|
"35402429" |
|
] |
|
}, |
|
{ |
|
"text": "depth of invasion, and lymphovascular space invasion", |
|
"score": 12.02792739868164, |
|
"articlesIDs": [ |
|
"37386310" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension and severe hyperplasia", |
|
"score": 12.024653434753418, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "non-diploid tumors, lymphovascular space invasion and increasing age", |
|
"score": 12.024307250976562, |
|
"articlesIDs": [ |
|
"34078319" |
|
] |
|
}, |
|
{ |
|
"text": "circulating telomere length", |
|
"score": 12.02267074584961, |
|
"articlesIDs": [ |
|
"35105367" |
|
] |
|
}, |
|
{ |
|
"text": "weight gain and weight cycling", |
|
"score": 12.019371032714844, |
|
"articlesIDs": [ |
|
"28069684" |
|
] |
|
}, |
|
{ |
|
"text": "esterified to free carnitine", |
|
"score": 12.015244483947754, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal bleeding, endometrial thickness≥5 mm, cdo1 δct≤8.4", |
|
"score": 12.014283180236816, |
|
"articlesIDs": [ |
|
"36973218" |
|
] |
|
}, |
|
{ |
|
"text": "women with postmenopausal bleeding (pmb)", |
|
"score": 12.014062881469727, |
|
"articlesIDs": [ |
|
"30234731", |
|
"30083701" |
|
] |
|
}, |
|
{ |
|
"text": "macrometastasis in the pelvic basin", |
|
"score": 12.012179374694824, |
|
"articlesIDs": [ |
|
"31324453" |
|
] |
|
}, |
|
{ |
|
"text": "use of approved prescription estrogen-progestogen combination products", |
|
"score": 12.00997543334961, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "patients with lvsi", |
|
"score": 12.00907039642334, |
|
"articlesIDs": [ |
|
"31328462" |
|
] |
|
}, |
|
{ |
|
"text": "specific histological type; high tumor and node stages; larger tumor size", |
|
"score": 12.006647109985352, |
|
"articlesIDs": [ |
|
"35910482" |
|
] |
|
}, |
|
{ |
|
"text": "family history (or=3.555, 95% ci 1.055-11.971), age ≥40 years", |
|
"score": 11.99958324432373, |
|
"articlesIDs": [ |
|
"36825346" |
|
] |
|
}, |
|
{ |
|
"text": "women that underwent chemotherapy", |
|
"score": 11.99730110168457, |
|
"articlesIDs": [ |
|
"34717579" |
|
] |
|
}, |
|
{ |
|
"text": "albumin\u003c3.5 g/dl", |
|
"score": 11.997063636779785, |
|
"articlesIDs": [ |
|
"35241292" |
|
] |
|
}, |
|
{ |
|
"text": "increasing bmi", |
|
"score": 11.995414733886719, |
|
"articlesIDs": [ |
|
"37290247" |
|
] |
|
}, |
|
{ |
|
"text": "preoperative he4 levels", |
|
"score": 11.993827819824219, |
|
"articlesIDs": [ |
|
"28006994" |
|
] |
|
}, |
|
{ |
|
"text": "fsh", |
|
"score": 11.990730285644531, |
|
"articlesIDs": [ |
|
"29434922" |
|
] |
|
}, |
|
{ |
|
"text": "family history of breast cancer", |
|
"score": 11.990138053894043, |
|
"articlesIDs": [ |
|
"35442132" |
|
] |
|
}, |
|
{ |
|
"text": "overweight/obesity", |
|
"score": 11.98741626739502, |
|
"articlesIDs": [ |
|
"31591991" |
|
] |
|
}, |
|
{ |
|
"text": "obese women with pcos", |
|
"score": 11.986202239990234, |
|
"articlesIDs": [ |
|
"28901968" |
|
] |
|
}, |
|
{ |
|
"text": "women consuming 10 + g total nuts/day", |
|
"score": 11.983735084533691, |
|
"articlesIDs": [ |
|
"31601449" |
|
] |
|
}, |
|
{ |
|
"text": "premenopausal patients", |
|
"score": 11.976250648498535, |
|
"articlesIDs": [ |
|
"37290247", |
|
"28239284" |
|
] |
|
}, |
|
{ |
|
"text": "greater hydrometra volume", |
|
"score": 11.975931167602539, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "those who experienced cervical cancer", |
|
"score": 11.964873313903809, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "nonalcoholic fatty liver disease and endometrial cancer", |
|
"score": 11.959455490112305, |
|
"articlesIDs": [ |
|
"34617616" |
|
] |
|
}, |
|
{ |
|
"text": "acute survivorship stage", |
|
"score": 11.957526206970215, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "maternal coffee drinking during pregnancy", |
|
"score": 11.956972122192383, |
|
"articlesIDs": [ |
|
"28288025" |
|
] |
|
}, |
|
{ |
|
"text": "peritoneal endometriosis", |
|
"score": 11.956443786621094, |
|
"articlesIDs": [ |
|
"29742675" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes (or 3.049, 95% ci 1.781-5.114), hypertension", |
|
"score": 11.956197738647461, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "exposure to soil", |
|
"score": 11.955162048339844, |
|
"articlesIDs": [ |
|
"36540800" |
|
] |
|
}, |
|
{ |
|
"text": "family history of colon cancer", |
|
"score": 11.954848289489746, |
|
"articlesIDs": [ |
|
"35442132" |
|
] |
|
}, |
|
{ |
|
"text": "higher age", |
|
"score": 11.954092979431152, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "ivf and cc treatment", |
|
"score": 11.953125, |
|
"articlesIDs": [ |
|
"33586777" |
|
] |
|
}, |
|
{ |
|
"text": "among males, trunk fat:trunk fat free mass ratio", |
|
"score": 11.951821327209473, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology and parametrial invasion", |
|
"score": 11.949906349182129, |
|
"articlesIDs": [ |
|
"36316771" |
|
] |
|
}, |
|
{ |
|
"text": "black women with high-risk cancer", |
|
"score": 11.9498872756958, |
|
"articlesIDs": [ |
|
"30096321" |
|
] |
|
}, |
|
{ |
|
"text": "patients with severe obesity (class iii)", |
|
"score": 11.949828147888184, |
|
"articlesIDs": [ |
|
"36589506", |
|
"36506038" |
|
] |
|
}, |
|
{ |
|
"text": "male infertility, peyronie's disease", |
|
"score": 11.949076652526855, |
|
"articlesIDs": [ |
|
"30611645" |
|
] |
|
}, |
|
{ |
|
"text": "cbht use, and the prevalence of obesity and diabetes", |
|
"score": 11.934754371643066, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "metabolically healthy obesity", |
|
"score": 11.932706832885742, |
|
"articlesIDs": [ |
|
"36647199" |
|
] |
|
}, |
|
{ |
|
"text": "patients with tumors with mi ≥ 50%", |
|
"score": 11.932319641113281, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial cancer (ec)", |
|
"score": 11.931358337402344, |
|
"articlesIDs": [ |
|
"34501584", |
|
"29049937", |
|
"36008183", |
|
"35409473", |
|
"32107136", |
|
"29567460", |
|
"32854222", |
|
"31844128" |
|
] |
|
}, |
|
{ |
|
"text": "contact with cats (or, 6.67; 95% ci [2.89-10.75]; = 0.001), exposure to soil", |
|
"score": 11.92495346069336, |
|
"articlesIDs": [ |
|
"36540800" |
|
] |
|
}, |
|
{ |
|
"text": "high-grade disease", |
|
"score": 11.923873901367188, |
|
"articlesIDs": [ |
|
"36316771" |
|
] |
|
}, |
|
{ |
|
"text": "patients aged over 59 presenting aub", |
|
"score": 11.92275619506836, |
|
"articlesIDs": [ |
|
"28763739" |
|
] |
|
}, |
|
{ |
|
"text": "age \u003e 50 y (or 3.064, 95% ci 1.945-5.931), bmi ≥ 25 kg/m", |
|
"score": 11.922544479370117, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "women greater than median years of pws use with levels", |
|
"score": 11.92232608795166, |
|
"articlesIDs": [ |
|
"35622390" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic macrometastasis, lymphovascular space invasion (lvsi)", |
|
"score": 11.92207145690918, |
|
"articlesIDs": [ |
|
"31324453" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, each component of mets, and mets", |
|
"score": 11.920516967773438, |
|
"articlesIDs": [ |
|
"35320886" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 25 kg/m, diabetes, hypertension and severe hyperplasia", |
|
"score": 11.913473129272461, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "type 2 diabetes mellitus (t2dm), obesity", |
|
"score": 11.913084030151367, |
|
"articlesIDs": [ |
|
"34822059" |
|
] |
|
}, |
|
{ |
|
"text": "absi", |
|
"score": 11.912571907043457, |
|
"articlesIDs": [ |
|
"33550945" |
|
] |
|
}, |
|
{ |
|
"text": "male infertility, peyronie's disease, cryptorchidism, and hypospadias", |
|
"score": 11.910627365112305, |
|
"articlesIDs": [ |
|
"30611645" |
|
] |
|
}, |
|
{ |
|
"text": "patients with a high-volume index", |
|
"score": 11.908049583435059, |
|
"articlesIDs": [ |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "chronic adipose tissue inflammation", |
|
"score": 11.907510757446289, |
|
"articlesIDs": [ |
|
"35276057" |
|
] |
|
}, |
|
{ |
|
"text": "single nucleotide polymorphisms (snps) in , , , , and", |
|
"score": 11.905048370361328, |
|
"articlesIDs": [ |
|
"32066633" |
|
] |
|
}, |
|
{ |
|
"text": "leukocytosis", |
|
"score": 11.899309158325195, |
|
"articlesIDs": [ |
|
"36574873" |
|
] |
|
}, |
|
{ |
|
"text": "female gut microbiome", |
|
"score": 11.89887809753418, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 25 kg/m (or 2.705, 95% ci 1.121-3.889), diabetes", |
|
"score": 11.89831829071045, |
|
"articlesIDs": [ |
|
"34433451" |
|
] |
|
}, |
|
{ |
|
"text": "decreased use of approved estrogen-progestogen therapy", |
|
"score": 11.895483016967773, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "in women diagnosed with endometrial hyperplasia, diabetes mellitus", |
|
"score": 11.89461898803711, |
|
"articlesIDs": [ |
|
"31203571" |
|
] |
|
}, |
|
{ |
|
"text": "laparotomic approach", |
|
"score": 11.892008781433105, |
|
"articlesIDs": [ |
|
"36738486" |
|
] |
|
}, |
|
{ |
|
"text": "those who experienced ovarian cancer", |
|
"score": 11.88659954071045, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "women with hyperglycemia, dyslipidemia and hypertension", |
|
"score": 11.885658264160156, |
|
"articlesIDs": [ |
|
"30788634" |
|
] |
|
}, |
|
{ |
|
"text": "overweight pcos", |
|
"score": 11.883057594299316, |
|
"articlesIDs": [ |
|
"33645403" |
|
] |
|
}, |
|
{ |
|
"text": "elevated body mass index (bmi), diabetes", |
|
"score": 11.8824462890625, |
|
"articlesIDs": [ |
|
"29706522" |
|
] |
|
}, |
|
{ |
|
"text": "highest versus the lowest age at menopause", |
|
"score": 11.881792068481445, |
|
"articlesIDs": [ |
|
"31275987" |
|
] |
|
}, |
|
{ |
|
"text": "bmi greater than 30", |
|
"score": 11.878802299499512, |
|
"articlesIDs": [ |
|
"31226466" |
|
] |
|
}, |
|
{ |
|
"text": "primary tumor diameter (ptd) ≥ 20 mm", |
|
"score": 11.878621101379395, |
|
"articlesIDs": [ |
|
"30056447" |
|
] |
|
}, |
|
{ |
|
"text": "dihydrotestosterone (dht)", |
|
"score": 11.876582145690918, |
|
"articlesIDs": [ |
|
"29465427" |
|
] |
|
}, |
|
{ |
|
"text": "glucose and insulin", |
|
"score": 11.871942520141602, |
|
"articlesIDs": [ |
|
"29438162" |
|
] |
|
}, |
|
{ |
|
"text": "treated with radiation or chemotherapy", |
|
"score": 11.866042137145996, |
|
"articlesIDs": [ |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "increased oxidative stress", |
|
"score": 11.865623474121094, |
|
"articlesIDs": [ |
|
"31420039" |
|
] |
|
}, |
|
{ |
|
"text": "post-menopausal status", |
|
"score": 11.865589141845703, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "somatic mmr-deficient ec", |
|
"score": 11.864730834960938, |
|
"articlesIDs": [ |
|
"29533022" |
|
] |
|
}, |
|
{ |
|
"text": "ratio of esterified to free carnitine", |
|
"score": 11.861167907714844, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "b12 (q5 vs q1: hr 1.38 ci 1.17-1.63) and methionine", |
|
"score": 11.860095024108887, |
|
"articlesIDs": [ |
|
"30544261" |
|
] |
|
}, |
|
{ |
|
"text": "estrogen (or=1.192) and fsh", |
|
"score": 11.858875274658203, |
|
"articlesIDs": [ |
|
"29434922" |
|
] |
|
}, |
|
{ |
|
"text": "atypical hyperplasia", |
|
"score": 11.854508399963379, |
|
"articlesIDs": [ |
|
"32343732" |
|
] |
|
}, |
|
{ |
|
"text": "advanced age (90.9%) and overweight/obesity", |
|
"score": 11.853849411010742, |
|
"articlesIDs": [ |
|
"31591991" |
|
] |
|
}, |
|
{ |
|
"text": "positive lymphonode metastasis, positive lvsi", |
|
"score": 11.848066329956055, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "patients with both postmenopausal status and ca125 ≥ 35 u/ml", |
|
"score": 11.844319343566895, |
|
"articlesIDs": [ |
|
"35054175" |
|
] |
|
}, |
|
{ |
|
"text": "lymph-vascular space invasion (lvsi)", |
|
"score": 11.843210220336914, |
|
"articlesIDs": [ |
|
"31328462", |
|
"33217679" |
|
] |
|
}, |
|
{ |
|
"text": "black/haitian (vs. caucasian) race", |
|
"score": 11.83797836303711, |
|
"articlesIDs": [ |
|
"33259765" |
|
] |
|
}, |
|
{ |
|
"text": "a 1-h increase in daily tv viewing time", |
|
"score": 11.835739135742188, |
|
"articlesIDs": [ |
|
"32746843" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal women with endometrial thickening and vaginal bleeding", |
|
"score": 11.830756187438965, |
|
"articlesIDs": [ |
|
"36006486" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes mellitus, dyslipidemia, heart diseases and cerebrovascular diseases", |
|
"score": 11.828996658325195, |
|
"articlesIDs": [ |
|
"32190316" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology, stages 3 and 4 disease, laparotomy", |
|
"score": 11.828615188598633, |
|
"articlesIDs": [ |
|
"32905281" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index [(or30 25:2.11, \u003c .001) and or35 30: 1.65, \u003c .001], diabetes", |
|
"score": 11.828460693359375, |
|
"articlesIDs": [ |
|
"35442132" |
|
] |
|
}, |
|
{ |
|
"text": "higher figo stage, non-endometrioid histology, non-diploid tumors", |
|
"score": 11.827827453613281, |
|
"articlesIDs": [ |
|
"34078319" |
|
] |
|
}, |
|
{ |
|
"text": "women with ec", |
|
"score": 11.826519966125488, |
|
"articlesIDs": [ |
|
"29049937", |
|
"36008183", |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "tumor long diameter greater than or equal to 60 mm for endometrial cancer", |
|
"score": 11.818140983581543, |
|
"articlesIDs": [ |
|
"32147891" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space invasion (lvsi), and extracapsular invasion", |
|
"score": 11.817482948303223, |
|
"articlesIDs": [ |
|
"31324453" |
|
] |
|
}, |
|
{ |
|
"text": "patients with ec", |
|
"score": 11.811807632446289, |
|
"articlesIDs": [ |
|
"36924355" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 30 kg/m", |
|
"score": 11.807903289794922, |
|
"articlesIDs": [ |
|
"33185805" |
|
] |
|
}, |
|
{ |
|
"text": "dietary inflammation index (dii)", |
|
"score": 11.806156158447266, |
|
"articlesIDs": [ |
|
"30887752" |
|
] |
|
}, |
|
{ |
|
"text": "decreased number of lymph nodes dissected and additional paolnd", |
|
"score": 11.799756050109863, |
|
"articlesIDs": [ |
|
"36738486" |
|
] |
|
}, |
|
{ |
|
"text": "patients with central venous catheters (cvcs)", |
|
"score": 11.798871994018555, |
|
"articlesIDs": [ |
|
"32300436" |
|
] |
|
}, |
|
{ |
|
"text": "men who were overweight and centrally obese", |
|
"score": 11.793147087097168, |
|
"articlesIDs": [ |
|
"33381801" |
|
] |
|
}, |
|
{ |
|
"text": "cancer type, cancer survivorship stage", |
|
"score": 11.791451454162598, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "c-met", |
|
"score": 11.790443420410156, |
|
"articlesIDs": [ |
|
"31686413" |
|
] |
|
}, |
|
{ |
|
"text": "high preoperative ca125", |
|
"score": 11.790304183959961, |
|
"articlesIDs": [ |
|
"28800309" |
|
] |
|
}, |
|
{ |
|
"text": "women with somatic mmr-deficient ec", |
|
"score": 11.790191650390625, |
|
"articlesIDs": [ |
|
"29533022" |
|
] |
|
}, |
|
{ |
|
"text": "hormonal therapy use (or: 2.93, \u003c .001), personal history of colon cancer", |
|
"score": 11.787202835083008, |
|
"articlesIDs": [ |
|
"35442132" |
|
] |
|
}, |
|
{ |
|
"text": "smoking and bmi greater than 30 or smoking and a history of pcos", |
|
"score": 11.787029266357422, |
|
"articlesIDs": [ |
|
"31226466" |
|
] |
|
}, |
|
{ |
|
"text": "lack of recognition and evaluation of postmenopausal bleeding", |
|
"score": 11.785154342651367, |
|
"articlesIDs": [ |
|
"30291839" |
|
] |
|
}, |
|
{ |
|
"text": "reduction of adiponectin activity", |
|
"score": 11.781820297241211, |
|
"articlesIDs": [ |
|
"35072951" |
|
] |
|
}, |
|
{ |
|
"text": "advanced age (or 1.11) and vaginitis", |
|
"score": 11.778203964233398, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "high dietary gl", |
|
"score": 11.773237228393555, |
|
"articlesIDs": [ |
|
"27986350" |
|
] |
|
}, |
|
{ |
|
"text": "non-endometrioid histology, tumor size, tumor cytology", |
|
"score": 11.771507263183594, |
|
"articlesIDs": [ |
|
"37386310" |
|
] |
|
}, |
|
{ |
|
"text": "uterine transverse diameter of ≥5 cm", |
|
"score": 11.76590347290039, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "rs10189857", |
|
"score": 11.762796401977539, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "long-term use of estrogen-only menopausal hormones", |
|
"score": 11.759675979614258, |
|
"articlesIDs": [ |
|
"36418803" |
|
] |
|
}, |
|
{ |
|
"text": "larger tumor size; and liver, brain, and bone metastases", |
|
"score": 11.758668899536133, |
|
"articlesIDs": [ |
|
"35910482" |
|
] |
|
}, |
|
{ |
|
"text": "later age at menopause", |
|
"score": 11.757654190063477, |
|
"articlesIDs": [ |
|
"35462044" |
|
] |
|
}, |
|
{ |
|
"text": "rs7581162 (or = 1.29, = 0.012), rs10189857", |
|
"score": 11.74882698059082, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "acs malnutrition", |
|
"score": 11.745780944824219, |
|
"articlesIDs": [ |
|
"35241292" |
|
] |
|
}, |
|
{ |
|
"text": "women with polycystic ovary syndrome (pcos)", |
|
"score": 11.745129585266113, |
|
"articlesIDs": [ |
|
"33645403" |
|
] |
|
}, |
|
{ |
|
"text": "women with a bmi of at least 27.0 kg/m", |
|
"score": 11.7388916015625, |
|
"articlesIDs": [ |
|
"29672353" |
|
] |
|
}, |
|
{ |
|
"text": "progesterone receptor ( = 0.001), p53 ( = 0.004), and ki67 ( = 0.002)", |
|
"score": 11.731512069702148, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space involvement", |
|
"score": 11.720970153808594, |
|
"articlesIDs": [ |
|
"28226030" |
|
] |
|
}, |
|
{ |
|
"text": "laparotomic approach, decreased number of lymph nodes dissected", |
|
"score": 11.715605735778809, |
|
"articlesIDs": [ |
|
"36738486" |
|
] |
|
}, |
|
{ |
|
"text": "general and central obesity", |
|
"score": 11.715555191040039, |
|
"articlesIDs": [ |
|
"33381801" |
|
] |
|
}, |
|
{ |
|
"text": "weight cycling \"4 to 6 times\"", |
|
"score": 11.709251403808594, |
|
"articlesIDs": [ |
|
"28069684" |
|
] |
|
}, |
|
{ |
|
"text": "deeper myometrial invasion, positive lymphonode metastasis, positive lvsi", |
|
"score": 11.69869613647461, |
|
"articlesIDs": [ |
|
"29408747" |
|
] |
|
}, |
|
{ |
|
"text": "chronic adipose tissue inflammation and insulin resistance", |
|
"score": 11.695844650268555, |
|
"articlesIDs": [ |
|
"35276057" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular invasion", |
|
"score": 11.69118881225586, |
|
"articlesIDs": [ |
|
"31474587", |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "subfertile women who required clomiphene citrate", |
|
"score": 11.69020938873291, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of diffuse lvsi", |
|
"score": 11.687326431274414, |
|
"articlesIDs": [ |
|
"33217679" |
|
] |
|
}, |
|
{ |
|
"text": "advanced tumor stage and leukocytosis", |
|
"score": 11.676280975341797, |
|
"articlesIDs": [ |
|
"36574873" |
|
] |
|
}, |
|
{ |
|
"text": "tamofixen", |
|
"score": 11.668038368225098, |
|
"articlesIDs": [ |
|
"36995835" |
|
] |
|
}, |
|
{ |
|
"text": "metabolically unhealthy obesity", |
|
"score": 11.666041374206543, |
|
"articlesIDs": [ |
|
"36647199" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes and high bmi combined. individually, high bmi", |
|
"score": 11.661762237548828, |
|
"articlesIDs": [ |
|
"29195904", |
|
"29803268" |
|
] |
|
}, |
|
{ |
|
"text": "bmi of 40 or over", |
|
"score": 11.657846450805664, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "higher age (or 2.19, 95% ci 1.69-2.24), post-menopausal status", |
|
"score": 11.65530014038086, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "patients with type 2 disease", |
|
"score": 11.651631355285645, |
|
"articlesIDs": [ |
|
"30602164" |
|
] |
|
}, |
|
{ |
|
"text": "imb", |
|
"score": 11.650270462036133, |
|
"articlesIDs": [ |
|
"29696944" |
|
] |
|
}, |
|
{ |
|
"text": "ibd patients", |
|
"score": 11.648680686950684, |
|
"articlesIDs": [ |
|
"29462389" |
|
] |
|
}, |
|
{ |
|
"text": "former users immediately (≤2 years) after discontinued oral contraceptive use", |
|
"score": 11.647178649902344, |
|
"articlesIDs": [ |
|
"33334812" |
|
] |
|
}, |
|
{ |
|
"text": "fbg and tc", |
|
"score": 11.646173477172852, |
|
"articlesIDs": [ |
|
"35971461" |
|
] |
|
}, |
|
{ |
|
"text": "increase in cbht use", |
|
"score": 11.645014762878418, |
|
"articlesIDs": [ |
|
"30484734" |
|
] |
|
}, |
|
{ |
|
"text": "a doubling of et", |
|
"score": 11.643818855285645, |
|
"articlesIDs": [ |
|
"31614036" |
|
] |
|
}, |
|
{ |
|
"text": "complex subtype", |
|
"score": 11.636470794677734, |
|
"articlesIDs": [ |
|
"32945047" |
|
] |
|
}, |
|
{ |
|
"text": "cd4+ t%", |
|
"score": 11.632001876831055, |
|
"articlesIDs": [ |
|
"36386586" |
|
] |
|
}, |
|
{ |
|
"text": "patients who were diagnosed with bc", |
|
"score": 11.62946605682373, |
|
"articlesIDs": [ |
|
"29019328" |
|
] |
|
}, |
|
{ |
|
"text": "ow status", |
|
"score": 11.626615524291992, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "overweight, obesity, and metabolic syndrome (mets)", |
|
"score": 11.624674797058105, |
|
"articlesIDs": [ |
|
"34625915" |
|
] |
|
}, |
|
{ |
|
"text": "higher body mass index (\u003e23.92 kg/m), greater hydrometra volume", |
|
"score": 11.621490478515625, |
|
"articlesIDs": [ |
|
"36686793" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular invasion, age ≥70, grade 2-3 disease", |
|
"score": 11.619644165039062, |
|
"articlesIDs": [ |
|
"31474587" |
|
] |
|
}, |
|
{ |
|
"text": "disruption of pict-1 protein expression and codon 389 polymorphism", |
|
"score": 11.618837356567383, |
|
"articlesIDs": [ |
|
"29617699" |
|
] |
|
}, |
|
{ |
|
"text": "post-menopausal status (or 1.89, 95% ci 1.36-1.94), and diabetes type 2", |
|
"score": 11.613938331604004, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "hgsc", |
|
"score": 11.607847213745117, |
|
"articlesIDs": [ |
|
"31815095" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 30, current smoking, and parity ≥ 3", |
|
"score": 11.607257843017578, |
|
"articlesIDs": [ |
|
"33608145" |
|
] |
|
}, |
|
{ |
|
"text": "histological grade", |
|
"score": 11.60621452331543, |
|
"articlesIDs": [ |
|
"36438921" |
|
] |
|
}, |
|
{ |
|
"text": "rs10189857 (or = 1.26, = 0.028), rs1427407", |
|
"score": 11.605192184448242, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "patients with polycystic ovary syndrome (pcos)", |
|
"score": 11.602511405944824, |
|
"articlesIDs": [ |
|
"35686317" |
|
] |
|
}, |
|
{ |
|
"text": "cdh10, arid1a, and emt-associated gene mutation", |
|
"score": 11.599692344665527, |
|
"articlesIDs": [ |
|
"28448305" |
|
] |
|
}, |
|
{ |
|
"text": "rs7581162 (or = 1.29, = 0.012), rs10189857 (or = 1.26, = 0.028), rs1427407", |
|
"score": 11.591224670410156, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "higher leptin", |
|
"score": 11.588713645935059, |
|
"articlesIDs": [ |
|
"31003933" |
|
] |
|
}, |
|
{ |
|
"text": "cervical stromal invasion", |
|
"score": 11.587972640991211, |
|
"articlesIDs": [ |
|
"31651558" |
|
] |
|
}, |
|
{ |
|
"text": "genetically predicted higher levels of vitc were", |
|
"score": 11.574017524719238, |
|
"articlesIDs": [ |
|
"35402429" |
|
] |
|
}, |
|
{ |
|
"text": "older age and treated with radiation or chemotherapy", |
|
"score": 11.572931289672852, |
|
"articlesIDs": [ |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "ec patients with a germline pathogenic mmr gene variant", |
|
"score": 11.572766304016113, |
|
"articlesIDs": [ |
|
"30485707" |
|
] |
|
}, |
|
{ |
|
"text": "tumor cytology, depth of invasion, and lymphovascular space invasion", |
|
"score": 11.570293426513672, |
|
"articlesIDs": [ |
|
"37386310" |
|
] |
|
}, |
|
{ |
|
"text": "single nucleotide polymorphisms (snps) in , , , , and were", |
|
"score": 11.568273544311523, |
|
"articlesIDs": [ |
|
"32066633" |
|
] |
|
}, |
|
{ |
|
"text": "arg194trp, arg280his single nucleotide polymorphisms", |
|
"score": 11.566396713256836, |
|
"articlesIDs": [ |
|
"34918657" |
|
] |
|
}, |
|
{ |
|
"text": "figo grade 3 compared to grade 1-2 tumors", |
|
"score": 11.563042640686035, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": ", women with a first hospital-diagnosed postmenopausal bleeding", |
|
"score": 11.560590744018555, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "bmi of 30 or over gave an increase of 5.24%, and a bmi of 40 or over", |
|
"score": 11.5598726272583, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "women developing ec after tamoxifen treatment for breast cancer", |
|
"score": 11.559231758117676, |
|
"articlesIDs": [ |
|
"30485707" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular invasion, age ≥70, grade 2-3 disease, and figo stage ib", |
|
"score": 11.559098243713379, |
|
"articlesIDs": [ |
|
"31474587" |
|
] |
|
}, |
|
{ |
|
"text": "those with insufficient physical activity", |
|
"score": 11.557512283325195, |
|
"articlesIDs": [ |
|
"35886467" |
|
] |
|
}, |
|
{ |
|
"text": "pretreatment tg/hdl-c ratio", |
|
"score": 11.557051658630371, |
|
"articlesIDs": [ |
|
"30887645" |
|
] |
|
}, |
|
{ |
|
"text": "patients with the hgsc subtype", |
|
"score": 11.555622100830078, |
|
"articlesIDs": [ |
|
"31815095" |
|
] |
|
}, |
|
{ |
|
"text": "presence of diabetes mellitus (dm)", |
|
"score": 11.54914665222168, |
|
"articlesIDs": [ |
|
"36042597" |
|
] |
|
}, |
|
{ |
|
"text": "rural patients with advanced stage endometrial cancer", |
|
"score": 11.548150062561035, |
|
"articlesIDs": [ |
|
"31291920" |
|
] |
|
}, |
|
{ |
|
"text": "current use of postmenopausal hormones at baseline (pmh-e; vs never use)", |
|
"score": 11.546720504760742, |
|
"articlesIDs": [ |
|
"33723396" |
|
] |
|
}, |
|
{ |
|
"text": "one-year before- and peridiagnosis anthropometric measures of obesity", |
|
"score": 11.541555404663086, |
|
"articlesIDs": [ |
|
"34597394" |
|
] |
|
}, |
|
{ |
|
"text": "variation in levels of glycine, serine, sm c18:0 and free carnitine", |
|
"score": 11.537614822387695, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "grade ( = 0.040), estrogen receptor", |
|
"score": 11.536834716796875, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "elevated agr2 level", |
|
"score": 11.534385681152344, |
|
"articlesIDs": [ |
|
"28402678" |
|
] |
|
}, |
|
{ |
|
"text": "high risk endometrial cancer histological subtypes", |
|
"score": 11.531196594238281, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "women with higher body mass index (bmi)", |
|
"score": 11.52666187286377, |
|
"articlesIDs": [ |
|
"31508476" |
|
] |
|
}, |
|
{ |
|
"text": ", people with type 2 diabetes", |
|
"score": 11.52519416809082, |
|
"articlesIDs": [ |
|
"36690836" |
|
] |
|
}, |
|
{ |
|
"text": "endometriosis, polycystic ovary syndrome (pcos) and uterine fibroids", |
|
"score": 11.522849082946777, |
|
"articlesIDs": [ |
|
"34268601" |
|
] |
|
}, |
|
{ |
|
"text": "heavy menstrual bleeding, and vasomotor symptoms", |
|
"score": 11.520636558532715, |
|
"articlesIDs": [ |
|
"30288370" |
|
] |
|
}, |
|
{ |
|
"text": "endocrine disruptor compounds (edcs)", |
|
"score": 11.5198974609375, |
|
"articlesIDs": [ |
|
"28327540" |
|
] |
|
}, |
|
{ |
|
"text": "adult body size", |
|
"score": 11.519081115722656, |
|
"articlesIDs": [ |
|
"36357562" |
|
] |
|
}, |
|
{ |
|
"text": "patients who had been treated with chemotherapy", |
|
"score": 11.51649284362793, |
|
"articlesIDs": [ |
|
"31915135" |
|
] |
|
}, |
|
{ |
|
"text": "individuals with cgg haplotypes", |
|
"score": 11.514823913574219, |
|
"articlesIDs": [ |
|
"31880028" |
|
] |
|
}, |
|
{ |
|
"text": "grade ( = 0.040), estrogen receptor ( \u003c 0.001), progesterone receptor", |
|
"score": 11.502077102661133, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "pc1 (overall adiposity)", |
|
"score": 11.49865436553955, |
|
"articlesIDs": [ |
|
"36460776" |
|
] |
|
}, |
|
{ |
|
"text": "pten hamartoma tumor syndrome (phts)", |
|
"score": 11.497769355773926, |
|
"articlesIDs": [ |
|
"29233840" |
|
] |
|
}, |
|
{ |
|
"text": "arg399gln, arg194trp, arg280his single nucleotide polymorphisms", |
|
"score": 11.487131118774414, |
|
"articlesIDs": [ |
|
"34918657" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi, kg/m ), use of postmenopausal hormone therapy (ht)", |
|
"score": 11.474893569946289, |
|
"articlesIDs": [ |
|
"32011733" |
|
] |
|
}, |
|
{ |
|
"text": "patients with endometrioid subtype somatic mmr-deficient tumors", |
|
"score": 11.47433853149414, |
|
"articlesIDs": [ |
|
"29533022" |
|
] |
|
}, |
|
{ |
|
"text": "advanced stage of cancer", |
|
"score": 11.470014572143555, |
|
"articlesIDs": [ |
|
"31759190" |
|
] |
|
}, |
|
{ |
|
"text": "gg genotype", |
|
"score": 11.467777252197266, |
|
"articlesIDs": [ |
|
"29096752" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes mellitus, using of tamoxifen)", |
|
"score": 11.461912155151367, |
|
"articlesIDs": [ |
|
"32527101" |
|
] |
|
}, |
|
{ |
|
"text": "glucose concentration, bmi", |
|
"score": 11.454018592834473, |
|
"articlesIDs": [ |
|
"29559794" |
|
] |
|
}, |
|
{ |
|
"text": "1-5 years (sir = 2.55 (95% ci: 2.19-2.94)) and \u003e5 years of follow-up", |
|
"score": 11.445907592773438, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "pc2 (tall stature with low whr)", |
|
"score": 11.443087577819824, |
|
"articlesIDs": [ |
|
"36460776" |
|
] |
|
}, |
|
{ |
|
"text": "higher (3.75-5.5 vs. 3.26-3.75kg) birth weights", |
|
"score": 11.440083503723145, |
|
"articlesIDs": [ |
|
"29331371" |
|
] |
|
}, |
|
{ |
|
"text": "perimenopausal women often experience menstrual irregularity", |
|
"score": 11.439862251281738, |
|
"articlesIDs": [ |
|
"30288370" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickening in postmenopausal asymptomatic women", |
|
"score": 11.43674087524414, |
|
"articlesIDs": [ |
|
"36006486" |
|
] |
|
}, |
|
{ |
|
"text": "between 1 and 5years after cancer diagnosis", |
|
"score": 11.436279296875, |
|
"articlesIDs": [ |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal or nulliparous women", |
|
"score": 11.435795783996582, |
|
"articlesIDs": [ |
|
"33118172" |
|
] |
|
}, |
|
{ |
|
"text": "clomiphene citrate and art exposure", |
|
"score": 11.430177688598633, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "women with high risk endometrial cancer histological subtypes", |
|
"score": 11.415143966674805, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of lvsi and ptd ≥ 20 mm", |
|
"score": 11.410841941833496, |
|
"articlesIDs": [ |
|
"30056447" |
|
] |
|
}, |
|
{ |
|
"text": "laparotomy, and age ( \u003c 0.1)", |
|
"score": 11.40860366821289, |
|
"articlesIDs": [ |
|
"32905281" |
|
] |
|
}, |
|
{ |
|
"text": "postoperative pain", |
|
"score": 11.398897171020508, |
|
"articlesIDs": [ |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (or 0.39 [0.15-0.98], = 0.044), and number of years since menopause", |
|
"score": 11.397958755493164, |
|
"articlesIDs": [ |
|
"33259765" |
|
] |
|
}, |
|
{ |
|
"text": "increasing waist circumference (per 5 cm)", |
|
"score": 11.393030166625977, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "presence of preoperative pelvic pain", |
|
"score": 11.386177062988281, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "estrogen receptor ( \u003c 0.001), progesterone receptor ( = 0.001), p53", |
|
"score": 11.383814811706543, |
|
"articlesIDs": [ |
|
"36250543" |
|
] |
|
}, |
|
{ |
|
"text": "vitamin c and macronutrients", |
|
"score": 11.372281074523926, |
|
"articlesIDs": [ |
|
"36771310" |
|
] |
|
}, |
|
{ |
|
"text": "preoperative heat pain hyperalgesia", |
|
"score": 11.370976448059082, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "lnym and ec", |
|
"score": 11.369939804077148, |
|
"articlesIDs": [ |
|
"29782643" |
|
] |
|
}, |
|
{ |
|
"text": "a history of hip, forearm, or spine fractures, or hip fracture alone", |
|
"score": 11.369568824768066, |
|
"articlesIDs": [ |
|
"31355356" |
|
] |
|
}, |
|
{ |
|
"text": "dietary inflammation index (dii) score", |
|
"score": 11.368108749389648, |
|
"articlesIDs": [ |
|
"30887752" |
|
] |
|
}, |
|
{ |
|
"text": "lnym and ec, with a 9.1% higher risk for each additional year of lnym", |
|
"score": 11.365707397460938, |
|
"articlesIDs": [ |
|
"29782643" |
|
] |
|
}, |
|
{ |
|
"text": "homa-ir (or=1.240), estrogen (or=1.192) and fsh", |
|
"score": 11.363103866577148, |
|
"articlesIDs": [ |
|
"29434922" |
|
] |
|
}, |
|
{ |
|
"text": "primary tumor diameter of at least 3 cm, and lvsi of at least 50%", |
|
"score": 11.360668182373047, |
|
"articlesIDs": [ |
|
"33118165" |
|
] |
|
}, |
|
{ |
|
"text": "total testosterone", |
|
"score": 11.360209465026855, |
|
"articlesIDs": [ |
|
"35436960" |
|
] |
|
}, |
|
{ |
|
"text": "surgery in the first and second weeks after diagnosis", |
|
"score": 11.359113693237305, |
|
"articlesIDs": [ |
|
"27939327" |
|
] |
|
}, |
|
{ |
|
"text": "lvsi (emr = 7.69, ci 2.03-29.10,) and non-diploidy", |
|
"score": 11.350415229797363, |
|
"articlesIDs": [ |
|
"31373248" |
|
] |
|
}, |
|
{ |
|
"text": "nsaid use", |
|
"score": 11.345853805541992, |
|
"articlesIDs": [ |
|
"28376204" |
|
] |
|
}, |
|
{ |
|
"text": "western dietary pattern", |
|
"score": 11.344399452209473, |
|
"articlesIDs": [ |
|
"30806608" |
|
] |
|
}, |
|
{ |
|
"text": "cardiometabolic risk factors", |
|
"score": 11.344379425048828, |
|
"articlesIDs": [ |
|
"33151547" |
|
] |
|
}, |
|
{ |
|
"text": "smoking status", |
|
"score": 11.343571662902832, |
|
"articlesIDs": [ |
|
"36168194" |
|
] |
|
}, |
|
{ |
|
"text": "higher intakes of total folate, natural folate, b6 and b12", |
|
"score": 11.343194961547852, |
|
"articlesIDs": [ |
|
"30544261" |
|
] |
|
}, |
|
{ |
|
"text": "lifetime number of years of menstruation (lnym)", |
|
"score": 11.341712951660156, |
|
"articlesIDs": [ |
|
"29782643" |
|
] |
|
}, |
|
{ |
|
"text": "positive lymph nodes and myometrial invasion of \u003e50%", |
|
"score": 11.340296745300293, |
|
"articlesIDs": [ |
|
"28147240" |
|
] |
|
}, |
|
{ |
|
"text": "older age (odds ratio = 1.09, p \u003c 0.01) and complex subtype", |
|
"score": 11.335058212280273, |
|
"articlesIDs": [ |
|
"32945047" |
|
] |
|
}, |
|
{ |
|
"text": "in premenopausal bc patients treated with tamoxifen", |
|
"score": 11.328349113464355, |
|
"articlesIDs": [ |
|
"32233174" |
|
] |
|
}, |
|
{ |
|
"text": "the ratio of esterified to free carnitine", |
|
"score": 11.320877075195312, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "higher grade, older age and treated with radiation or chemotherapy", |
|
"score": 11.320650100708008, |
|
"articlesIDs": [ |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "trajectory 'overweight increasing to obese'", |
|
"score": 11.320446968078613, |
|
"articlesIDs": [ |
|
"34962692" |
|
] |
|
}, |
|
{ |
|
"text": "people of white ethnicity", |
|
"score": 11.313908576965332, |
|
"articlesIDs": [ |
|
"36690836" |
|
] |
|
}, |
|
{ |
|
"text": "women with high grade endometrioid", |
|
"score": 11.312784194946289, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "individuals with the higher body mass index (bmi)", |
|
"score": 11.309924125671387, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "a bmi of 25 or over", |
|
"score": 11.306678771972656, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "endocrine disruptors", |
|
"score": 11.30505657196045, |
|
"articlesIDs": [ |
|
"28327540" |
|
] |
|
}, |
|
{ |
|
"text": "menstrual irregularity, heavy menstrual bleeding, and vasomotor symptoms", |
|
"score": 11.285938262939453, |
|
"articlesIDs": [ |
|
"30288370" |
|
] |
|
}, |
|
{ |
|
"text": "patients with deep myometrial invasion (ib)", |
|
"score": 11.283679008483887, |
|
"articlesIDs": [ |
|
"28448305" |
|
] |
|
}, |
|
{ |
|
"text": "pravastatin use", |
|
"score": 11.275493621826172, |
|
"articlesIDs": [ |
|
"29422345" |
|
] |
|
}, |
|
{ |
|
"text": "patients who had a bmi greater than 30 and were smokers", |
|
"score": 11.275167465209961, |
|
"articlesIDs": [ |
|
"31226466" |
|
] |
|
}, |
|
{ |
|
"text": "chronic diseases (cd), such as hypertension, diabetes mellitus, dyslipidemia", |
|
"score": 11.27051067352295, |
|
"articlesIDs": [ |
|
"32190316" |
|
] |
|
}, |
|
{ |
|
"text": "bmi being above 25", |
|
"score": 11.269622802734375, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "presence of both macrometastasis in the pelvic basin", |
|
"score": 11.263537406921387, |
|
"articlesIDs": [ |
|
"31324453" |
|
] |
|
}, |
|
{ |
|
"text": "women who have 3 or 4 risk factors", |
|
"score": 11.255620956420898, |
|
"articlesIDs": [ |
|
"33151547" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, and insulin resistance", |
|
"score": 11.25132942199707, |
|
"articlesIDs": [ |
|
"32732107" |
|
] |
|
}, |
|
{ |
|
"text": "overweight women with pcos", |
|
"score": 11.245645523071289, |
|
"articlesIDs": [ |
|
"33645403" |
|
] |
|
}, |
|
{ |
|
"text": "rs4430796 a", |
|
"score": 11.242380142211914, |
|
"articlesIDs": [ |
|
"30053805" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥30 versus ≥18.5-\u003c25 kg/m", |
|
"score": 11.242351531982422, |
|
"articlesIDs": [ |
|
"35048536" |
|
] |
|
}, |
|
{ |
|
"text": "higher e-dii scores", |
|
"score": 11.236595153808594, |
|
"articlesIDs": [ |
|
"31823169" |
|
] |
|
}, |
|
{ |
|
"text": "high gi", |
|
"score": 11.23158073425293, |
|
"articlesIDs": [ |
|
"31581675" |
|
] |
|
}, |
|
{ |
|
"text": "widowed and unmarried patients", |
|
"score": 11.228705406188965, |
|
"articlesIDs": [ |
|
"31746633" |
|
] |
|
}, |
|
{ |
|
"text": "expression levels of mirna 205", |
|
"score": 11.221549987792969, |
|
"articlesIDs": [ |
|
"37056852" |
|
] |
|
}, |
|
{ |
|
"text": "greater recalled weight 1 year before diagnosis", |
|
"score": 11.221212387084961, |
|
"articlesIDs": [ |
|
"34597394" |
|
] |
|
}, |
|
{ |
|
"text": "a uterine transverse diameter of ≥5 cm", |
|
"score": 11.215553283691406, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "a western dietary pattern", |
|
"score": 11.21332836151123, |
|
"articlesIDs": [ |
|
"30806608" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome group", |
|
"score": 11.212305068969727, |
|
"articlesIDs": [ |
|
"35785211" |
|
] |
|
}, |
|
{ |
|
"text": "preoperative-aeh women with postmenopausal time ≥ 5 years", |
|
"score": 11.210976600646973, |
|
"articlesIDs": [ |
|
"35054175" |
|
] |
|
}, |
|
{ |
|
"text": "mets and mets components", |
|
"score": 11.208580017089844, |
|
"articlesIDs": [ |
|
"35320886" |
|
] |
|
}, |
|
{ |
|
"text": "people of white ethnicity and former/current smokers", |
|
"score": 11.208353042602539, |
|
"articlesIDs": [ |
|
"36690836" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparous women with ovulatory disturbances", |
|
"score": 11.201019287109375, |
|
"articlesIDs": [ |
|
"30623293" |
|
] |
|
}, |
|
{ |
|
"text": "glucose concentration, bmi, waist circumference", |
|
"score": 11.198892593383789, |
|
"articlesIDs": [ |
|
"29559794" |
|
] |
|
}, |
|
{ |
|
"text": "the malat1 rs664589 c\u003eg polymorphism", |
|
"score": 11.197721481323242, |
|
"articlesIDs": [ |
|
"31880028" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickness \u003e20 mm", |
|
"score": 11.186532020568848, |
|
"articlesIDs": [ |
|
"33071171" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi). in fact, (bmi \u003e 30 and \u003c35 kg/m2)", |
|
"score": 11.185375213623047, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "high body mass index (bmi)", |
|
"score": 11.184759140014648, |
|
"articlesIDs": [ |
|
"29297146" |
|
] |
|
}, |
|
{ |
|
"text": "bioavailable testosterone", |
|
"score": 11.179155349731445, |
|
"articlesIDs": [ |
|
"35436960" |
|
] |
|
}, |
|
{ |
|
"text": "myometrial infiltration \u003e50%, lymphovascular space involvement", |
|
"score": 11.177997589111328, |
|
"articlesIDs": [ |
|
"28226030" |
|
] |
|
}, |
|
{ |
|
"text": "never smoking", |
|
"score": 11.168760299682617, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "black men", |
|
"score": 11.163955688476562, |
|
"articlesIDs": [ |
|
"35143040" |
|
] |
|
}, |
|
{ |
|
"text": "short chain to free acylcarnitines", |
|
"score": 11.162073135375977, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic diseases", |
|
"score": 11.162004470825195, |
|
"articlesIDs": [ |
|
"36825346" |
|
] |
|
}, |
|
{ |
|
"text": "a bmi of 25 or over gave an increased risk of 2.01%, a bmi of 30 or over", |
|
"score": 11.15905475616455, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "never smokers", |
|
"score": 11.156604766845703, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "tamoxifen treatment in breast cancer patients", |
|
"score": 11.15414047241211, |
|
"articlesIDs": [ |
|
"28402678" |
|
] |
|
}, |
|
{ |
|
"text": "daily recreational screen time, particularly tv viewing,", |
|
"score": 11.152069091796875, |
|
"articlesIDs": [ |
|
"32746843" |
|
] |
|
}, |
|
{ |
|
"text": "tc were both independent risk factors for lvsi in ec. fbg and apo b", |
|
"score": 11.148778915405273, |
|
"articlesIDs": [ |
|
"35971461" |
|
] |
|
}, |
|
{ |
|
"text": "those with higher stage, higher grade, older age", |
|
"score": 11.14431381225586, |
|
"articlesIDs": [ |
|
"29289418" |
|
] |
|
}, |
|
{ |
|
"text": "adipose-tissue-derived bmi variants", |
|
"score": 11.141050338745117, |
|
"articlesIDs": [ |
|
"36434155" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding, obesity", |
|
"score": 11.137142181396484, |
|
"articlesIDs": [ |
|
"32360632" |
|
] |
|
}, |
|
{ |
|
"text": "never smoking. compared with controls, women with ec", |
|
"score": 11.136320114135742, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "l/a ratio", |
|
"score": 11.13370132446289, |
|
"articlesIDs": [ |
|
"36815556" |
|
] |
|
}, |
|
{ |
|
"text": "stage ii disease, deep myometrial invasion", |
|
"score": 11.132922172546387, |
|
"articlesIDs": [ |
|
"31650820" |
|
] |
|
}, |
|
{ |
|
"text": "the arg399gln", |
|
"score": 11.131278991699219, |
|
"articlesIDs": [ |
|
"28391259" |
|
] |
|
}, |
|
{ |
|
"text": "genetically predicted higher plasma vitc levels", |
|
"score": 11.117749214172363, |
|
"articlesIDs": [ |
|
"35402429" |
|
] |
|
}, |
|
{ |
|
"text": "the arg194trp", |
|
"score": 11.093698501586914, |
|
"articlesIDs": [ |
|
"28391259" |
|
] |
|
}, |
|
{ |
|
"text": "stages 3 and 4 disease, laparotomy, and age ( \u003c 0.1)", |
|
"score": 11.091638565063477, |
|
"articlesIDs": [ |
|
"32905281" |
|
] |
|
}, |
|
{ |
|
"text": "trunk fat mass index (hr: 1.72, 95% ci: 1.02-2.89) and wc", |
|
"score": 11.085697174072266, |
|
"articlesIDs": [ |
|
"33723399" |
|
] |
|
}, |
|
{ |
|
"text": "lnm", |
|
"score": 11.082452774047852, |
|
"articlesIDs": [ |
|
"36562131" |
|
] |
|
}, |
|
{ |
|
"text": "rs6729815", |
|
"score": 11.071975708007812, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of ≥2 other co-morbidities (excluding diabetes)", |
|
"score": 11.07163143157959, |
|
"articlesIDs": [ |
|
"29706522" |
|
] |
|
}, |
|
{ |
|
"text": "rs1427407 (or = 1.30, = 0.015), rs766432 (or = 1.27, = 0.025), and rs6729815", |
|
"score": 11.065397262573242, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "bmi, fasting blood sugar, triglyceride, hyper density lipoprotein (hdl)", |
|
"score": 11.062077522277832, |
|
"articlesIDs": [ |
|
"33258710" |
|
] |
|
}, |
|
{ |
|
"text": "a blood cadmium concentration above the median", |
|
"score": 11.045062065124512, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "older age, stage ii disease, deep myometrial invasion", |
|
"score": 11.029623031616211, |
|
"articlesIDs": [ |
|
"31650820" |
|
] |
|
}, |
|
{ |
|
"text": "bmi of 40 or over led to an increase of 6.9%. pcos", |
|
"score": 11.013565063476562, |
|
"articlesIDs": [ |
|
"34359595" |
|
] |
|
}, |
|
{ |
|
"text": "arg399gln genotype", |
|
"score": 11.009553909301758, |
|
"articlesIDs": [ |
|
"34918657" |
|
] |
|
}, |
|
{ |
|
"text": "deep myometrial invasion, and receiving adjuvant radiotherapy", |
|
"score": 11.0092134475708, |
|
"articlesIDs": [ |
|
"31650820" |
|
] |
|
}, |
|
{ |
|
"text": "patients received chest irradiation at young age", |
|
"score": 11.007728576660156, |
|
"articlesIDs": [ |
|
"29019328" |
|
] |
|
}, |
|
{ |
|
"text": "higher a median cd concentration", |
|
"score": 11.007057189941406, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "increase in tumor size per centimeter", |
|
"score": 11.006855010986328, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "weight gain and bmi gain", |
|
"score": 10.998004913330078, |
|
"articlesIDs": [ |
|
"37029916" |
|
] |
|
}, |
|
{ |
|
"text": "patients without uterine leiomyomas", |
|
"score": 10.99339771270752, |
|
"articlesIDs": [ |
|
"32850188" |
|
] |
|
}, |
|
{ |
|
"text": "'normal weight increasing to overweight'", |
|
"score": 10.992940902709961, |
|
"articlesIDs": [ |
|
"34962692" |
|
] |
|
}, |
|
{ |
|
"text": "surgery in the first 2 weeks after diagnosis of endometrial cancer", |
|
"score": 10.987480163574219, |
|
"articlesIDs": [ |
|
"27939327" |
|
] |
|
}, |
|
{ |
|
"text": "sphingomyelin [sm] c18:0", |
|
"score": 10.984527587890625, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "women diagnosed with endometriosis", |
|
"score": 10.982938766479492, |
|
"articlesIDs": [ |
|
"30623293" |
|
] |
|
}, |
|
{ |
|
"text": "that of short chain to free acylcarnitines", |
|
"score": 10.980756759643555, |
|
"articlesIDs": [ |
|
"34099314" |
|
] |
|
}, |
|
{ |
|
"text": "fbg and tc were both independent risk factors for lvsi in ec. fbg and apo b", |
|
"score": 10.980204582214355, |
|
"articlesIDs": [ |
|
"35971461" |
|
] |
|
}, |
|
{ |
|
"text": "genetically predicted circulating protein concentrations", |
|
"score": 10.973563194274902, |
|
"articlesIDs": [ |
|
"33925895" |
|
] |
|
}, |
|
{ |
|
"text": "never smokers (rr 0.68, 95% ci: 0.56-0.84), ever smokers", |
|
"score": 10.963619232177734, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "patients with dm", |
|
"score": 10.9622163772583, |
|
"articlesIDs": [ |
|
"36042597" |
|
] |
|
}, |
|
{ |
|
"text": "weight cycling and weight gain in middle age", |
|
"score": 10.961332321166992, |
|
"articlesIDs": [ |
|
"30426278" |
|
] |
|
}, |
|
{ |
|
"text": "prolonged sedentary behavior", |
|
"score": 10.96006965637207, |
|
"articlesIDs": [ |
|
"30887424" |
|
] |
|
}, |
|
{ |
|
"text": "patients with diabetes than in those without diabetes", |
|
"score": 10.959846496582031, |
|
"articlesIDs": [ |
|
"32392663" |
|
] |
|
}, |
|
{ |
|
"text": "women with ec more often reported a history of diabetes, hypertension", |
|
"score": 10.958599090576172, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal uterine bleeding, obesity, elevated fasting glucose)", |
|
"score": 10.954465866088867, |
|
"articlesIDs": [ |
|
"32360632" |
|
] |
|
}, |
|
{ |
|
"text": "age, educational status, smoking status", |
|
"score": 10.953535079956055, |
|
"articlesIDs": [ |
|
"36168194" |
|
] |
|
}, |
|
{ |
|
"text": "crf", |
|
"score": 10.953472137451172, |
|
"articlesIDs": [ |
|
"31012272" |
|
] |
|
}, |
|
{ |
|
"text": "lymphatic vascular space invasion (lvsi), diffuse lesions", |
|
"score": 10.952441215515137, |
|
"articlesIDs": [ |
|
"29061125" |
|
] |
|
}, |
|
{ |
|
"text": "any gout drugs use", |
|
"score": 10.948396682739258, |
|
"articlesIDs": [ |
|
"29427783" |
|
] |
|
}, |
|
{ |
|
"text": "heavy menstrual bleeding (aub-hmb) and intermenstrual bleeding (aub-imb)", |
|
"score": 10.941404342651367, |
|
"articlesIDs": [ |
|
"29696944" |
|
] |
|
}, |
|
{ |
|
"text": "women undergoing primary treatment for endometrial cancer", |
|
"score": 10.938400268554688, |
|
"articlesIDs": [ |
|
"29174567" |
|
] |
|
}, |
|
{ |
|
"text": "symptomatic vte", |
|
"score": 10.930696487426758, |
|
"articlesIDs": [ |
|
"36652383" |
|
] |
|
}, |
|
{ |
|
"text": "aromatization of androstenedione to estrogen", |
|
"score": 10.927454948425293, |
|
"articlesIDs": [ |
|
"32489965" |
|
] |
|
}, |
|
{ |
|
"text": "plasma leptin level and l/a ratio", |
|
"score": 10.926136016845703, |
|
"articlesIDs": [ |
|
"36815556" |
|
] |
|
}, |
|
{ |
|
"text": "myometrial invasion and lymphovascular space invasion", |
|
"score": 10.923650741577148, |
|
"articlesIDs": [ |
|
"34706876" |
|
] |
|
}, |
|
{ |
|
"text": "existence of aub (or=2.4; 95% ci [1.07-5.42]) and family history", |
|
"score": 10.921844482421875, |
|
"articlesIDs": [ |
|
"28763739" |
|
] |
|
}, |
|
{ |
|
"text": "1 cup of coffee/day", |
|
"score": 10.91378402709961, |
|
"articlesIDs": [ |
|
"28288025" |
|
] |
|
}, |
|
{ |
|
"text": "cd4+ t% and natural killer cell (nk)%", |
|
"score": 10.90665054321289, |
|
"articlesIDs": [ |
|
"36386586" |
|
] |
|
}, |
|
{ |
|
"text": "uterine risk groups", |
|
"score": 10.902579307556152, |
|
"articlesIDs": [ |
|
"31912677" |
|
] |
|
}, |
|
{ |
|
"text": "high dietary gi but not gl", |
|
"score": 10.900093078613281, |
|
"articlesIDs": [ |
|
"27986350" |
|
] |
|
}, |
|
{ |
|
"text": "loss of mlh1/pms2", |
|
"score": 10.898292541503906, |
|
"articlesIDs": [ |
|
"32294063" |
|
] |
|
}, |
|
{ |
|
"text": "adipose-tissue-derived bmi variants may predominantly drive the effect of bmi", |
|
"score": 10.897974014282227, |
|
"articlesIDs": [ |
|
"36434155" |
|
] |
|
}, |
|
{ |
|
"text": "women that underwent only chemotherapy during the first six months", |
|
"score": 10.891624450683594, |
|
"articlesIDs": [ |
|
"34717579" |
|
] |
|
}, |
|
{ |
|
"text": "those who recovered, developed, or had persistent mets", |
|
"score": 10.887880325317383, |
|
"articlesIDs": [ |
|
"37139668" |
|
] |
|
}, |
|
{ |
|
"text": "rs10189857 (or = 1.26, = 0.028), rs1427407 (or = 1.30, = 0.015), rs766432", |
|
"score": 10.882989883422852, |
|
"articlesIDs": [ |
|
"35418772" |
|
] |
|
}, |
|
{ |
|
"text": "obesity and insulin resistance", |
|
"score": 10.879377365112305, |
|
"articlesIDs": [ |
|
"31954096" |
|
] |
|
}, |
|
{ |
|
"text": "10 mm endometrial thickness", |
|
"score": 10.869930267333984, |
|
"articlesIDs": [ |
|
"36576124" |
|
] |
|
}, |
|
{ |
|
"text": "overweight and obese women with pcos", |
|
"score": 10.86775016784668, |
|
"articlesIDs": [ |
|
"33645403" |
|
] |
|
}, |
|
{ |
|
"text": "cvcs in endometrial, colorectal and ovarian; chemotherapy", |
|
"score": 10.866766929626465, |
|
"articlesIDs": [ |
|
"32300436" |
|
] |
|
}, |
|
{ |
|
"text": "3-12 months", |
|
"score": 10.865646362304688, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "frailty", |
|
"score": 10.864897727966309, |
|
"articlesIDs": [ |
|
"33640158" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi) and bmi-adjusted waist-to-hip ratio (whradjbmi)", |
|
"score": 10.862883567810059, |
|
"articlesIDs": [ |
|
"36558416" |
|
] |
|
}, |
|
{ |
|
"text": "mi ≥ 50%, nonendometrioid histology and figo grade 3", |
|
"score": 10.858881950378418, |
|
"articlesIDs": [ |
|
"28340503" |
|
] |
|
}, |
|
{ |
|
"text": "systemic arterial hypertension", |
|
"score": 10.855417251586914, |
|
"articlesIDs": [ |
|
"29454147" |
|
] |
|
}, |
|
{ |
|
"text": "0-3 months (sir = 330.36 (95% ci: 315.43-345.81)), 3-12 months", |
|
"score": 10.849720001220703, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "high level of cd", |
|
"score": 10.847243309020996, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "sugar-sweetened beverages (ssbs) intake in the highest tertile", |
|
"score": 10.8464994430542, |
|
"articlesIDs": [ |
|
"33220638" |
|
] |
|
}, |
|
{ |
|
"text": "high mvpa (≥ 15 met-hours/week", |
|
"score": 10.84427261352539, |
|
"articlesIDs": [ |
|
"33185805" |
|
] |
|
}, |
|
{ |
|
"text": "microbiome dysbiosis", |
|
"score": 10.82138729095459, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "exposure to gonadotropins", |
|
"score": 10.818567276000977, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "the lack of recognition and evaluation of postmenopausal bleeding", |
|
"score": 10.816780090332031, |
|
"articlesIDs": [ |
|
"30291839" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥50", |
|
"score": 10.81613540649414, |
|
"articlesIDs": [ |
|
"37172411" |
|
] |
|
}, |
|
{ |
|
"text": "both lower and higher birth weights", |
|
"score": 10.801759719848633, |
|
"articlesIDs": [ |
|
"29331371" |
|
] |
|
}, |
|
{ |
|
"text": "the hogg1 ser326cys polymorphism", |
|
"score": 10.79790210723877, |
|
"articlesIDs": [ |
|
"33210702" |
|
] |
|
}, |
|
{ |
|
"text": "hypothyroidism", |
|
"score": 10.79013729095459, |
|
"articlesIDs": [ |
|
"30705778" |
|
] |
|
}, |
|
{ |
|
"text": "sex hormone-binding globulin (shbg", |
|
"score": 10.785439491271973, |
|
"articlesIDs": [ |
|
"35436960" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi) greater than 30", |
|
"score": 10.783288955688477, |
|
"articlesIDs": [ |
|
"31226466" |
|
] |
|
}, |
|
{ |
|
"text": "3-12 months (sir = 11.39 (95% ci: 9.79-13.17)), 1-5 years", |
|
"score": 10.765481948852539, |
|
"articlesIDs": [ |
|
"31806879" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular space involvement, pelvic lymph node involvement by imaging", |
|
"score": 10.762548446655273, |
|
"articlesIDs": [ |
|
"28226030" |
|
] |
|
}, |
|
{ |
|
"text": "obese women who recovered from mets or persistently had mets", |
|
"score": 10.75768756866455, |
|
"articlesIDs": [ |
|
"37139668" |
|
] |
|
}, |
|
{ |
|
"text": "long-term use (\u003e20 years", |
|
"score": 10.746675491333008, |
|
"articlesIDs": [ |
|
"33433939" |
|
] |
|
}, |
|
{ |
|
"text": "insulin resistance, and diabetes", |
|
"score": 10.742242813110352, |
|
"articlesIDs": [ |
|
"32489965" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic syndrome components in the pre-menopausal subgroup", |
|
"score": 10.739660263061523, |
|
"articlesIDs": [ |
|
"35785211" |
|
] |
|
}, |
|
{ |
|
"text": "hispanic or asian/other/unknown race/ethnicity", |
|
"score": 10.732580184936523, |
|
"articlesIDs": [ |
|
"37172411" |
|
] |
|
}, |
|
{ |
|
"text": "ca125, roma, fbg, tc and er", |
|
"score": 10.730463027954102, |
|
"articlesIDs": [ |
|
"35971461" |
|
] |
|
}, |
|
{ |
|
"text": "sustained oestrogen exposure", |
|
"score": 10.726339340209961, |
|
"articlesIDs": [ |
|
"30706844" |
|
] |
|
}, |
|
{ |
|
"text": "10 mm endometrial thickness cut-off point", |
|
"score": 10.719383239746094, |
|
"articlesIDs": [ |
|
"36576124" |
|
] |
|
}, |
|
{ |
|
"text": "the highest dbp levels", |
|
"score": 10.716541290283203, |
|
"articlesIDs": [ |
|
"35622390" |
|
] |
|
}, |
|
{ |
|
"text": "anovulatory cycles, obesity, and insulin resistance", |
|
"score": 10.71400260925293, |
|
"articlesIDs": [ |
|
"32732107" |
|
] |
|
}, |
|
{ |
|
"text": "high nox4 expression", |
|
"score": 10.71390438079834, |
|
"articlesIDs": [ |
|
"30813866" |
|
] |
|
}, |
|
{ |
|
"text": "highest dii category", |
|
"score": 10.698400497436523, |
|
"articlesIDs": [ |
|
"30887752" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular invasion, and volume index ≥36", |
|
"score": 10.696216583251953, |
|
"articlesIDs": [ |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "mrs", |
|
"score": 10.687719345092773, |
|
"articlesIDs": [ |
|
"36844632" |
|
] |
|
}, |
|
{ |
|
"text": "abnormalities in ovarian morphology as well as metabolic disorders. pcos", |
|
"score": 10.685853958129883, |
|
"articlesIDs": [ |
|
"31485206" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥ 40 vs. \u003c 25 kg/m", |
|
"score": 10.678609848022461, |
|
"articlesIDs": [ |
|
"36418803" |
|
] |
|
}, |
|
{ |
|
"text": "patients with low levels", |
|
"score": 10.668248176574707, |
|
"articlesIDs": [ |
|
"35267933" |
|
] |
|
}, |
|
{ |
|
"text": "patients with gynecologic cancer and symptomatic vte", |
|
"score": 10.664958953857422, |
|
"articlesIDs": [ |
|
"36652383" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, diabetes, and increased estrogen exposure", |
|
"score": 10.65650749206543, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "circulating concentrations of testosterone and shbg", |
|
"score": 10.64876937866211, |
|
"articlesIDs": [ |
|
"34363033" |
|
] |
|
}, |
|
{ |
|
"text": "female smokers diagnosed with cancer of the breast, ovary, or endometrium", |
|
"score": 10.6410493850708, |
|
"articlesIDs": [ |
|
"36805551" |
|
] |
|
}, |
|
{ |
|
"text": "overweight bmi and of ht use", |
|
"score": 10.639413833618164, |
|
"articlesIDs": [ |
|
"32011733" |
|
] |
|
}, |
|
{ |
|
"text": "leisure sedentary behavior (lsb)", |
|
"score": 10.633010864257812, |
|
"articlesIDs": [ |
|
"37148539" |
|
] |
|
}, |
|
{ |
|
"text": "users aged 20-39 years", |
|
"score": 10.63093376159668, |
|
"articlesIDs": [ |
|
"36835224" |
|
] |
|
}, |
|
{ |
|
"text": "women with hyperglycemia, dyslipidemia and hypertension, in combination", |
|
"score": 10.615715026855469, |
|
"articlesIDs": [ |
|
"30788634" |
|
] |
|
}, |
|
{ |
|
"text": "menopausal status (pr, 1.67; 95% ci, 1.48-1.89; i, 78.4%), age \u003e60 years", |
|
"score": 10.607568740844727, |
|
"articlesIDs": [ |
|
"29454147" |
|
] |
|
}, |
|
{ |
|
"text": "highest dose-responses per 50 g increases in processed meat intake", |
|
"score": 10.600603103637695, |
|
"articlesIDs": [ |
|
"28792013" |
|
] |
|
}, |
|
{ |
|
"text": "parametrial invasion and no lymphadenectomy", |
|
"score": 10.59788703918457, |
|
"articlesIDs": [ |
|
"36316771" |
|
] |
|
}, |
|
{ |
|
"text": "high level of cd (or 1.49; 95% ci 1.31-1.63) and a low level of co", |
|
"score": 10.597162246704102, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "exposure to soil (or, 2.16; 95% ci [1.14-4.10]; = 0.019), being a farm-worker", |
|
"score": 10.59415054321289, |
|
"articlesIDs": [ |
|
"36540800" |
|
] |
|
}, |
|
{ |
|
"text": "'normal weight increasing to overweight' and the 'overweight-stable'", |
|
"score": 10.592543601989746, |
|
"articlesIDs": [ |
|
"34962692" |
|
] |
|
}, |
|
{ |
|
"text": "caffeinated coffee drinkers", |
|
"score": 10.592228889465332, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "additional paraaortic lymph node dissection (paolnd)", |
|
"score": 10.579540252685547, |
|
"articlesIDs": [ |
|
"36738486" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension, diabetes mellitus, using of tamoxifen)", |
|
"score": 10.563096046447754, |
|
"articlesIDs": [ |
|
"32527101" |
|
] |
|
}, |
|
{ |
|
"text": "increase in body mass index", |
|
"score": 10.557199478149414, |
|
"articlesIDs": [ |
|
"34610970" |
|
] |
|
}, |
|
{ |
|
"text": "a significant family history of cancer and hgsc", |
|
"score": 10.556825637817383, |
|
"articlesIDs": [ |
|
"31815095" |
|
] |
|
}, |
|
{ |
|
"text": "type 2 cancer", |
|
"score": 10.544252395629883, |
|
"articlesIDs": [ |
|
"30602164" |
|
] |
|
}, |
|
{ |
|
"text": "women with mets", |
|
"score": 10.543509483337402, |
|
"articlesIDs": [ |
|
"32439832" |
|
] |
|
}, |
|
{ |
|
"text": "patients with inflammatory bowel disease (ibd)", |
|
"score": 10.53480339050293, |
|
"articlesIDs": [ |
|
"29462389" |
|
] |
|
}, |
|
{ |
|
"text": "high body-mass index (bmi)", |
|
"score": 10.533687591552734, |
|
"articlesIDs": [ |
|
"29195904", |
|
"29803268" |
|
] |
|
}, |
|
{ |
|
"text": "menopausal change and obesity", |
|
"score": 10.533348083496094, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "elevated insulin or insulin-like growth factor signaling in obese women", |
|
"score": 10.53129768371582, |
|
"articlesIDs": [ |
|
"31520353" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes status of patients", |
|
"score": 10.530281066894531, |
|
"articlesIDs": [ |
|
"36981043" |
|
] |
|
}, |
|
{ |
|
"text": "women with 3 to 4 risk factors (vs none)", |
|
"score": 10.521982192993164, |
|
"articlesIDs": [ |
|
"33151547" |
|
] |
|
}, |
|
{ |
|
"text": "women aged 60+ years", |
|
"score": 10.521291732788086, |
|
"articlesIDs": [ |
|
"32268124" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index (bmi) ≥30 versus ≥18.5-\u003c25 kg/m", |
|
"score": 10.52078914642334, |
|
"articlesIDs": [ |
|
"33008875" |
|
] |
|
}, |
|
{ |
|
"text": "women using e alone", |
|
"score": 10.51962661743164, |
|
"articlesIDs": [ |
|
"30183089" |
|
] |
|
}, |
|
{ |
|
"text": "high cd levels with gstp1", |
|
"score": 10.511805534362793, |
|
"articlesIDs": [ |
|
"35893933" |
|
] |
|
}, |
|
{ |
|
"text": "age \u003e60 years (pr, 2.41; 95% ci, 1.84-3.16; i, 81.5%), diabetes mellitus", |
|
"score": 10.509540557861328, |
|
"articlesIDs": [ |
|
"29454147" |
|
] |
|
}, |
|
{ |
|
"text": "high blood pressure, bmi", |
|
"score": 10.486221313476562, |
|
"articlesIDs": [ |
|
"33258710" |
|
] |
|
}, |
|
{ |
|
"text": "bmi and ec incidence (p \u003c 0.0001) the or comparing bmi ≥ 40 vs. \u003c 25 kg/m", |
|
"score": 10.48124885559082, |
|
"articlesIDs": [ |
|
"36418803" |
|
] |
|
}, |
|
{ |
|
"text": "lynch syndrome-related cancers", |
|
"score": 10.475824356079102, |
|
"articlesIDs": [ |
|
"34114732" |
|
] |
|
}, |
|
{ |
|
"text": "bmi of at least 30.0 kg/m", |
|
"score": 10.47545051574707, |
|
"articlesIDs": [ |
|
"29672353" |
|
] |
|
}, |
|
{ |
|
"text": "being overweight and centrally obese", |
|
"score": 10.475183486938477, |
|
"articlesIDs": [ |
|
"33381801" |
|
] |
|
}, |
|
{ |
|
"text": "older age, advanced stage", |
|
"score": 10.463523864746094, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "microcystic, elongated and fragmented (melf) pattern of invasion", |
|
"score": 10.460289001464844, |
|
"articlesIDs": [ |
|
"29061125" |
|
] |
|
}, |
|
{ |
|
"text": "bmi, he4 levels", |
|
"score": 10.45803451538086, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "leptin, crp", |
|
"score": 10.445094108581543, |
|
"articlesIDs": [ |
|
"35048536" |
|
] |
|
}, |
|
{ |
|
"text": "patients with normal-sized uteri, a uterine transverse diameter of ≥5 cm", |
|
"score": 10.444639205932617, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "the number of live births", |
|
"score": 10.439546585083008, |
|
"articlesIDs": [ |
|
"36320039" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (pr, 1.41; 95% ci:1.13-1.76; i, 41.2%), and tamoxifen use", |
|
"score": 10.433859825134277, |
|
"articlesIDs": [ |
|
"29454147" |
|
] |
|
}, |
|
{ |
|
"text": "age (or=1.06; 95%ci [1.02-1.10]), existence of aub", |
|
"score": 10.429094314575195, |
|
"articlesIDs": [ |
|
"28763739" |
|
] |
|
}, |
|
{ |
|
"text": "rural endometrial cancer patients in utah were older at diagnosis", |
|
"score": 10.415616989135742, |
|
"articlesIDs": [ |
|
"31291920" |
|
] |
|
}, |
|
{ |
|
"text": "gc", |
|
"score": 10.415056228637695, |
|
"articlesIDs": [ |
|
"31651558" |
|
] |
|
}, |
|
{ |
|
"text": "\u003e 50% myometrial invasion", |
|
"score": 10.4002685546875, |
|
"articlesIDs": [ |
|
"29541859" |
|
] |
|
}, |
|
{ |
|
"text": "age (aor 1.06 95% ci 1.02, 1.10) and bmi", |
|
"score": 10.39773941040039, |
|
"articlesIDs": [ |
|
"28396018" |
|
] |
|
}, |
|
{ |
|
"text": "black ethnicity", |
|
"score": 10.391067504882812, |
|
"articlesIDs": [ |
|
"31104512" |
|
] |
|
}, |
|
{ |
|
"text": "early (\u003c55 years) onset endometrial cancer", |
|
"score": 10.390575408935547, |
|
"articlesIDs": [ |
|
"28815572" |
|
] |
|
}, |
|
{ |
|
"text": "asymptomatic endometrial thickening (aet)", |
|
"score": 10.385272979736328, |
|
"articlesIDs": [ |
|
"36576124" |
|
] |
|
}, |
|
{ |
|
"text": "dietary gi/gl", |
|
"score": 10.382369995117188, |
|
"articlesIDs": [ |
|
"33745582" |
|
] |
|
}, |
|
{ |
|
"text": "first year after diagnosis", |
|
"score": 10.381211280822754, |
|
"articlesIDs": [ |
|
"31761945" |
|
] |
|
}, |
|
{ |
|
"text": "ppi use", |
|
"score": 10.376697540283203, |
|
"articlesIDs": [ |
|
"35968582" |
|
] |
|
}, |
|
{ |
|
"text": "genetic risk", |
|
"score": 10.371600151062012, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "exposure to endocrine disruptor compounds (edcs)", |
|
"score": 10.370526313781738, |
|
"articlesIDs": [ |
|
"28327540" |
|
] |
|
}, |
|
{ |
|
"text": "nox4 transcripts", |
|
"score": 10.366020202636719, |
|
"articlesIDs": [ |
|
"30813866" |
|
] |
|
}, |
|
{ |
|
"text": "a higher waist circumference", |
|
"score": 10.362916946411133, |
|
"articlesIDs": [ |
|
"33151547" |
|
] |
|
}, |
|
{ |
|
"text": "patients with the hgsc subtype. selected patients with hgsc", |
|
"score": 10.360271453857422, |
|
"articlesIDs": [ |
|
"31815095" |
|
] |
|
}, |
|
{ |
|
"text": "the female gut microbiome", |
|
"score": 10.350903511047363, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "g allele", |
|
"score": 10.349011421203613, |
|
"articlesIDs": [ |
|
"29096752" |
|
] |
|
}, |
|
{ |
|
"text": "ivf (or 1.32; 95% ci 1.03-1.69) and clomiphene citrate (cc) treatment", |
|
"score": 10.342155456542969, |
|
"articlesIDs": [ |
|
"33586777" |
|
] |
|
}, |
|
{ |
|
"text": "menopausal hormone therapy (mht)", |
|
"score": 10.335409164428711, |
|
"articlesIDs": [ |
|
"34379634", |
|
"33813609" |
|
] |
|
}, |
|
{ |
|
"text": "lymphovascular invasion (lvi)", |
|
"score": 10.334894180297852, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "variants in mlh1", |
|
"score": 10.333478927612305, |
|
"articlesIDs": [ |
|
"34245638" |
|
] |
|
}, |
|
{ |
|
"text": ", higher dietary inflammatory and insulinemic potential", |
|
"score": 10.330731391906738, |
|
"articlesIDs": [ |
|
"36515492" |
|
] |
|
}, |
|
{ |
|
"text": "women with endometrial cancer", |
|
"score": 10.3302001953125, |
|
"articlesIDs": [ |
|
"34717579", |
|
"28006994", |
|
"29174567" |
|
] |
|
}, |
|
{ |
|
"text": "those with class iii obesity (bmi \u003e 40 kg/m)", |
|
"score": 10.32866096496582, |
|
"articlesIDs": [ |
|
"36589506", |
|
"36506038" |
|
] |
|
}, |
|
{ |
|
"text": "postoperative pain, liver disease", |
|
"score": 10.324460983276367, |
|
"articlesIDs": [ |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "presence of lymphovascular invasion (lvi)", |
|
"score": 10.319292068481445, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": ", blood type o", |
|
"score": 10.317763328552246, |
|
"articlesIDs": [ |
|
"36606697" |
|
] |
|
}, |
|
{ |
|
"text": "marital status", |
|
"score": 10.313347816467285, |
|
"articlesIDs": [ |
|
"34047792" |
|
] |
|
}, |
|
{ |
|
"text": "in patients with diabetes", |
|
"score": 10.310064315795898, |
|
"articlesIDs": [ |
|
"32392663" |
|
] |
|
}, |
|
{ |
|
"text": "obese bmis", |
|
"score": 10.303609848022461, |
|
"articlesIDs": [ |
|
"29346467" |
|
] |
|
}, |
|
{ |
|
"text": "higher he4 and ca125 levels among premenopausal patients", |
|
"score": 10.298050880432129, |
|
"articlesIDs": [ |
|
"28239284" |
|
] |
|
}, |
|
{ |
|
"text": "bmi, waist circumference, leptin, and vaspin concentrations", |
|
"score": 10.291719436645508, |
|
"articlesIDs": [ |
|
"29559794" |
|
] |
|
}, |
|
{ |
|
"text": "gynecologic cancer survivors", |
|
"score": 10.286691665649414, |
|
"articlesIDs": [ |
|
"36526929" |
|
] |
|
}, |
|
{ |
|
"text": "those with class i obesity (bmi 30 to 34.9 kg/m)", |
|
"score": 10.28114128112793, |
|
"articlesIDs": [ |
|
"36589506", |
|
"36506038" |
|
] |
|
}, |
|
{ |
|
"text": "significantly greater wc and bmi", |
|
"score": 10.277956008911133, |
|
"articlesIDs": [ |
|
"33184824" |
|
] |
|
}, |
|
{ |
|
"text": "premenopausal bc patients treated with tamoxifen, abnormal uterine bleeding", |
|
"score": 10.266938209533691, |
|
"articlesIDs": [ |
|
"32233174" |
|
] |
|
}, |
|
{ |
|
"text": "older black women", |
|
"score": 10.259891510009766, |
|
"articlesIDs": [ |
|
"30291839" |
|
] |
|
}, |
|
{ |
|
"text": "pc3 (tall stature with high whr)", |
|
"score": 10.259076118469238, |
|
"articlesIDs": [ |
|
"36460776" |
|
] |
|
}, |
|
{ |
|
"text": "upsc (or 1.73, 95% ci 1.48-2.02, p \u003c 0.001) histology", |
|
"score": 10.251385688781738, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "extensive lvsi", |
|
"score": 10.246502876281738, |
|
"articlesIDs": [ |
|
"28359690" |
|
] |
|
}, |
|
{ |
|
"text": "especially obese women with pcos", |
|
"score": 10.240543365478516, |
|
"articlesIDs": [ |
|
"28901968" |
|
] |
|
}, |
|
{ |
|
"text": "preoperative pelvic pain (p\u003c0.001), preoperative heat pain hyperalgesia", |
|
"score": 10.236213684082031, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "symptom, bmi, he4 levels", |
|
"score": 10.226950645446777, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "advanced age, advanced disease esmo/esgo/estro subgroup", |
|
"score": 10.224832534790039, |
|
"articlesIDs": [ |
|
"30217355" |
|
] |
|
}, |
|
{ |
|
"text": "hypertensive individuals", |
|
"score": 10.224056243896484, |
|
"articlesIDs": [ |
|
"31189941" |
|
] |
|
}, |
|
{ |
|
"text": "type i ec had and association with ms with obesity", |
|
"score": 10.223457336425781, |
|
"articlesIDs": [ |
|
"33258710" |
|
] |
|
}, |
|
{ |
|
"text": "women who received bt", |
|
"score": 10.222585678100586, |
|
"articlesIDs": [ |
|
"28332987" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal pap smears", |
|
"score": 10.220319747924805, |
|
"articlesIDs": [ |
|
"31554386" |
|
] |
|
}, |
|
{ |
|
"text": "women with high grade endometrioid (sir=1.12, 95% ci 1.05 to 1.19), serous", |
|
"score": 10.218063354492188, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "obese women with intentional weight loss", |
|
"score": 10.215787887573242, |
|
"articlesIDs": [ |
|
"28165909" |
|
] |
|
}, |
|
{ |
|
"text": "had obese bmis", |
|
"score": 10.212820053100586, |
|
"articlesIDs": [ |
|
"29346467" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal cytology", |
|
"score": 10.210371971130371, |
|
"articlesIDs": [ |
|
"29280216" |
|
] |
|
}, |
|
{ |
|
"text": "high dosage", |
|
"score": 10.20180606842041, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "ri ≤0.5 (or=8.733, 95% ci 4.311-17.692), and et ≥10 mm", |
|
"score": 10.197086334228516, |
|
"articlesIDs": [ |
|
"36825346" |
|
] |
|
}, |
|
{ |
|
"text": "the level of selenium in the blood serum", |
|
"score": 10.197064399719238, |
|
"articlesIDs": [ |
|
"35267933" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial thickness ≥8 mm", |
|
"score": 10.195688247680664, |
|
"articlesIDs": [ |
|
"33148069" |
|
] |
|
}, |
|
{ |
|
"text": "γ-linolenic acid derived from plant sources", |
|
"score": 10.19095230102539, |
|
"articlesIDs": [ |
|
"36797668" |
|
] |
|
}, |
|
{ |
|
"text": "atypical glandular cells on screening cervical cytology)", |
|
"score": 10.183682441711426, |
|
"articlesIDs": [ |
|
"29683904", |
|
"29683909" |
|
] |
|
}, |
|
{ |
|
"text": "highest versus lowest gi and gl intakes", |
|
"score": 10.178585052490234, |
|
"articlesIDs": [ |
|
"31581675" |
|
] |
|
}, |
|
{ |
|
"text": "women ≤39 and ≥50 years old with eh", |
|
"score": 10.177877426147461, |
|
"articlesIDs": [ |
|
"33259545" |
|
] |
|
}, |
|
{ |
|
"text": "nulliparous women after art treatment", |
|
"score": 10.177013397216797, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "male-origin microchimerism (mom)", |
|
"score": 10.174920082092285, |
|
"articlesIDs": [ |
|
"35526517" |
|
] |
|
}, |
|
{ |
|
"text": "variants in mlh1 (p = 3.5 × 10 ), msh2", |
|
"score": 10.171643257141113, |
|
"articlesIDs": [ |
|
"34245638" |
|
] |
|
}, |
|
{ |
|
"text": "absence of cancer treatment", |
|
"score": 10.167791366577148, |
|
"articlesIDs": [ |
|
"31759190" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of diabetes mellitus (dm)", |
|
"score": 10.166930198669434, |
|
"articlesIDs": [ |
|
"36042597" |
|
] |
|
}, |
|
{ |
|
"text": "severe malnutrition (body mass index (bmi) \u003c18.5 + 10% weight loss)", |
|
"score": 10.161322593688965, |
|
"articlesIDs": [ |
|
"35241292" |
|
] |
|
}, |
|
{ |
|
"text": "variants in mlh1 (p = 3.5 × 10 ), msh2 (p = 3.1 × 10 ), and pms2", |
|
"score": 10.153587341308594, |
|
"articlesIDs": [ |
|
"34245638" |
|
] |
|
}, |
|
{ |
|
"text": "ivf (or 1.32; 95% ci 1.03-1.69) and clomiphene citrate (cc) treatment group", |
|
"score": 10.1494722366333, |
|
"articlesIDs": [ |
|
"33586777" |
|
] |
|
}, |
|
{ |
|
"text": "high versus low gi", |
|
"score": 10.147303581237793, |
|
"articlesIDs": [ |
|
"31581675" |
|
] |
|
}, |
|
{ |
|
"text": "serum insulin", |
|
"score": 10.134010314941406, |
|
"articlesIDs": [ |
|
"29438162" |
|
] |
|
}, |
|
{ |
|
"text": "nitrate-nitrogen () in public water supplies (pws)", |
|
"score": 10.132987022399902, |
|
"articlesIDs": [ |
|
"35622390" |
|
] |
|
}, |
|
{ |
|
"text": "tg/hdl-c ratio ≥ 1.52", |
|
"score": 10.130146026611328, |
|
"articlesIDs": [ |
|
"30887645" |
|
] |
|
}, |
|
{ |
|
"text": "no tamoxifen use group", |
|
"score": 10.123064041137695, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "patients with significantly greater wc and bmi", |
|
"score": 10.120948791503906, |
|
"articlesIDs": [ |
|
"33184824" |
|
] |
|
}, |
|
{ |
|
"text": "cardiometabolic risk factors before the cancer diagnosis", |
|
"score": 10.120081901550293, |
|
"articlesIDs": [ |
|
"33151547" |
|
] |
|
}, |
|
{ |
|
"text": "among those classified as mu/nw", |
|
"score": 10.112462043762207, |
|
"articlesIDs": [ |
|
"35437568" |
|
] |
|
}, |
|
{ |
|
"text": "aromatization of androstenedione to estrogen, insulin resistance", |
|
"score": 10.101181030273438, |
|
"articlesIDs": [ |
|
"32489965" |
|
] |
|
}, |
|
{ |
|
"text": "high-fat and meat diets", |
|
"score": 10.099285125732422, |
|
"articlesIDs": [ |
|
"30706844" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension, and never smoking", |
|
"score": 10.096830368041992, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "age, symptom, bmi, he4 levels", |
|
"score": 10.095891952514648, |
|
"articlesIDs": [ |
|
"29660578" |
|
] |
|
}, |
|
{ |
|
"text": "increment of 1 cup of coffee/day", |
|
"score": 10.094148635864258, |
|
"articlesIDs": [ |
|
"28288025" |
|
] |
|
}, |
|
{ |
|
"text": "long-term oc users who were smokers", |
|
"score": 10.07722282409668, |
|
"articlesIDs": [ |
|
"29346467" |
|
] |
|
}, |
|
{ |
|
"text": "radiation exposure", |
|
"score": 10.076797485351562, |
|
"articlesIDs": [ |
|
"28396018" |
|
] |
|
}, |
|
{ |
|
"text": "higher prevalence of preoperative pelvic pain", |
|
"score": 10.074861526489258, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "free testosterone (hr per unit log scale = 2.07, 95% ci = 1.66-2.58)", |
|
"score": 10.070657730102539, |
|
"articlesIDs": [ |
|
"34363033" |
|
] |
|
}, |
|
{ |
|
"text": "ec patients with prior bc and family history of ec for brca1", |
|
"score": 10.069788932800293, |
|
"articlesIDs": [ |
|
"34245638" |
|
] |
|
}, |
|
{ |
|
"text": "hypertension, and never smoking. compared with controls, women with ec", |
|
"score": 10.064390182495117, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "serous (sir=1.24, 95% ci 1.11 to 1.38), carcinosarcoma", |
|
"score": 10.0527982711792, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "cancer-related fatigue (crf)", |
|
"score": 10.045101165771484, |
|
"articlesIDs": [ |
|
"31012272" |
|
] |
|
}, |
|
{ |
|
"text": "women with low mvpa (\u003e 0-\u003c 7.5 met-hours/week", |
|
"score": 10.042313575744629, |
|
"articlesIDs": [ |
|
"33185805" |
|
] |
|
}, |
|
{ |
|
"text": "insulin resistance (ir)", |
|
"score": 10.02498722076416, |
|
"articlesIDs": [ |
|
"32911852" |
|
] |
|
}, |
|
{ |
|
"text": "black tea", |
|
"score": 10.024919509887695, |
|
"articlesIDs": [ |
|
"36678274" |
|
] |
|
}, |
|
{ |
|
"text": "postoperative pain, liver disease, and decreased immune function", |
|
"score": 10.02248477935791, |
|
"articlesIDs": [ |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "multiple polyps compared to single polyp group", |
|
"score": 10.001886367797852, |
|
"articlesIDs": [ |
|
"36332539" |
|
] |
|
}, |
|
{ |
|
"text": "nonendometrioid grade 1 or 2, lymphovascular invasion", |
|
"score": 10.001062393188477, |
|
"articlesIDs": [ |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "reduced adiponectin", |
|
"score": 9.997371673583984, |
|
"articlesIDs": [ |
|
"33008875" |
|
] |
|
}, |
|
{ |
|
"text": "recurrent episode of bleeding", |
|
"score": 9.98599624633789, |
|
"articlesIDs": [ |
|
"31942153" |
|
] |
|
}, |
|
{ |
|
"text": "those with lvsi", |
|
"score": 9.969406127929688, |
|
"articlesIDs": [ |
|
"31328462" |
|
] |
|
}, |
|
{ |
|
"text": "those who never used hormone replacement therapy (hrt)", |
|
"score": 9.96923828125, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "cadmium (cd) and lead (pb)", |
|
"score": 9.967039108276367, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "1p36.12", |
|
"score": 9.963508605957031, |
|
"articlesIDs": [ |
|
"34268601" |
|
] |
|
}, |
|
{ |
|
"text": "upstaged ≥ib, nonendometrioid grade 1 or 2, lymphovascular invasion", |
|
"score": 9.961029052734375, |
|
"articlesIDs": [ |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "high number of cycles", |
|
"score": 9.958368301391602, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "in women with a bmi of at least 27.0 kg/m", |
|
"score": 9.947556495666504, |
|
"articlesIDs": [ |
|
"29672353" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal state, obesity", |
|
"score": 9.945756912231445, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "obese women with mets", |
|
"score": 9.942934036254883, |
|
"articlesIDs": [ |
|
"35320886" |
|
] |
|
}, |
|
{ |
|
"text": "urban areas and in buddhists", |
|
"score": 9.936969757080078, |
|
"articlesIDs": [ |
|
"30740954" |
|
] |
|
}, |
|
{ |
|
"text": "age, postmenopausal state, obesity", |
|
"score": 9.924345016479492, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "dietary gi and risk of endometrial cancer; such that a-10 unit increase in gi", |
|
"score": 9.923600196838379, |
|
"articlesIDs": [ |
|
"31477367" |
|
] |
|
}, |
|
{ |
|
"text": "the number of years ovulating", |
|
"score": 9.91718864440918, |
|
"articlesIDs": [ |
|
"36320039" |
|
] |
|
}, |
|
{ |
|
"text": "users aged 20-39 years (aor: 2.54, 95% ci: 1.79-3.61), 40-64 years", |
|
"score": 9.914320945739746, |
|
"articlesIDs": [ |
|
"36835224" |
|
] |
|
}, |
|
{ |
|
"text": "marriage benefits the diagnosis and prognosis of emc. widowed and unmarried", |
|
"score": 9.912440299987793, |
|
"articlesIDs": [ |
|
"31746633" |
|
] |
|
}, |
|
{ |
|
"text": "estrogen and progesterone receptor expression", |
|
"score": 9.907745361328125, |
|
"articlesIDs": [ |
|
"33232359" |
|
] |
|
}, |
|
{ |
|
"text": "endometrial cancer, the first year after diagnosis", |
|
"score": 9.906778335571289, |
|
"articlesIDs": [ |
|
"31761945" |
|
] |
|
}, |
|
{ |
|
"text": "performing sh during sc", |
|
"score": 9.901466369628906, |
|
"articlesIDs": [ |
|
"33867213" |
|
] |
|
}, |
|
{ |
|
"text": "patients with a vte", |
|
"score": 9.901166915893555, |
|
"articlesIDs": [ |
|
"32905281" |
|
] |
|
}, |
|
{ |
|
"text": "leptin, crp, fasting insulin, and estradiol", |
|
"score": 9.885817527770996, |
|
"articlesIDs": [ |
|
"35048536" |
|
] |
|
}, |
|
{ |
|
"text": "tumor size 25 mm or greater", |
|
"score": 9.879765510559082, |
|
"articlesIDs": [ |
|
"29489475" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal state, obesity, diabetes", |
|
"score": 9.872279167175293, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "long-term use (\u003e20 years; hr = 1.12, 95% ci: 0.96-1.31; p-for-trend = 0.14)", |
|
"score": 9.861224174499512, |
|
"articlesIDs": [ |
|
"33433939" |
|
] |
|
}, |
|
{ |
|
"text": "patients with cervical and endometrial cancer an advanced stage of cancer", |
|
"score": 9.859485626220703, |
|
"articlesIDs": [ |
|
"31759190" |
|
] |
|
}, |
|
{ |
|
"text": "human papilloma virus infection and obesity", |
|
"score": 9.856239318847656, |
|
"articlesIDs": [ |
|
"34756291" |
|
] |
|
}, |
|
{ |
|
"text": "age, postmenopausal state, obesity, diabetes", |
|
"score": 9.850866317749023, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "patients undergoing surgery in the first or second week postdiagnosis", |
|
"score": 9.8475980758667, |
|
"articlesIDs": [ |
|
"27939327" |
|
] |
|
}, |
|
{ |
|
"text": "among women with high grade endometrioid", |
|
"score": 9.84223747253418, |
|
"articlesIDs": [ |
|
"30718311" |
|
] |
|
}, |
|
{ |
|
"text": "age, menopausal status, and diabetes status of patients", |
|
"score": 9.837023735046387, |
|
"articlesIDs": [ |
|
"36981043" |
|
] |
|
}, |
|
{ |
|
"text": "women with dm2", |
|
"score": 9.830183029174805, |
|
"articlesIDs": [ |
|
"31681146" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of preoperative pelvic pain", |
|
"score": 9.82049560546875, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "pcos, and uterine fibroids", |
|
"score": 9.815959930419922, |
|
"articlesIDs": [ |
|
"34268601" |
|
] |
|
}, |
|
{ |
|
"text": "the combination of general and central obesity", |
|
"score": 9.808877944946289, |
|
"articlesIDs": [ |
|
"33381801" |
|
] |
|
}, |
|
{ |
|
"text": "lymph and vascular space invasion", |
|
"score": 9.797971725463867, |
|
"articlesIDs": [ |
|
"29541859" |
|
] |
|
}, |
|
{ |
|
"text": "the metabolic syndrome, in particular central adiposity", |
|
"score": 9.792769432067871, |
|
"articlesIDs": [ |
|
"32600790" |
|
] |
|
}, |
|
{ |
|
"text": "pedigrees tested for breast cancer risk", |
|
"score": 9.790231704711914, |
|
"articlesIDs": [ |
|
"31296927" |
|
] |
|
}, |
|
{ |
|
"text": "cereal fiber", |
|
"score": 9.789945602416992, |
|
"articlesIDs": [ |
|
"30037138" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic lymph node involvement by imaging, and a ca-125 value \u003e21.5 u/ml", |
|
"score": 9.786758422851562, |
|
"articlesIDs": [ |
|
"28226030" |
|
] |
|
}, |
|
{ |
|
"text": "for women consuming 10 + g total nuts/day", |
|
"score": 9.777918815612793, |
|
"articlesIDs": [ |
|
"31601449" |
|
] |
|
}, |
|
{ |
|
"text": "blood type o was the most prevalent abo blood type", |
|
"score": 9.771047592163086, |
|
"articlesIDs": [ |
|
"36606697" |
|
] |
|
}, |
|
{ |
|
"text": "with reduced gfr. patients with mild-to-moderate ckd", |
|
"score": 9.769166946411133, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "both exposures in nulliparous", |
|
"score": 9.763898849487305, |
|
"articlesIDs": [ |
|
"28108444" |
|
] |
|
}, |
|
{ |
|
"text": "lower bmi (p=0.032), a higher prevalence of preoperative pelvic pain", |
|
"score": 9.761800765991211, |
|
"articlesIDs": [ |
|
"32817584" |
|
] |
|
}, |
|
{ |
|
"text": "increasing levels of total coffee, caffeinated coffee and/or caffeine", |
|
"score": 9.75637435913086, |
|
"articlesIDs": [ |
|
"30075330" |
|
] |
|
}, |
|
{ |
|
"text": "dietary total carbohydrate intake, gi and gl", |
|
"score": 9.755362510681152, |
|
"articlesIDs": [ |
|
"31477367" |
|
] |
|
}, |
|
{ |
|
"text": "mmrd", |
|
"score": 9.750844955444336, |
|
"articlesIDs": [ |
|
"32294063" |
|
] |
|
}, |
|
{ |
|
"text": "dietary fiber intake", |
|
"score": 9.741079330444336, |
|
"articlesIDs": [ |
|
"31584301" |
|
] |
|
}, |
|
{ |
|
"text": "patients with large myomas", |
|
"score": 9.739258766174316, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "histological grading (g1-g3)", |
|
"score": 9.734871864318848, |
|
"articlesIDs": [ |
|
"33184824" |
|
] |
|
}, |
|
{ |
|
"text": "undifferentiated nonendometrioid tumors", |
|
"score": 9.731002807617188, |
|
"articlesIDs": [ |
|
"29541859" |
|
] |
|
}, |
|
{ |
|
"text": "low literacy (or = 1.943, = 0.042), postoperative pain", |
|
"score": 9.730865478515625, |
|
"articlesIDs": [ |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "rare variants near the imprinted genes mkrn3 and dlk1", |
|
"score": 9.729201316833496, |
|
"articlesIDs": [ |
|
"28436984" |
|
] |
|
}, |
|
{ |
|
"text": "ii/il", |
|
"score": 9.726116180419922, |
|
"articlesIDs": [ |
|
"33745582" |
|
] |
|
}, |
|
{ |
|
"text": "family history of liver", |
|
"score": 9.723318099975586, |
|
"articlesIDs": [ |
|
"37243749" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal state, obesity, diabetes, and increased estrogen exposure", |
|
"score": 9.722536087036133, |
|
"articlesIDs": [ |
|
"36626395" |
|
] |
|
}, |
|
{ |
|
"text": "pcos is characterised by menstrual disorders", |
|
"score": 9.722201347351074, |
|
"articlesIDs": [ |
|
"31485206" |
|
] |
|
}, |
|
{ |
|
"text": "patients with type 2 disease were older (p \u003c 0.001), less obese", |
|
"score": 9.714341163635254, |
|
"articlesIDs": [ |
|
"30602164" |
|
] |
|
}, |
|
{ |
|
"text": "1 sd increase in bmi", |
|
"score": 9.709526062011719, |
|
"articlesIDs": [ |
|
"32338769" |
|
] |
|
}, |
|
{ |
|
"text": "ever- versus never-use of therapies other than mht for menopausal symptoms", |
|
"score": 9.700730323791504, |
|
"articlesIDs": [ |
|
"34379634" |
|
] |
|
}, |
|
{ |
|
"text": "women with ovarian endometriosis and especially for endometrioid", |
|
"score": 9.694862365722656, |
|
"articlesIDs": [ |
|
"29742675" |
|
] |
|
}, |
|
{ |
|
"text": "family history of any cancer", |
|
"score": 9.69484806060791, |
|
"articlesIDs": [ |
|
"30485707" |
|
] |
|
}, |
|
{ |
|
"text": "higher leptin level ( = 0.042) and l/a ratio", |
|
"score": 9.692798614501953, |
|
"articlesIDs": [ |
|
"36815556" |
|
] |
|
}, |
|
{ |
|
"text": "low pa levels", |
|
"score": 9.691428184509277, |
|
"articlesIDs": [ |
|
"28108996" |
|
] |
|
}, |
|
{ |
|
"text": "gut microbiome dysbiosis", |
|
"score": 9.6912260055542, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "age and extensive lvsi", |
|
"score": 9.689708709716797, |
|
"articlesIDs": [ |
|
"28359690" |
|
] |
|
}, |
|
{ |
|
"text": "hereditary breast and ovarian cancer syndrome and lynch syndrome", |
|
"score": 9.687018394470215, |
|
"articlesIDs": [ |
|
"31355450" |
|
] |
|
}, |
|
{ |
|
"text": "combined liver disease", |
|
"score": 9.683248519897461, |
|
"articlesIDs": [ |
|
"31518506" |
|
] |
|
}, |
|
{ |
|
"text": "younger patients with pcos", |
|
"score": 9.681764602661133, |
|
"articlesIDs": [ |
|
"34872233" |
|
] |
|
}, |
|
{ |
|
"text": "higher body mass index (bmi) (rr 0.65, 95% ci: 0.54-0.79), never smokers", |
|
"score": 9.671819686889648, |
|
"articlesIDs": [ |
|
"35048465" |
|
] |
|
}, |
|
{ |
|
"text": "the highest dose-responses per each 65 g increases in total red meat intake", |
|
"score": 9.659852027893066, |
|
"articlesIDs": [ |
|
"28792013" |
|
] |
|
}, |
|
{ |
|
"text": "in postmenopausal women, later age at menopause", |
|
"score": 9.648717880249023, |
|
"articlesIDs": [ |
|
"35462044" |
|
] |
|
}, |
|
{ |
|
"text": "breast cancer (bc)", |
|
"score": 9.646581649780273, |
|
"articlesIDs": [ |
|
"29019328" |
|
] |
|
}, |
|
{ |
|
"text": "\u003e 50% myometrial invasion, undifferentiated nonendometrioid tumors", |
|
"score": 9.639915466308594, |
|
"articlesIDs": [ |
|
"29541859" |
|
] |
|
}, |
|
{ |
|
"text": "adenomyosis, gonadotropin-releasing hormone agonist use", |
|
"score": 9.631813049316406, |
|
"articlesIDs": [ |
|
"36158298" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic signature of bmi", |
|
"score": 9.629364967346191, |
|
"articlesIDs": [ |
|
"33926456" |
|
] |
|
}, |
|
{ |
|
"text": "patients diagnosed with breast, prostate, or bladder cancer", |
|
"score": 9.625251770019531, |
|
"articlesIDs": [ |
|
"31761945" |
|
] |
|
}, |
|
{ |
|
"text": "high dietary gi but not gl was", |
|
"score": 9.610973358154297, |
|
"articlesIDs": [ |
|
"27986350" |
|
] |
|
}, |
|
{ |
|
"text": "jewish patients", |
|
"score": 9.608964920043945, |
|
"articlesIDs": [ |
|
"29742279" |
|
] |
|
}, |
|
{ |
|
"text": "insulin resistance, and genetic risk", |
|
"score": 9.608448028564453, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "diabetics", |
|
"score": 9.603487014770508, |
|
"articlesIDs": [ |
|
"32547697" |
|
] |
|
}, |
|
{ |
|
"text": "the tamoxifen use group", |
|
"score": 9.600276947021484, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "history of chemotherapy", |
|
"score": 9.5934419631958, |
|
"articlesIDs": [ |
|
"36540800" |
|
] |
|
}, |
|
{ |
|
"text": "aub_group", |
|
"score": 9.577508926391602, |
|
"articlesIDs": [ |
|
"32349386" |
|
] |
|
}, |
|
{ |
|
"text": "in women with than without endometriosis", |
|
"score": 9.574052810668945, |
|
"articlesIDs": [ |
|
"36357191" |
|
] |
|
}, |
|
{ |
|
"text": "preoperative ah patients", |
|
"score": 9.56467056274414, |
|
"articlesIDs": [ |
|
"35793641" |
|
] |
|
}, |
|
{ |
|
"text": "histological grading (g1-g3), external conjugate, intertrochanteric distance", |
|
"score": 9.562909126281738, |
|
"articlesIDs": [ |
|
"33184824" |
|
] |
|
}, |
|
{ |
|
"text": "figo stage and expression levels of mirna 205", |
|
"score": 9.547856330871582, |
|
"articlesIDs": [ |
|
"37056852" |
|
] |
|
}, |
|
{ |
|
"text": "aub_group and et_group", |
|
"score": 9.546819686889648, |
|
"articlesIDs": [ |
|
"32349386" |
|
] |
|
}, |
|
{ |
|
"text": "for women whose menopausal age over 46.5 years old", |
|
"score": 9.543272018432617, |
|
"articlesIDs": [ |
|
"31275987" |
|
] |
|
}, |
|
{ |
|
"text": "the mpo polymorphism", |
|
"score": 9.540519714355469, |
|
"articlesIDs": [ |
|
"29631687" |
|
] |
|
}, |
|
{ |
|
"text": "high dietary gi/gl with increased risk of some cancers. high dietary gi", |
|
"score": 9.53945541381836, |
|
"articlesIDs": [ |
|
"27986350" |
|
] |
|
}, |
|
{ |
|
"text": "women previously treated with tamoxifen", |
|
"score": 9.525309562683105, |
|
"articlesIDs": [ |
|
"28402678" |
|
] |
|
}, |
|
{ |
|
"text": "women with pcos at reproductive age", |
|
"score": 9.515401840209961, |
|
"articlesIDs": [ |
|
"34288042" |
|
] |
|
}, |
|
{ |
|
"text": "among women with ovarian endometriosis", |
|
"score": 9.496200561523438, |
|
"articlesIDs": [ |
|
"29742675" |
|
] |
|
}, |
|
{ |
|
"text": "the highest versus the lowest age at menopause", |
|
"score": 9.495746612548828, |
|
"articlesIDs": [ |
|
"31275987" |
|
] |
|
}, |
|
{ |
|
"text": "women with ec aged ≥65 years", |
|
"score": 9.491880416870117, |
|
"articlesIDs": [ |
|
"30217355" |
|
] |
|
}, |
|
{ |
|
"text": "among obese patients, those with class i obesity (bmi 30 to 34.9 kg/m)", |
|
"score": 9.483229637145996, |
|
"articlesIDs": [ |
|
"36589506", |
|
"36506038" |
|
] |
|
}, |
|
{ |
|
"text": "women in the third tertile", |
|
"score": 9.482192039489746, |
|
"articlesIDs": [ |
|
"35704044" |
|
] |
|
}, |
|
{ |
|
"text": "first full-term pregnancy", |
|
"score": 9.477840423583984, |
|
"articlesIDs": [ |
|
"33105052" |
|
] |
|
}, |
|
{ |
|
"text": "women with endometrial cancer (ec)", |
|
"score": 9.4771089553833, |
|
"articlesIDs": [ |
|
"34501584" |
|
] |
|
}, |
|
{ |
|
"text": "human epididymis secretory protein e4 (he4)", |
|
"score": 9.476037979125977, |
|
"articlesIDs": [ |
|
"28006994" |
|
] |
|
}, |
|
{ |
|
"text": "pcos cohort", |
|
"score": 9.466625213623047, |
|
"articlesIDs": [ |
|
"30278576" |
|
] |
|
}, |
|
{ |
|
"text": "size of sln metastasis", |
|
"score": 9.460137367248535, |
|
"articlesIDs": [ |
|
"33259650" |
|
] |
|
}, |
|
{ |
|
"text": "age, bmi, and radiation exposure", |
|
"score": 9.45944881439209, |
|
"articlesIDs": [ |
|
"28396018" |
|
] |
|
}, |
|
{ |
|
"text": "mean body mass index (bmi) of ≥30", |
|
"score": 9.447580337524414, |
|
"articlesIDs": [ |
|
"35562051" |
|
] |
|
}, |
|
{ |
|
"text": "first 6 months after cholecystectomy", |
|
"score": 9.436286926269531, |
|
"articlesIDs": [ |
|
"35326635" |
|
] |
|
}, |
|
{ |
|
"text": "the highest dose-responses per 50 g increases in processed meat intake", |
|
"score": 9.429815292358398, |
|
"articlesIDs": [ |
|
"28792013" |
|
] |
|
}, |
|
{ |
|
"text": "subfertility", |
|
"score": 9.427766799926758, |
|
"articlesIDs": [ |
|
"28349511" |
|
] |
|
}, |
|
{ |
|
"text": "women with a menstrual cycle length of 28-30 days", |
|
"score": 9.42530632019043, |
|
"articlesIDs": [ |
|
"29371818" |
|
] |
|
}, |
|
{ |
|
"text": "cancer antigen 125 (ca125)", |
|
"score": 9.423328399658203, |
|
"articlesIDs": [ |
|
"28800309" |
|
] |
|
}, |
|
{ |
|
"text": "bmi ≥40kg/m", |
|
"score": 9.422697067260742, |
|
"articlesIDs": [ |
|
"28947174" |
|
] |
|
}, |
|
{ |
|
"text": "subtotal hysterectomy (sh) for postmenopausal women scheduled for sc for pop", |
|
"score": 9.417035102844238, |
|
"articlesIDs": [ |
|
"33867213" |
|
] |
|
}, |
|
{ |
|
"text": "intentional weight loss in postmenopausal women", |
|
"score": 9.396869659423828, |
|
"articlesIDs": [ |
|
"28165909" |
|
] |
|
}, |
|
{ |
|
"text": "laparoscopically confirmed endometriosis", |
|
"score": 9.39547348022461, |
|
"articlesIDs": [ |
|
"28299512" |
|
] |
|
}, |
|
{ |
|
"text": "early coitarche (30, 60%), or having an abortion", |
|
"score": 9.391707420349121, |
|
"articlesIDs": [ |
|
"31467962" |
|
] |
|
}, |
|
{ |
|
"text": "patients with lynch syndrome", |
|
"score": 9.383005142211914, |
|
"articlesIDs": [ |
|
"28376523", |
|
"32835719" |
|
] |
|
}, |
|
{ |
|
"text": "mismatch repair deficiency (mmrd)", |
|
"score": 9.381704330444336, |
|
"articlesIDs": [ |
|
"32294063" |
|
] |
|
}, |
|
{ |
|
"text": "clear cell, uterine papillary serous carcinoma (upsc)", |
|
"score": 9.37570571899414, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "pelvic floor repair (pfr) for pelvic organ prolapse (pop)", |
|
"score": 9.357536315917969, |
|
"articlesIDs": [ |
|
"37401960" |
|
] |
|
}, |
|
{ |
|
"text": "body mass index ≥40", |
|
"score": 9.357187271118164, |
|
"articlesIDs": [ |
|
"32668563" |
|
] |
|
}, |
|
{ |
|
"text": ", obesity (bmi ≥ 27)", |
|
"score": 9.341353416442871, |
|
"articlesIDs": [ |
|
"35462044" |
|
] |
|
}, |
|
{ |
|
"text": "high-risk uterine factors", |
|
"score": 9.337425231933594, |
|
"articlesIDs": [ |
|
"33232359" |
|
] |
|
}, |
|
{ |
|
"text": "history of fractures, especially of the hip", |
|
"score": 9.334129333496094, |
|
"articlesIDs": [ |
|
"31355356" |
|
] |
|
}, |
|
{ |
|
"text": "polycystic ovary syndrome, type 2 diabetes mellitus", |
|
"score": 9.328758239746094, |
|
"articlesIDs": [ |
|
"29683904", |
|
"29683909" |
|
] |
|
}, |
|
{ |
|
"text": "each 5 μg/ml increase in adiponectin", |
|
"score": 9.325528144836426, |
|
"articlesIDs": [ |
|
"31003933" |
|
] |
|
}, |
|
{ |
|
"text": "high body mass index, or comorbidities", |
|
"score": 9.323994636535645, |
|
"articlesIDs": [ |
|
"32499070" |
|
] |
|
}, |
|
{ |
|
"text": "rs11649743 g", |
|
"score": 9.316143035888672, |
|
"articlesIDs": [ |
|
"30053805" |
|
] |
|
}, |
|
{ |
|
"text": "raised blood pressure, and hyperglycemia", |
|
"score": 9.300000190734863, |
|
"articlesIDs": [ |
|
"35785211" |
|
] |
|
}, |
|
{ |
|
"text": "higher intake of total flavonoids", |
|
"score": 9.298412322998047, |
|
"articlesIDs": [ |
|
"35545772" |
|
] |
|
}, |
|
{ |
|
"text": "butter intake", |
|
"score": 9.276714324951172, |
|
"articlesIDs": [ |
|
"29283380" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic signature of bmi (or 1.50, 95% ci 1.30-1.74), wc", |
|
"score": 9.275029182434082, |
|
"articlesIDs": [ |
|
"33926456" |
|
] |
|
}, |
|
{ |
|
"text": "a mean number of lymph nodes dissected of \u003c21", |
|
"score": 9.270740509033203, |
|
"articlesIDs": [ |
|
"36738486" |
|
] |
|
}, |
|
{ |
|
"text": "hiv", |
|
"score": 9.269954681396484, |
|
"articlesIDs": [ |
|
"32169796" |
|
] |
|
}, |
|
{ |
|
"text": "and later age at first birth (≥30 vs. \u003c20 years", |
|
"score": 9.266714096069336, |
|
"articlesIDs": [ |
|
"28361447" |
|
] |
|
}, |
|
{ |
|
"text": "patients' menopausal status", |
|
"score": 9.260002136230469, |
|
"articlesIDs": [ |
|
"37630795" |
|
] |
|
}, |
|
{ |
|
"text": "synthetic estrogens and progestins", |
|
"score": 9.250720977783203, |
|
"articlesIDs": [ |
|
"33813609" |
|
] |
|
}, |
|
{ |
|
"text": "presence of gc at the preoperative cervical smear", |
|
"score": 9.248798370361328, |
|
"articlesIDs": [ |
|
"31651558" |
|
] |
|
}, |
|
{ |
|
"text": "insulin/igf axis", |
|
"score": 9.248029708862305, |
|
"articlesIDs": [ |
|
"32547697" |
|
] |
|
}, |
|
{ |
|
"text": "obesity and insulin resistance in women with benign endometrium", |
|
"score": 9.240066528320312, |
|
"articlesIDs": [ |
|
"31954096" |
|
] |
|
}, |
|
{ |
|
"text": "unrecognized and inadequately treated cardiovascular risk factors", |
|
"score": 9.237394332885742, |
|
"articlesIDs": [ |
|
"29174567" |
|
] |
|
}, |
|
{ |
|
"text": "anti-mullerian hormone (amh)", |
|
"score": 9.234790802001953, |
|
"articlesIDs": [ |
|
"28873086" |
|
] |
|
}, |
|
{ |
|
"text": "obese women with cancer", |
|
"score": 9.231912612915039, |
|
"articlesIDs": [ |
|
"31954096" |
|
] |
|
}, |
|
{ |
|
"text": "women with a brca pathogenic variant", |
|
"score": 9.222474098205566, |
|
"articlesIDs": [ |
|
"32698099" |
|
] |
|
}, |
|
{ |
|
"text": "frail patients", |
|
"score": 9.217018127441406, |
|
"articlesIDs": [ |
|
"33640158" |
|
] |
|
}, |
|
{ |
|
"text": "patients with abnormal pap smears", |
|
"score": 9.216287612915039, |
|
"articlesIDs": [ |
|
"31554386" |
|
] |
|
}, |
|
{ |
|
"text": "estrogen signaling", |
|
"score": 9.216060638427734, |
|
"articlesIDs": [ |
|
"30712080" |
|
] |
|
}, |
|
{ |
|
"text": "neutrophil to lymphocyte ratio", |
|
"score": 9.208439826965332, |
|
"articlesIDs": [ |
|
"28339318" |
|
] |
|
}, |
|
{ |
|
"text": "ageing women with pcos", |
|
"score": 9.198779106140137, |
|
"articlesIDs": [ |
|
"34288042" |
|
] |
|
}, |
|
{ |
|
"text": "the polycystic ovary syndrome (pcos)", |
|
"score": 9.194862365722656, |
|
"articlesIDs": [ |
|
"32103691" |
|
] |
|
}, |
|
{ |
|
"text": "sleep disturbances", |
|
"score": 9.192562103271484, |
|
"articlesIDs": [ |
|
"36349806" |
|
] |
|
}, |
|
{ |
|
"text": "greater inflammatory potential", |
|
"score": 9.16275405883789, |
|
"articlesIDs": [ |
|
"31823169" |
|
] |
|
}, |
|
{ |
|
"text": "brain-tissue bmi", |
|
"score": 9.160123825073242, |
|
"articlesIDs": [ |
|
"36434155" |
|
] |
|
}, |
|
{ |
|
"text": "radiation therapy (hr: 1.73, 95% ci: 1.29, 2.31), and chemotherapy", |
|
"score": 9.156654357910156, |
|
"articlesIDs": [ |
|
"36526929" |
|
] |
|
}, |
|
{ |
|
"text": "high kaposi-sarcoma-associated-herpesvirus titres", |
|
"score": 9.154918670654297, |
|
"articlesIDs": [ |
|
"32169796" |
|
] |
|
}, |
|
{ |
|
"text": "chronologic age", |
|
"score": 9.151895523071289, |
|
"articlesIDs": [ |
|
"34763940" |
|
] |
|
}, |
|
{ |
|
"text": "genetic risk of lynch syndrome", |
|
"score": 9.144543647766113, |
|
"articlesIDs": [ |
|
"28334914" |
|
] |
|
}, |
|
{ |
|
"text": "high doses or many cycles of clomiphene citrate", |
|
"score": 9.144046783447266, |
|
"articlesIDs": [ |
|
"30536354" |
|
] |
|
}, |
|
{ |
|
"text": "glandular cells (gc)", |
|
"score": 9.140026092529297, |
|
"articlesIDs": [ |
|
"31651558" |
|
] |
|
}, |
|
{ |
|
"text": "advanced stage and high-risk histology", |
|
"score": 9.138528823852539, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "bmi is associated to figo stage and endometrial sampling (es)", |
|
"score": 9.134957313537598, |
|
"articlesIDs": [ |
|
"31508476" |
|
] |
|
}, |
|
{ |
|
"text": "older age, advanced stage and high-risk histology", |
|
"score": 9.125609397888184, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "bilateral oophorectomy vs no oophorectomy", |
|
"score": 9.115120887756348, |
|
"articlesIDs": [ |
|
"34379634" |
|
] |
|
}, |
|
{ |
|
"text": "higher-risk groups", |
|
"score": 9.099695205688477, |
|
"articlesIDs": [ |
|
"33259650" |
|
] |
|
}, |
|
{ |
|
"text": "lvsi-positive tumors and negative lymph nodes", |
|
"score": 9.0936918258667, |
|
"articlesIDs": [ |
|
"31373248" |
|
] |
|
}, |
|
{ |
|
"text": "glomerular filtration rate (gfr)", |
|
"score": 9.091771125793457, |
|
"articlesIDs": [ |
|
"31677054" |
|
] |
|
}, |
|
{ |
|
"text": "advanced stage and high-risk histology-", |
|
"score": 9.068955421447754, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "vh for pop", |
|
"score": 9.067338943481445, |
|
"articlesIDs": [ |
|
"37401960" |
|
] |
|
}, |
|
{ |
|
"text": "women who first reported infertility earlier in life (≤25 years", |
|
"score": 9.06612777709961, |
|
"articlesIDs": [ |
|
"36849034" |
|
] |
|
}, |
|
{ |
|
"text": "having a higher body mass index (bmi) at baseline or age 21 years was", |
|
"score": 9.057575225830078, |
|
"articlesIDs": [ |
|
"33723396" |
|
] |
|
}, |
|
{ |
|
"text": "obesity (bmi≥30", |
|
"score": 9.056989669799805, |
|
"articlesIDs": [ |
|
"29174567" |
|
] |
|
}, |
|
{ |
|
"text": "older age, advanced stage and high-risk histology-", |
|
"score": 9.056035995483398, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "postmenopausal women with asymptomatic endometrial thickening", |
|
"score": 9.051166534423828, |
|
"articlesIDs": [ |
|
"36576124" |
|
] |
|
}, |
|
{ |
|
"text": "smokers (aor= 0.53 95% ci: 0.43 - 0.65; value: \u003c.001), and divorced women", |
|
"score": 9.045469284057617, |
|
"articlesIDs": [ |
|
"36168194" |
|
] |
|
}, |
|
{ |
|
"text": "women with pcos are metabolically obese. pcos", |
|
"score": 9.043606758117676, |
|
"articlesIDs": [ |
|
"31657237" |
|
] |
|
}, |
|
{ |
|
"text": "arg399gln and arg194trp variants", |
|
"score": 9.038500785827637, |
|
"articlesIDs": [ |
|
"28391259" |
|
] |
|
}, |
|
{ |
|
"text": "il.\n\nconclusion:\nwe concluded a weak association between dietary gi/gl", |
|
"score": 9.038444519042969, |
|
"articlesIDs": [ |
|
"33745582" |
|
] |
|
}, |
|
{ |
|
"text": "uterine risk factors (low-, intermediate-, and high-)", |
|
"score": 9.035834312438965, |
|
"articlesIDs": [ |
|
"31912677" |
|
] |
|
}, |
|
{ |
|
"text": "oral contraceptives (oc) (potentially modifiable)", |
|
"score": 9.035638809204102, |
|
"articlesIDs": [ |
|
"32011733" |
|
] |
|
}, |
|
{ |
|
"text": "flavones", |
|
"score": 9.032307624816895, |
|
"articlesIDs": [ |
|
"35545772" |
|
] |
|
}, |
|
{ |
|
"text": "age (or 1.14, 95% ci 1.1-1.2) and bmi", |
|
"score": 9.031063079833984, |
|
"articlesIDs": [ |
|
"31718832" |
|
] |
|
}, |
|
{ |
|
"text": "concentration of cd", |
|
"score": 9.006392478942871, |
|
"articlesIDs": [ |
|
"37237530" |
|
] |
|
}, |
|
{ |
|
"text": "nonendometrioid grade 1 or 2, lymphovascular invasion, and volume index ≥36", |
|
"score": 9.00609016418457, |
|
"articlesIDs": [ |
|
"35746912" |
|
] |
|
}, |
|
{ |
|
"text": "the first 6 months after cholecystectomy", |
|
"score": 8.995361328125, |
|
"articlesIDs": [ |
|
"35326635" |
|
] |
|
}, |
|
{ |
|
"text": "serum levels of he4 and ca125", |
|
"score": 8.984476089477539, |
|
"articlesIDs": [ |
|
"29463191" |
|
] |
|
}, |
|
{ |
|
"text": "metabolic aberrations", |
|
"score": 8.975089073181152, |
|
"articlesIDs": [ |
|
"36647199" |
|
] |
|
}, |
|
{ |
|
"text": "rs11649743 g (or = 1.138, p = 1.08 × 10), rs3760511 c", |
|
"score": 8.97431755065918, |
|
"articlesIDs": [ |
|
"30053805" |
|
] |
|
}, |
|
{ |
|
"text": "women with endometrial cancer had higher proportions of obesity (bmi≥30", |
|
"score": 8.968660354614258, |
|
"articlesIDs": [ |
|
"29174567" |
|
] |
|
}, |
|
{ |
|
"text": "hypertriglyceridemia", |
|
"score": 8.968440055847168, |
|
"articlesIDs": [ |
|
"35785211" |
|
] |
|
}, |
|
{ |
|
"text": "ca125 in involvement of the ovaries", |
|
"score": 8.961048126220703, |
|
"articlesIDs": [ |
|
"28800309" |
|
] |
|
}, |
|
{ |
|
"text": "in women with obesity (body mass index (bmi) \u003e 25)", |
|
"score": 8.931541442871094, |
|
"articlesIDs": [ |
|
"34501584" |
|
] |
|
}, |
|
{ |
|
"text": "in patients with diffuse lvsi", |
|
"score": 8.92175006866455, |
|
"articlesIDs": [ |
|
"33217679" |
|
] |
|
}, |
|
{ |
|
"text": "reproduction, insulin resistance", |
|
"score": 8.906413078308105, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "asian bmi standard for obesity at 25 kg/m2", |
|
"score": 8.903121948242188, |
|
"articlesIDs": [ |
|
"34183566" |
|
] |
|
}, |
|
{ |
|
"text": "hei-2005 and ahei-2010 indices", |
|
"score": 8.891386032104492, |
|
"articlesIDs": [ |
|
"34084748" |
|
] |
|
}, |
|
{ |
|
"text": "abnormal cervical cytology", |
|
"score": 8.890970230102539, |
|
"articlesIDs": [ |
|
"29280216" |
|
] |
|
}, |
|
{ |
|
"text": "age-associated scnas and mutations", |
|
"score": 8.88632583618164, |
|
"articlesIDs": [ |
|
"33879792" |
|
] |
|
}, |
|
{ |
|
"text": "one session of mvpa 5 years pre-interview", |
|
"score": 8.885570526123047, |
|
"articlesIDs": [ |
|
"35040017" |
|
] |
|
}, |
|
{ |
|
"text": "pcos was", |
|
"score": 8.882213592529297, |
|
"articlesIDs": [ |
|
"35686317" |
|
] |
|
}, |
|
{ |
|
"text": "women with high adherence to the md", |
|
"score": 8.879556655883789, |
|
"articlesIDs": [ |
|
"29132343" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, reproduction, insulin resistance", |
|
"score": 8.867240905761719, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "that television watching", |
|
"score": 8.863015174865723, |
|
"articlesIDs": [ |
|
"37148539" |
|
] |
|
}, |
|
{ |
|
"text": "low levels of high-density lipoprotein cholesterol", |
|
"score": 8.860997200012207, |
|
"articlesIDs": [ |
|
"35785211" |
|
] |
|
}, |
|
{ |
|
"text": "patients with hgsc and a family history of cancer", |
|
"score": 8.860204696655273, |
|
"articlesIDs": [ |
|
"31815095" |
|
] |
|
}, |
|
{ |
|
"text": "intrauterine manipulator (ium)", |
|
"score": 8.860164642333984, |
|
"articlesIDs": [ |
|
"29324541" |
|
] |
|
}, |
|
{ |
|
"text": "history of diabetes, hypertension, and never smoking", |
|
"score": 8.85873031616211, |
|
"articlesIDs": [ |
|
"28864924" |
|
] |
|
}, |
|
{ |
|
"text": "higher leptin ( = 0.059) and visfatin ( = 0.003) levels, higher l/a ratio", |
|
"score": 8.85867691040039, |
|
"articlesIDs": [ |
|
"36815556" |
|
] |
|
}, |
|
{ |
|
"text": "women with low pa levels (≤ 4 in a 1-10 degree self reported pa scale)", |
|
"score": 8.858475685119629, |
|
"articlesIDs": [ |
|
"28108996" |
|
] |
|
}, |
|
{ |
|
"text": "women with endometrial cancer exhibited higher concentrations of he4 levels", |
|
"score": 8.847640991210938, |
|
"articlesIDs": [ |
|
"28006994" |
|
] |
|
}, |
|
{ |
|
"text": "women with a higher body mass index (bmi)", |
|
"score": 8.847319602966309, |
|
"articlesIDs": [ |
|
"29283380" |
|
] |
|
}, |
|
{ |
|
"text": "ln-resected stage ii", |
|
"score": 8.832497596740723, |
|
"articlesIDs": [ |
|
"31912677" |
|
] |
|
}, |
|
{ |
|
"text": ", the hogg1 ser326cys polymorphism", |
|
"score": 8.83049201965332, |
|
"articlesIDs": [ |
|
"33210702" |
|
] |
|
}, |
|
{ |
|
"text": "high-risk histology-and three treatment-related variables-no hysterectomy", |
|
"score": 8.821231842041016, |
|
"articlesIDs": [ |
|
"33532843" |
|
] |
|
}, |
|
{ |
|
"text": "myeloperoxidase (mpo)", |
|
"score": 8.803027153015137, |
|
"articlesIDs": [ |
|
"29631687" |
|
] |
|
}, |
|
{ |
|
"text": "early life obesity", |
|
"score": 8.799581527709961, |
|
"articlesIDs": [ |
|
"35908000" |
|
] |
|
}, |
|
{ |
|
"text": ", distinct body shape phenotypes", |
|
"score": 8.788606643676758, |
|
"articlesIDs": [ |
|
"36460776" |
|
] |
|
}, |
|
{ |
|
"text": "women with an endometrial thickness of \u003e4 mm (5.8%; 1.3%-10.3%) and ≤4 mm", |
|
"score": 8.785951614379883, |
|
"articlesIDs": [ |
|
"32268124" |
|
] |
|
}, |
|
{ |
|
"text": "and glucose and insulin", |
|
"score": 8.783763885498047, |
|
"articlesIDs": [ |
|
"29438162" |
|
] |
|
}, |
|
{ |
|
"text": "chemotherapy and hb \u003c 100 g/l in pancreatic", |
|
"score": 8.778145790100098, |
|
"articlesIDs": [ |
|
"32300436" |
|
] |
|
}, |
|
{ |
|
"text": "1 sd increase in bmi, body fat percentage and fat mass", |
|
"score": 8.771965026855469, |
|
"articlesIDs": [ |
|
"32338769" |
|
] |
|
}, |
|
{ |
|
"text": "clear cell (or 1.54, 95% ci 1.22-1.95, p \u003c 0.001) and upsc", |
|
"score": 8.769359588623047, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "new (postdiagnosis only) users", |
|
"score": 8.763298034667969, |
|
"articlesIDs": [ |
|
"29923185" |
|
] |
|
}, |
|
{ |
|
"text": "body shape index (absi)", |
|
"score": 8.74455451965332, |
|
"articlesIDs": [ |
|
"33550945" |
|
] |
|
}, |
|
{ |
|
"text": "mirna-205", |
|
"score": 8.742437362670898, |
|
"articlesIDs": [ |
|
"37056852" |
|
] |
|
}, |
|
{ |
|
"text": "er ( = 0.004), pr", |
|
"score": 8.741543769836426, |
|
"articlesIDs": [ |
|
"35721388" |
|
] |
|
}, |
|
{ |
|
"text": "the presence of lymphovascular invasion (lvi)", |
|
"score": 8.737760543823242, |
|
"articlesIDs": [ |
|
"35216809" |
|
] |
|
}, |
|
{ |
|
"text": "diabetes risk reduction diet (drrd)", |
|
"score": 8.730718612670898, |
|
"articlesIDs": [ |
|
"34444790" |
|
] |
|
}, |
|
{ |
|
"text": "prs19", |
|
"score": 8.707456588745117, |
|
"articlesIDs": [ |
|
"35704044" |
|
] |
|
}, |
|
{ |
|
"text": "3-4 cups/d (∼120 ml/cup)", |
|
"score": 8.705994606018066, |
|
"articlesIDs": [ |
|
"33570108" |
|
] |
|
}, |
|
{ |
|
"text": "bmi and mvpa", |
|
"score": 8.699270248413086, |
|
"articlesIDs": [ |
|
"33185805" |
|
] |
|
}, |
|
{ |
|
"text": "family history and young age of onset", |
|
"score": 8.689858436584473, |
|
"articlesIDs": [ |
|
"29019328" |
|
] |
|
}, |
|
{ |
|
"text": "in postmenopausal or nulliparous women", |
|
"score": 8.6873140335083, |
|
"articlesIDs": [ |
|
"33118172" |
|
] |
|
}, |
|
{ |
|
"text": "reproduction, insulin resistance, and genetic risk", |
|
"score": 8.68560791015625, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "each 10 points increase in the hei-2005 and ahei-2010 indices", |
|
"score": 8.683000564575195, |
|
"articlesIDs": [ |
|
"34084748" |
|
] |
|
}, |
|
{ |
|
"text": "assisted reproduction techniques (art)", |
|
"score": 8.682320594787598, |
|
"articlesIDs": [ |
|
"30536354" |
|
] |
|
}, |
|
{ |
|
"text": ", women with a bmi ≥30 kg/m", |
|
"score": 8.679750442504883, |
|
"articlesIDs": [ |
|
"34223280" |
|
] |
|
}, |
|
{ |
|
"text": "delay in surgical treatment", |
|
"score": 8.676593780517578, |
|
"articlesIDs": [ |
|
"27939327" |
|
] |
|
}, |
|
{ |
|
"text": "brca1 mutation carriers and 390 brca2 mutation carriers", |
|
"score": 8.670797348022461, |
|
"articlesIDs": [ |
|
"28802188" |
|
] |
|
}, |
|
{ |
|
"text": "higher intakes of lcn3pufa were", |
|
"score": 8.660890579223633, |
|
"articlesIDs": [ |
|
"36934308" |
|
] |
|
}, |
|
{ |
|
"text": "women with atypical hyperplasia", |
|
"score": 8.66067886352539, |
|
"articlesIDs": [ |
|
"32343732" |
|
] |
|
}, |
|
{ |
|
"text": "obesity, reproduction, insulin resistance, and genetic risk", |
|
"score": 8.646435737609863, |
|
"articlesIDs": [ |
|
"27965288" |
|
] |
|
}, |
|
{ |
|
"text": "the no tamoxifen use group", |
|
"score": 8.644892692565918, |
|
"articlesIDs": [ |
|
"30969185" |
|
] |
|
}, |
|
{ |
|
"text": "each 5 μg/ml increase in adiponectin and 5 ng/ml increase in leptin", |
|
"score": 8.629055976867676, |
|
"articlesIDs": [ |
|
"31003933" |
|
] |
|
}, |
|
{ |
|
"text": ", men who were overweight and centrally obese", |
|
"score": 8.624774932861328, |
|
"articlesIDs": [ |
|
"33381801" |
|
] |
|
}, |
|
{ |
|
"text": "stress urinary incontinence (sui)", |
|
"score": 8.62452220916748, |
|
"articlesIDs": [ |
|
"29420401" |
|
] |
|
}, |
|
{ |
|
"text": "marital status were attributable to early diagnosis", |
|
"score": 8.616769790649414, |
|
"articlesIDs": [ |
|
"34047792" |
|
] |
|
}, |
|
{ |
|
"text": "european population", |
|
"score": 8.616286277770996, |
|
"articlesIDs": [ |
|
"33210702" |
|
] |
|
}, |
|
{ |
|
"text": ", bmi ≥25 kg/m2", |
|
"score": 8.616168975830078, |
|
"articlesIDs": [ |
|
"34183566" |
|
] |
|
}, |
|
{ |
|
"text": "combined hormonal contraception (chc)", |
|
"score": 8.609018325805664, |
|
"articlesIDs": [ |
|
"35060888" |
|
] |
|
}, |
|
{ |
|
"text": "age, bmi, and type 2 diabetes", |
|
"score": 8.608779907226562, |
|
"articlesIDs": [ |
|
"33232359" |
|
] |
|
}, |
|
{ |
|
"text": "both the menopausal change and obesity", |
|
"score": 8.608558654785156, |
|
"articlesIDs": [ |
|
"34209916" |
|
] |
|
}, |
|
{ |
|
"text": "among current users of estrogen-only", |
|
"score": 8.601812362670898, |
|
"articlesIDs": [ |
|
"29475971" |
|
] |
|
}, |
|
{ |
|
"text": "presence of comorbidities", |
|
"score": 8.600444793701172, |
|
"articlesIDs": [ |
|
"32499070" |
|
] |
|
}, |
|
{ |
|
"text": "mets and endometrial cancer was most prominent in obese women", |
|
"score": 8.598169326782227, |
|
"articlesIDs": [ |
|
"35320886" |
|
] |
|
}, |
|
{ |
|
"text": "ever breastfeeding", |
|
"score": 8.593215942382812, |
|
"articlesIDs": [ |
|
"28486362" |
|
] |
|
} |
|
] |
|
} |